Search Results for Scholarship - Journal:
No. Item
JOURNAL PUBLICATIONS
1. (2010). Utilising the medical literature for market research: Finding new approaches to marketing substance abuse treatment clinics. Journal of Medical Marketing, 10 (4), 344-351.
2. Popovici, I. & French, M.T. (2014). Cannabis Use, Employment, and Income: Fixed-effects Analysis of Panel Data. Journal of Behavioral Health Services & Research , 41 (2), 185-202.
3.16) Trivedi M, Talekar M, Shah P, Ouyang Q, Oka A, Gandham S, Amiji MM (2016). Combination wt-p53 and MicroRNA-125b Transfection in a Genetically-Engineered Lung Cancer Model using Dual CD44/EGFR Targeting Nanoparticles Mol Ther., 24 (4), .
4.24. K Kabiri, S Hesarian, MJ Zohuriaan-Mehr, A Jamshidi, H Bouhendi, MR Pourheravi, SA Hashemi, H Omidian, S Fathollahi (2011). Effect of Long-Chain Monoacrylate on the Residual Monomer Content, Swelling, and Thermo-mechanical Properties of SAP Hydrogels Journal of Polymer Research, 18 (6), 1863-1870.
5.4. Husain K, Ferder L, Ansari, R.A. , Lalla J (2011). Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats Hum Exp Toxicol, 30 (8), 930-939.
6.4. Husain K, Ferder L, Ansari, R.A., Lalla J (2011). Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats Hum Exp Toxicol, 30 (8), 930-939.
7.A Omidian, D Mastropietro, H Omidian (2014). Reported Methods of Abuse for Common Analgesic Opioids, Journal of Developing Drugs, 3 ( 2), .
8.A Omidian, DJ Mastropietro, H Omidian (2015). Routes of Opioid Abuse and its Novel Deterrent Formulations Journal of Developing Dugs, 4 (5), .[website]
9.A Omidian, DJ Mastropietro, H Omidian (2015). Nano-Prevention/Nano-Treatment Source Journal of Pharmaceutical Sciences, 1 (1), 1-4.[website]
10.A. Penn-Nicholson , D.P. Han, S.J. Kim, H. Park, R.A. Ansari, D.C.Montefiori and M.W. Cho (2008). Assessment of antibody response against gp41 in HIV-1 infected patients using soluble gp41 fusion proteins and peptides derived from M group concensus envelope Virology, 372 (2), 442-456.
11.A. Pourjavadi, M.R. Mahdavinia, M.J. Zohuriaan-Mehr, H. Omidian, (2003). Modified Chitosan. 1. Optimized Cerium Ammonium Nitrate-Induced Synthesis of Chitosan-graft-Polyacrylonitrile Journal of Applied Polymer Science, 88 (8), 2048-2054.
12.A. Salimi, H. Omidian, M.J. Zohuriaan-Mehr (2003). Mechanical and Thermal Behavior of Epoxy-Novolak Film Adhesive Journal of Adhesion Science & Technology, 17 (15), 1847-1861.
13.Abbadi A, Alkhateeb FM, Khanfar NM, Mujtaba BG, Latif DA (2009). Pharmacy Students' Perceptions of the Teaching Evaluation Process In Jordan. Education, Business and Society: Contemporary Middle Eastern Issues, 2 (3), 191-190.
14.Absar S., Choi S., Ahsan F., Cobos E., Yang V. C., Kwon Y. M. (2013). Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. Thrombosis Research, 131 (3), e91-99.
15.Absar S., Choi S., Yang V. C., Kwon Y. M. (2012). Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release, 157 (1), 46-54.
16.Absar S., Kwon Y. M, Ahsan F. (2014). Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis. Journal of Controlled Release, 177 (), 42-50.
17.Absar S., Kwon Y. M., Ahsan F. (2014). Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis. Journal of Controlled Release, 177 (), 42-50.
18.Absar S., Nahar K., Choi S., Ahsan F., Yang V. C., Kwon Y. M. (2014). Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules. Journal of Biomedical Materials Research Part A, 102 (8), 2481-90.
19.Absar S., Nahar K., Kwon Y. M., Ahsan F. (2013). Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharmaceutical Research, 30 (6), 1663-76.
20.Akhmedov, N.G., Gannett, P.M., Wu, B., Cummings, M.M., & Train, B. (2013). A Conformational NMR analysis of Methymycin Aglycones: Complete and Unambiguous Assignments of Stereochemically Diverse Glycosylated Methymycin Analogues by 1D and 2D NMR and Molecular Modeling Magnetic Resonance in Chemistry, 51 (), 156-167.
21.Alanazi, A., Patel, P., and Clark, M.A. (2014). P-38 Mitogen Activated Protein Kinase is stimulated by both Angiotensin II and Angiotensin III in cultured rat astrocytes. , Volume 34, pages 205-211, 2014 Journal of Receptors and Signal Transduction, 34 (), 205-211.
22.Alanazi, J.S., and Latimer, J.J. (2020). Host Cell Reactivation: Assay for Actively Transcribed DNA Nucleotide Excision Repair using Luciferase Family Expression Vectors. Methods in Molecular Biology, in press, 2102 (), .[website]
23.Alarfaj, S., Perez, A., Unger, N. (2019). Statin use and the point-prevalence of antibiotics in ambulatory patients with diabetes in the National Health and Nutrition Examination Survey (NHANES) 2003–2012 Antibiotics , 8 (), 64.
24.Alesch K, Bowen J, Khanfar NM (2007). Wall’s Pharmacy: A Management Case. Business Research Yearbook, 14 ( ), 976-983.
25.Alexandre, P.K., I. Beulaygue, M.T. French, K.E. McCollister, I. Popovici, and B.A. Sayed (2012). The Economic Cost of Substance Abuse Treatment in the State of Florida. Evaluation Review , 36 (3), 167-185.
26.Alfieri, A.B., Malave, A. and Cubeddu L.X. (2001). Nitric Oxide Synthase and Cyclophosphamide-Induced Cystitis in Rats Naunyn-Schmiedeberg's Archives of Pharmacology, 363 (3), 353-357.
27.Alkhafaji A, Khanfar NM (2006). Total quality management acceptance and applications in multinational companies: an empirical examination. Business Research Yearbook, 13 ( ), 666-670.
28.Alkhafaji A, Khanfar NM (2006). How do CEOS perceive total quality management and its benefits on a firm’s financial performance? The International Journal of Business and Economics Perspectives, 1 (1), 56-70.
29.Alkhateeb F.M, Unni E., Latif D., Shawaqfeh M.S., and Al-Rousan R.M. (2009). (Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists’ responsibilities in West Virginia.) J Am Pharm Assoc, 49 ( ), 797-800.
30.Alkhateeb FM, Alameddine S, Attarabeen OF, Latif DA, Osolin S. Khanfar NM, Al-Rousan RA (2015). Pharmacy Students' Use of Social Media Sites and Perception toward Facebook Use. Archives of Pharmacy Practice, 6 (4), 77-84.
31.Alkhateeb FM, Clauson KA, Khanfar NM, Latif DA (2008). Legal and Regulatory Risk Associated with Web 2.0 Adoption by Pharmaceutical Companies. Journal of Medical Marketing, 8 (4), 311-318.
32.Alkhateeb FM, Khanfar NM, Clauson KA (2009). Characteristics of physicians who frequently see pharmaceutical sales representatives. Journal of Hospital Marketing & Public Relations, 19 (1), 2-14.
33.Alkhateeb FM, Khanfar NM, Doucette WR, Loudon D (2009). Characteristics of Physicians Who Are Targeted by Pharmaceutical Industry to Participate in E-detailing. Health Marketing Quarterly, 26 (2), 98-116.
34.Alkhateeb FM, Khanfar NM, Loudon D (2010). Physicians’ Adoption of Pharmaceutical E-Detailing: Application of Rogers’ Innovation-Diffusion Model. Services Marketing Quarterly, 31 (1), 116-132.
35.Alkhateeb, F.M., Clauson, K.A., Khanfar, N.M., Latif, D.A. (2008). Legal and regulatory risks associated with Web 2.0 adoption by pharmaceutical companies. Journal of Medical Marketing, 8 (4), 311-318.
36.Alkhateeb, F.M., Clauson, K.A., Latif D.A. (2011). Pharmacists use of social media. International Journal of Pharmacy Practice., 19 (2), 140-142.
37.Alkhateeb, F.M., Clauson, K.A., Latif, D.A. (2012). Availability and perceived value of Masters of Business Administration degree programs in pharmaceutical marketing and management. American Journal of Pharmaceutical Education, 76 (4), Article 64.
38.Alkhateeb, F.M., Clauson, K.A., Latif, D.A., Al-Rousan R.M. (2010). The Foreign Pharmacy Graduate Equivalency Examination (FPGEE): Global educational implications American Journal of Pharmaceutical Education, 74 (5), Article 87.
39.Alkhateeb, F.M., Clauson, K.A., McCafferty, R., Latif, D.A. (2009). Physician attitudes toward pharmacist provision of medication therapy management services. Pharmacy World & Science., 31 (4), 487-93.
40.Alkhateeb, F.M., Khanfar, N.M., Clauson, K.A. (2009). Characteristics of physicians who frequently see pharmaceutical sales representatives. Journal of Hospital Marketing & Public Relations, 19 (1), 2-14.
41.Alkhateeb,F.M., Unni,E., Latif,D., Shawaqfeh M.S, Al-Rousan, R.M.. (2009). Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists’ responsibilities in West Virginia. J Am Pharm Assoc, 49 ( ), 797–800 .
42.Almetwazi, M. S., Noor, A. O., Almasri, D. M., Popovici, I., Alhawassi, T., Alburikan, K. A., & Harrington, C. A. (2017). The association of vitamin D deficiency and glucose control among diabetic patients. Saudi Pharmaceutical Journal , 25 (8), 1179-1183.
43.Almohammed OA, Lai L, Khanfar NM, Bleidt B, Aljadhey H (2019). Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005–2014) Thrombosis research, 185 (), 110-115.
44.Alsharif NZ, Khanfar NM, Brennan LF, Chahine EB, Al-Ghananeem AM, Retallick J, Schaalan M, Serhan N (2019). Cultural Sensitivity in Global Engagement in the Arab World. American Journal of Pharmacy Education, 83 (4), 619-636.[website]
45.Alsharif NZ, Khanfar NM, Chahine EB, Brennan LF, Law M, Parekh J, Kawaguchi-Suzuki M, Hogue MD J (2019). Cultural Sensitivity and Global Pharmacy Engagement in the United States. American Journal of Pharmaceutical Education, 83 (4), 699-715.[website]
46.Althemery, A., Lai, L., Alfaifi, A. (2015). Socioeconomic Factors Associated With Cholesterol Monitoring Among Patients with Hyperlipidemia; Application of The Andersen Behavioral Model. International Journal of Medical and Health Sciences, 4 (2), 275-281.
47.Alvarado Y, Cruz R, Gonzalez J, Perez Y, Wolowich W (2016). Safety of continuous infusion of polymyxin B therapy in critically ill patients[ABSTRACT] Critical Care Medicine, 44 (12), 254.[website]
48.Alvarado Y, Perez A, Rodriguez-Vega G (2017). Effects of vitamin D deficiency in aneurysmal subarachnoid hemorrhage. World Neurosurgery, 97 (), 501-504.[website]
49.Alvarado Y; Perez A, Rodriguez-Vega G (2015). Effects of vitamin D deficiency in aneurysmal subarachnoid hemorrhage.[ABSTRACT] Critical Care Medicine, 43 (12), 138.[website]
50.Alvarado, Y., Silva-Suarez, G. (2018). Assessment of critical care clinical pharmacy services in Puerto Rico. Journal of Pharmaceutical Health Services Research Journal of Pharmaceutical Health Services Research, 9 (4), 403-406.[website]
51.Ana M. Castejon, Anna Alfieri, Irene S. Hoffmann, Appu Rathinavelu, and Luigi X. Cubeddu (2003). Alpha-adducin polymorphism, salt sensitivity, nitric oxide and cardiovascular risk factors in healthy adult Venezuelans. American Journal of Hypertension, 16 (2), 1018-1024.
52.Anastasios Lymperopoulos, Michelle Clark, Jennifer Maning, Shmuel Negussie (). Biased agonism/antagonism at the AT1 receptor: Implications for adrenal aldosterone production and hypertension therapy Pharmacological Research, (), doi: 10.1016/j.phrs..
53.Anastasios Lymperopoulos, Michelle Clark, Jennifer Maning, Shmuel Negussie Biased agonism/antagonism at the AT1 receptor: Implications for adrenal aldosterone production and hypertension therapy. (2017). Biased agonism/antagonism at the AT1 receptor: Implications for adrenal aldosterone production and hypertension therapy. Pharmacological Research, (), doi: 10.1016/j.phrs..
54.Anderson, R.A., Joyce, C., Davis, M., Reagan, J., Clark, M., Shelness, G. and Rudel, L. (1998). Two Forms of Acyl CoA: Cholesterol acyltransferase Address Different Intracellular Compartments in Primate Liver. Journal of Biological Chemistry, 273 (), 26747-26754.
55.Anderson, R.A., Joyce, C., Davis, M., Reagan, J., Clark, MA, Shelness, G., and Lawrence, R. (1998). Two Forms of Acyl CoA: Cholesterol acyltransferase Address Different Intracellular Compartments in Primate Liver. J. Biol. Chem. , 273 (), 26747-26754.
56.Ansari, R.A (2012). Role of angiotensin peptides precursor in Ethanol mediated Hepatotoxicity: perspective on angiotensinogen The Open Gastroenterology Journal , 6 ( ), 16-24.
57.Ansari, R.A., Husain, K., and Rizvi, S.A.A. (2016). Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of Metabolism biomolecules, 6 (29), 1-15.
58.Ansari, R.A., Rizvi, S.A., Husain, K., Lymperopoulos, A., Berndt, W.O. (2012). Effect of sulfhydryl modification on rat kidney basolateral plasma membrane transport function. Bulletin of Environmental and Contamination Toxicology, 89 ( ), 699-703 .
59.Ansari, R.A., Syed A. A. Rizvi, Kazim Husain and Natalia Osna (2012). Role of angiotensin peptides precursor in Ethanol mediated Hepatotoxicity: perspective on angiotensinogen The Open Gastroenterology Journal , 6 ( ), 16-24.
60.Ansari, R.A., Syed A. A. Rizvi, Kazim Husain, Anastasios Lymperopoulos and William O Berndt (2012). Effect of sulfhydryl modification on rat kidney basolateral plasma membrane transport function Bulletin of Environmental Contamination and Toxicology, 89 (4), 699-703.
61.Antommattei O, Khanfar NM, Mujtaba BG (2009). Global Abortion and Marketing Challenges for Misoprostol (Cytotec): The Future of Women’s Health. International Business & Economics Research Journal., 8 (1), 105-112.
62.Appu Rathinavelu (2012). Bromelain-Induced Apoptosis in GI-101A Breast Cancer Cells Journal of Medicinal Food, 15 (4), 344 - 349.
63.Appu Rathinavelu, Arkene Levy, Dhandayuthapani Sivanesan, Rajeswari Murugan, Jackie Jornadal, Yanira Quinonez, Mark Jaffe, Monique Reboe (2014). Urtica Dioica Induces Cytotoxicity in Human Prostate Carcinoma LNCaP Cells: Involvement of Oxidative Stress, Mitochondrial Depolarization and Apoptosis Tropical Journal of Pharmaceutical Research, 13 (5), 711-717.
64.Appu Rathinavelu, Levy A, Sivanesan D, Murugan R, Jornadal J, Quinonez Y, Jaffe M, Gossell-Williams M, (2013). Cytotoxic effects of Pumpkin (Curcurbita pepo) Seed Extracts in LNCaP Prostate Cancer Cells is mediated through Oxidative Stress, Mitochondrial Depolarization and PARP Cleavage, Current Topics in Naturaceutical Research, 11 (), 137-144.
65.Appu Rathinavelu, Madhusudhanan Narasimhan and Praneetha Muthumani (2012). A novel regulation of VEGF expression by HIF-1alpha and STAT3 in HDM2 transfected prostate cancer cells Journal of Cellular and Molecular Medicine J. Cellular and Molecular Medicine, 16 (8), 1750 - 1757.
66.Appu Rathinavelu, Nagarajan Pattabiraman, Sivanesan Dakshanamurthy (2008). Specific Inhibitors for Vascular Endothelial Growth Factor Receptors. United States Patents Office Publication, ( ), 20080139585.
67.Appu Rathinavelu, Sivanesan Dhandayuthapani and Thanigaivelan Kanagasabai (2015). The anti-angiogenic and pro-apoptotic effects of a small molecule JFD-WS in breast cancer xenograft-mouse model Journal of Anticancer Research , (Submitted), .
68.Arce, L. (2005). La ensenanza de la Atencion Farmaceutica en pregrado: La experiencia de un una universidad de los EEUU de America. Teaching Pharmaceutical Care at a Traditional Program: The experience of one University in USA. Ciencia e Investigacion Facultad de Farmacia y Bioquimica UNMSM(Universidad Nacional Mayor de San Marcos) (ISSN 1561-0861), VIII (1), 59-61.
69.Armbrister, A., Vidal, A., James, S., Nunez Chiang, C., Steinberg, J., Perez, A. (2019). Clopidogrel safety communication impact on histamine-2 receptor antagonist and proton-pump inhibitor use trends. Journal of Pharmaceutical Health Services Research , (), .
70.Arneson D, Assa M, Marsh W (2001). Florida pharmacist salary & workload report, part 2: Workload & benefits Florida Pharmacy Today, 65 (11), 16-17.
71.Arneson D.L., Daniel, K.L. (2003). Survey of remedial policies in US Colleges/Schools of Pharmacy. American Journal of Pharmaceutical Education, 67 (3), 3.
72.Assa M, Marsh W, Arneson D (2001). Florida pharmacist salary & workload report, part 1: Salary Florida Pharmacy Today, 65 (10), 19-21.
73.Ayala-Rivera, K (2010). VIH/SIDA y Antirretrovirales Revista Farmacia de Comunidad Industria Farmaceutica de Puerto Rico, 3 (7), .
74.B. Goldstein, M. Trivedi, R.C. Speth (2017). Alterations in Gene Expression of Components of the Renin-Angiotensin System and Its Related Enzymes in Lung Cancer Lung Cancer International, 2017 (), .[website]
75.B. Goldstein, R.C. Speth, M. Trivedi (2016). Renin–angiotensin system gene expression and neurodegenerative diseases. J Renin Angiotensin Aldosterone Syst, 17 (3), .[website]
76.Bailin, A., Lai, L. (2001). Are Pharmacists In Mail Order Pharmacy Performing Pharmaceutical Care?. Journal of Managed Pharmaceutical Care, 1 (3), 61-69.
77.Balachandran, R., Grant, S.G., Welsh, M.J., & Day, B.W. (2000). Z-1,1-dichloro-2,3-diphenylcyclopropanes block human prostate carcinoma cell proliferation, inhibit prostate-specific antigen expression, and initiate apoptosis. The Prostate, 45 (4), 277-288.
78.Balachandran, R., Grant, S.G., Welsh, M.J., & Day, B.W. (1998). Increased sensitivity of the antiestrogen-resistant MCF7/LY2 human breast carcinoma cell line to apoptosis induced by the novel microtubule-stabilizing agent (+)-discodermolide. The Breast Journal, 4 (6), 409-419.
79.Balachandran, R., ter Haar, E., Welsh, M.J., Grant, S.G., & Day, B.W. (1998). The potent microtubule-stabilizing agent (+)-discodermolide induces apoptosis in human breast carcinoma cells—preliminary comparisons to paclitaxel. Anti-Cancer Drugs, 9 (1), 67-76.
80.Balachandran, R., ter Haar, E., Yalowich, J.C., Welsh, M.J., Grant, S.G., & Day, B.W. (1999). Induction of human breast cancer cell apoptosis from G2/M preceded by stimulation into the cell cycle by Z-1,1-dichloro-2,3-diphenylcyclopropane. Biochemical Pharmacology, 57 (1), 97-110.
81.Baldwin, H.J., Droege, M., Daniel, K.L. (2006). A message from the Vioxx® case American Journal of Health-System Pharmacy, 63 (March), 503.
82.Ballard. S.L., Wellborn-Kim, J.J., Clauson, K.A. (2010). Effect of commercial energy drink consumption on exercise performance and body composition. The Physician and Sports Medicine, 38 (1), 107-117.
83.Barlows III TG, Deitz MD, Egol AB (1998). Use of Erythropoietin following Emergent Surgery in a Jehovah Witness. Journal of Pharmacy Practice, 10 (1), 72-5.
84.Barlows III TG, Luber AD, Jacobs RA (1996). Hypothermia Related to Intravenous Administration of Amphotericin B. Clinical Infectious Diseases, 23 (), 1187-8.
85.Barlows III, T.G., Machado, C., Trimino, E., Salado, C. (2002). Evaluation of Reteplase for the Management of Acute Myocardial Infarction: Door-to-Drug Time and Safety Hospital Pharmacy, 37 (6), 610-614.
86.Barlows TG, Luque CA, Bernstein-Solomon BJ, Menendez LB. (2004). Evaluation of Once Daily Aminoglycoside Use in the Elderly Hospital Pharmacy, 39 (3), 238-242.
87.Barlows TG, Luque CA, Bernstein-Solomon BJ, Price VS, and Blanchard LM. (2004). Evaluation of once- daily-aminoglycoside (ODA) use in the elderly. Hospital Pharmacy, 39 (3), 238-242.
88.Basanez R, Caballero J (2012). Herbal supplements in the treatment of Alzheimer’s disease. Geriatric Education Center Channel (non-peer reviewed), 5 (1), .
89.Bathgate-Siryk, A., Dabul, S., Pandya, K., Walklett, K., Rengo, G., Gao, E., Leosco, D., Koch, W.J., Lymperopoulos, A. (2014). Negative Impact of beta-Arrestin-1 on Post-Myocardial Infarction Heart Failure via Cardiac and Adrenal-Dependent Neurohormonal Mechanisms. Hypertension, 63 (), 404-412.
90.Bello C, Garrett S (1999). Therapeutic issues in oral corticosteroid use. U.S. Pharmacist, 24 (8), HS27-38.
91.Bello C, Garrett S (1999). Therapeutic issues in oral corticosteroid use. Lippincott's Primary Care Practice, 3 (3), 333-341.
92.Bello C, Metzner M (1999). Celecoxib: a highly selective non-steroidal anti-inflammatory drug. The Florida Journal of Health-System Pharmacy, 17 (3), 7-8.
93.Benavides S (2001). Patient-controlled analgesia. Discourse Newsletter, UCSD Medical Center (Non peer-reviewed), 23 (5), 3.
94.Benavides S (2000). Neuraminidase inhibitors. Discourse Newsletter, UCSD Medical Center (Non peer-reviewed), 22 (2), 6-7.
95.Benavides S (2001). Drug interactions with alternatives therapies. Discourse Newsletter, UCSD Medical Center (Non peer-reviewed), 23 (3), 9-13.
96.Benavides S, Borja-Hart NL, Maniscalco-Feichtl M (2011). Implementation and faculty assessment of an oral examination in a therapeutics course in a distance synchronous education pharmacy programme. International Journal of Pharmacy Practice, 19 (6), 438-443.[website]
97.Benavides S, Caballero J (2009). Ashtanga yoga for children and adolescents for weight management and psychological well being: An uncontrolled open pilot study. Complementary Therapies in Clinical Practice, 15 (2), 110-114.[website]
98.Benavides S, Garcia AS, Caballero J, Wolowich W (2010). In reply to: Determining student-faculty ratios and faculty scholarship levels/rates. American Journal of Pharmaceutical Education, 74 (10), Article 193.
99.Benavides S, Garcia AS, Caballero J, Wolowich WR (2010). The impact of student-faculty ratio on pharmacy faculty scholarship. American Journal of Pharmaceutical Education, 74 (8), Article 138.[website]
100.Benavides S, Huynh D, Morgan J, Briars L (2011). Approach to the pediatric prescription in a community pharmacy. Journal of Pediatric Pharmacy and Therapeutics, 16 (4), 298-307.[website]
101.Benavides S, Kohler L, Souffrant G (2011). A clinical pharmacist's role in screening for metabolic syndrome in a rural pediatric ambulatory clinic. Journal of Rural Health, 27 (2), 184-189.[website]
102.Benavides S, Nahata MC (2002). Anthrax: Safe treatement for children. Annals of Pharmacotherapy, 36 (2), 334-337.[website]
103.Benavides S, Nahata MC (2004). Pharmacological therapy for HIV-associated lipodystrophy. Annals of Pharmacotherapy, 38 (3), 448-457.[website]
104.Benavides S, Nicol K, Koranyi K, Nahata MC (2003). Yersinia septic shock following an autologous transfusion in a pediatric patient. Transfusion and Apheresis Sciences, 28 (1), 19-23.[website]
105.Benavides S, Polen HH, Goncz CE, Clauson KA (2011). A systematic evaluation of paediatric medicines information content in clinical support tools on smartphones and mobile devices. Informatics in Primary Care, 19 (1), 39-46.[website]
106.Benavides S, Rambaran KA. (2013). Pharmacy technicians: Expanding role with uniform expectations, education and limits in scope of practice. J Res Pharm Pract, 2 (4), 135-137.[website]
107.Benavides S, Rodriguez JC, Maniscalco M (2009). Review of pharmacist involvement in improving asthma outcomes in various health care settings: 1997 to Present. Annals of Pharmacotherapy, 43 (1), 85-70.[website]
108.Benavides S, Streit J, Germak J, Nahata MC (2005). Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus. Pharmacotherapy, 25 (6), 803-809.[website]
109.Benavides S. (2014). The top 10 things every clinician should know about the 2013 Obesity Guidelines. iForumRx: The Evidence that Informs Ambulatory Care Pharmacy Practice, (), .[website]
110.Bensimon L, & Hale G (2017). Acclimating to the increase in statin use in accountable care organizations based on changes in quality measures: a report from the Accountable Care Organization Research Network, Services and Education. Journal of Managed Care and Specialty Pharmacy, 23 (9), 943-944.[website]
111.Bernasek C, Harrington C, Ramchand R et al (2002). Florida's Medicaid Prescription Drug Benefit: A Case Study Kaiser Commission on Medicaid and the Uninsured, Feb (), .
112.Bernstein, B. J Troner M (1999). Successful rechallenge with etoposide phosphate following acute hypersensitivity reaction to etoposide. Pharmacotherapy, 19 (8), 989-991.
113.Bernstein, B. J. (2000). Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions. The Annals of Pharmacotherapy, 34 (11), 1332-1335.
114.Bernstein, B. J. Blanchard L. M. (1999). Economic and clinical impact of implementing a pharmacy based filgrastim protocol in oncology patients. Am J Health-Syst Pharm, 56 (), 1330-3.
115.Bernstein, BJ, Grasso T. (2001). Prevalence of Complementary and Alternative Medicine Use in Cancer Patients Oncology, 15 (10), 1267-1272.
116.Bigbee, W.L., & Grant, S.G. (1994). Use of allele-specific glycophorin A antibodies to enumerate fetal erythroid cells in maternal circulation. Annals of the New York Academy of Sciences, 731 ( ), 128-132.
117.Bigbee, W.L., Day, R.D., Grant, S.G., Keohavong, P., Xi, L., Zhang, L., & Ness, R.B. (1999). Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum—Initial results from the Prenatal Exposures and Preeclampsia Prevention (PEPP) study. Mutation Research, 431 (2), 279-289.
118.Bigbee, W.L., Fuscoe, J.C., Grant, S.G., Jones, I.M., Gorvad, A.E., Harrington-Brock, K., Strout, C.L., Thomas, C.B., & Moore, M.M. (1998). Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies. Mutation Research, 397 (2), 119-136.
119.Bigbee, W.L., Grant, S.G., Langlois, R.G., Jensen, R.H., Anttila, A., Pfäffli, P., Pekari. K., & Norppa, H. (1996). Glycophorin A somatic cell mutation frequencies in Finnish reinforced plastics workers exposed to styrene. Cancer Epidemiology, Biomarkers and Prevention, 5 (10), 801-810.
120.Binsaleh, A., Perez, A., Popovici. I., Rabionet, S. (2018). Impact of antidepressant use on healthcare utilization among individuals with type 2 diabetes and depression symptoms in the US: Sociodemographic, clinical, and behavioral factor matter. International Journal of Environmental Research and Public Health, 15 (9), 1904.
121.Binsaleh, A.Y., A. Perez, I. Popovici, S.E. Rabionet (2018). Impact of antidepressants use on healthcare utilization among individuals with type 2 diabetes and depression symptoms in the US: Sociodemographic, clinical, and behavioral factors matter. International Journal of Environmental Research and Public Health, 15 (9), .
122.Bishayee A, Darvesh A, Politis T & McGory R (2010). Resveratrol and Liver Disease: From Bench to Bedside and Community. Liver Int, 30 (8), 1103-1114.
123.Blizzard S, Verbosky N, Stein BJ, Hale G, Patel NR, Chau YN, Cave B (2019). Evaluation of pharmacist impact within an interdisciplinary inpatient heart failure consult service. Annals of Pharmacotherapy, 53 (9), 905-915.[website]
124.Borja N, Daniel K (2007). Insulin Inhalation Powder (Exubera) for Diabetes Mellitus American Family Physician, 75 (10), 1546-1548.
125.Borja NL, Daniel K (2006). Ramelteon in the Treatment of Insomnia Clinical Therapeutics, 28 (10), 1540-1555.
126.Borja, N.L., Daniel K.L. (2007). Insulin Inhalation Powder. American Family Physician, 75 (10), 1546-1548.
127.Borja-Hart N, Garcia AS, Anderson-Worts P (2010). In reply to: Education plays a major role in a medical mission. Journal of American Pharmacists Association, 50 (3), 336-337.
128.Borja-Hart NL, Benavides S, Christensen C (2009). Human papillomavirus vaccine safety in pediatric patients: An evaluation of the vaccine adverse event reporting system. Annals of Pharmacotherapy, 43 (2), 356-359.[website]
129.Borja-Hart NL, Garcia A, Anderson-Worts P (2010). Education plays a major role in a medical mission Journal of the American Pharmacists Assocation, 50 (3), 336-337.
130.Borja-Hart NL, Marino J (2010). Role of Omega-3 fatty acids for prevention or treatment of perinatal depression Pharmacotherapy, 30 (2), 210-216.
131.Borja-Hart NL, Whalen KL (2010). Saxagliptin: A New Dipeptidyl Peptidase 4 Inhibitor for Type 2 Diabetes The Annals of Pharmacotherapy, 44 ( ), 1046-1053..
132.Borowitz, J.L., Rathinavelu, A., Kanthasamy, A. and Isom, G.E. (1994). Accumulation of Labeled Cyanide in Neuronal Tissue. Toxicol. Appl. Pharmcol., 129 (), 80-85.
133.Bostick C.D., Hickey, K.M., Wollenberg L.A., Flora, D.R., Tracy T.S., & Gannett P.M. (2016). Immobilized Cytochrome P450 for monitoring of P450-P450 Interactions and Metabolism. Drug Metab. Disp, 44 (), 741-749.
134.Bostick, C.D., Flora, D.R., Gannett, P.M., Tracy, T.S., & Lederman, D. (2015). Nanoscale Electron Transport Measurements of Immobilized Cytochrome P450 Proteins. Nanotechnology, 26 (), 155102.[website]
135.Boylan P, Joseph T, Hale G, Moreau, C., Seamon MJ, & Jones, R.S. (2018). Chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. The Consultant Pharmacist, 33 (3), 152-158.[website]
136.Brahm N, Caballero J, Dorson P, et al. (2010). References supporting the value of a psychiatric pharmacist. Clinical Psychiatric and Neurological Pharmacists: Shared Resources (non-peer reviewed), ( ), .[website]
137.Brown, L.M., Schommer, J.C., Mott, D.A., Gaither, C.A., Doucette, W.R., Zgarrick, D.P., Droege, M. (2006). Brown, L.M., Schommer, J.C., Mott, D.A., Gaither, C.A., Doucette, W.R., Zgarrick, D.P., Droege, M. (2006) Examining Gender Salary Disparities: An Analysis of the 2003 Multi-State Salary Survey Research in Social and Administrative Pharmacy, 2 (3), 370-387.
138.Bullock J, Rizvi S, Saleh A, Ahmed S, Do D, Ansari, R. A., Ahmed J (2018). Rheumatoid Arthritis: A Brief Overview of the Treatment. Medical Principles and Practice. , 9 (), 1-7.
139.Burdsal, C.A., Pedersen, R.A., Hyun, W.C., and Latimer, J.J. (1995). Novel flow-cytometric method for separating cell types in differentiated F9 embryoid bodies. Cytometry, 21 ( ), 145-152.
140.Butler, T.W., Waddell, J.A., & Solimando D.A. (2013). Drug monographs: Pomalidomide and ponatinib. Hospital Pharmacy, 48 (8), 636-641.[website]
141.Butler, T.W., Waddell, J.A., & Solimando D.A. (2012). Drug monographs: Carfilzomib and pertuzumab Hospital Pharmacy, 47 (12), 920-923.
142.C D Bertol, E M Schonhorst, N De Britto Tristacci, S Alaei, H Omidian (2018). Hydrophilic Matrices for Prolonged Release of the Antibiotic Nitrofurantoin , (), In submission.
143.C. Ferris, T. Morrison, S. Iriah, I. Kouranova, & M. Trivedi. (2018). Evidence of neurobiological changes in the presymptomatic PINK1-/- KO rat. Journal of Parkinson’s Disease, 8 (2), 281-301.[website]
144.C. Li, R.A. Ansari, Z. Yu and D. Shah (2000). Definitive molecular evidence of renin-angiotensin system in human decidual cells Hypertension, 36 (2), 159-164.
145.C. McKnight, M. Ferrara, J. Czerwinska (1992). Intercollegiate Ice Hockey Injuries, a three-year analysis. Journal of Athletic Training, 27 ( ), 338-343.
146.C. Zhao, R.A. Ansari, M.C. Schmidt and S. A. Khan (1998). An oligonucleotide inhibits oligomerization of a rolling circle initiator protein at pT181 origin of replication J. Biol. Chem. , 273 (26), 16082-16089.
147.Caballero J (2011). Adding 8 weeks of behavioural therapy to atomoxetine does not improve classroom behaviour in children with ADHD. Evidence Based Mental Health, 14 (3), 83.[website]
148.Caballero J (2011). How we are progressing towards the goals of the Manifesto. Clinical Psychiatric and Neurological Pharmacists: The Mental Health Clinician (non-peer reviewed), Oct ( ), .[website]
149.Caballero J, Benavides S, Clauson KA, Hardigan PC, Steinberg JG, Gauthier TP, Sherman EM, Seamon MJ, Valdes J, Thomas, JE (2017). Role of Residency Interview Preparatory Activities as a Determinant on Pharmacy Residency Match Rates. Journal of Pharmacy Practice, 30 (2), 219-222.
150.Caballero J, Benavides S, Steinberg JG, Clauson KA, Gauthier T, Borja-Hart NL, Marino J. (2012). Development of a residency interviewing preparatory seminar. Am J Health Sys Pharm, 69 (5), 400-404.[website]
151.Caballero J, Bishop JR (2010). Getting your research published: moving from a poster to a manuscript. Clinical Psychiatric and Neurological Pharmacists: Shared Resources (non-peer reviewed), ( ), .[website]
152.Caballero J, Gonzalez-Blanco M (2008). Treatment of post-partum depression with psychotic features in a patient with tropical spastic paraparesis. Annals of Pharmacotherapy, 42 (6), 903-904.[website]
153.Caballero J, Heffernan E, Souffrant G (2008). Development and outcomes of a psychiatric pharmacy clinic for indigent patients. American Journal of Health System Pharmacists, 65 (3), 229-233.[website]
154.Caballero J, Hitchcock M, Beversdorf D, Scharre DW, Nahata MC (2006). Long-term effects of antidepressants on cognition in patients with Alzheimer’s disease. Journal of Clinical Pharmacy and Therapeutics, 31 (6), 593-598.[website]
155.Caballero J, Hitchcock M, Scharre DW, Beversdorf D, Nahata MC (2006). Cognitve effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: A retrospective chart review. Clinical Therapeutics, 28 (10), 1695-1700.[website]
156.Caballero J, Koranyi KI, Brady MT, Nahata MC (2005). Depression in children with HIV: A case series. Journal of Pediatric Pharmacology and Therapeutics, 10 ( ), 51-60.
157.Caballero J, Nahata MC (2005). Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children. American Journal of Health System Pharmacists, 62 (8), 864-867.[website]
158.Caballero J, Nahata MC (2003). Atomoxetine for the treatment of attention deficit hyperactivity disorder. Clinical Therapeutics, 25 (12), 3065-3083.[website]
159.Caballero J, Nahata MC (2004). Do statins slow down Alzheimer's disease? Journal of Clinical Pharmacy and Therapeutics, 29 (3), 209-213.[website]
160.Caballero J, Nahata MC (2005). Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Annals of Pharmacotherapy, 1 (39), 141-145.[website]
161.Caballero J, Ownby RL, Clauson KA, Rey JA, (2015). Cognitive and Performance Enhancing Medication Use to Improve Performance in Poker Journal of Gambling Studies, (), .
162.Caballero J, Potter JL (2002). Guide to renal/dialysis considerations of psychotropic medications. Journal of the College of Psychiatric and Neurologic Pharmacists, 1 (1), 1-11.
163.Caballero J, Wolowich WR, Benavides S, Marino J. (2014). Difficulty and discrimination indices of multiple-choice examinations in a College of Pharmacy pathophysiology and therapeutics course sequence. Int J Pharm Pract, 22 (1), 76-83.[website]
164.Cacace, J. L. (2002). CH-Ch-Ch-Changes. Pharmaceutical Formulation and Quality, 3 (6), 14-15.
165.Cacace, J. L. (2002). Excipients: GMP's for Reduced Testing Pharmaceutical Formulation and Quality, 4 (1), .
166.Cannavo, A., Liccardo, D., Lymperopoulos, A., Gambino, G., D'Amico, M.L., Rengo, F., Koch, W.J., Leosco, D., Ferrara, N., Rengo, G. (2016). Beta-Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves ?2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia. J. Pharmacol. Exp. Ther. , 356 (), 503-513.
167.Cannavo, A., Liccardo, D., Lymperopoulos, A., Santangelo, M., Femminella, G.D., Leosco, D., Cittadini, A., Ferrara, N., Paolocci, N., Koch, W.J., Rengo, G. (2017). GRK2 Regulates beta2-Adrenergic Receptor-Dependent Catecholamine Release in Human Adrenal Chromaffin Cells. J. Am. Coll. Cardiol. , 69 (), 1515-1517 .
168.Capote, L.A., Mendez Perez, R., Lymperopoulos, A. (2015). GPCR signaling and cardiac function. Eur. J. Pharmacol., 763 (), 143-148.
169.Cardona C, Khanfar NM, Clauson J (2011). CARGUS: A Case Study Journal of Business Studies Quarterly, 2 (4), 53-61.
170.Carla A Luque and Jose A Rey (1999). Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of Obesity The Annals of Pharmacotherapy, (), .
171.Carla A. Luque, PharmD, Megan J. Ehret, PharmD, and Jose A. Rey, PharmD, BCPP (2007). Rimonabant (Acomplia): The First Cannabinoid-1 Receptor Blocker for Obesity Pharmacy and Therapeutics, (), .
172.Carmen Visus • Diasuke Ito • Rajiv Dhir • Miroslaw J. Szczepanski • Yoo Jung Chang, Jean J. Latimer, Stephen G. Grant, Albert B. DeLeo (2011). Identification of Hydroxysteroid (17b) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas Cancer Immunology, Immunotherapy, ( ), online 3-17-11.
173.Carvajal, M. & I. Popovici. (2016). The Labor Supply of Full-Time and Part-Time Pharmacists. Social Pharmacy Journal , 1 (1), e4748.
174.Carvajal, M. and I. Popovici (2018). Gender, Age, and Pharmacists’ Job Satisfaction. Pharmacy Practice, (), .
175.Carvajal, M. and I. Popovici. (2016). Interaction of gender and age in pharmacists’ labor outcomes. Journal of Pharmaceutical Health Services Research, 7 (1), 23-29.
176.Carvajal, M. and I. Popovici. (2016). Pharmacists’ Wages and Salaries: The Part-Time Versus the Full-Time Dichotomy. Research in Social and Administrative Pharmacy, 12 (2), 341-346.
177.Carvajal, M., I. Popovici, and Hardigan, P. (2018). Pockets of inequality in the distribution of U.S. pharmacists’ wages and salaries: A gender comparison. INNOVATIONS in Pharmacy, (), .
178.Carvajal, M., I. Popovici, and Hardigan, P. (2018). Gender differences in the measurement of pharmacists’ job satisfaction. Human Resources for Health, 16 (1), 33.
179.Carvajal, M., I. Popovici, and Hardigan, P. (2017). Pharmacists’ earnings determination: Are part-time practitioners homogeneous in their response? Journal of Pharmaceutical Health Services Research , 8 (1), 13-21.
180.Carvajal, M.J., Clauson, K.A., Gershman, J., Polen, H.H. (2013). Associations of gender and age groups on the knowledge and use of drug information resources by American pharmacists. Pharmacy Practice, 11 (2), 71-80.
181.Carvajal, Manuel J (2006). Views of research on statistics American Economic Review, 55 (1), 45-54.
182.Casavant, M.J., Walson, P.D., Wolowich, W.R., Kelley, M. (1998). Near Fatal Ingestions of Household Lamp Oil. MMWR, 47 (41), 880-882.
183.Castejon A, Calderon J, Perez A, et al (2013). A community based pilot study of a diabetes pharmacist interventions in Latinos: Impact on weight and hemoglobin A1c. Journal of Healthcare for the Poor and Underserved, 24 (4), 48-60.
184.Castejon A, Calderon J, Perez a, et al. (2013). A community based pilot study of a diabetes pharmacist interventions in Latinos: Impact on weight and hemoglobin A1c. Journal of Healthcare of the Poor and Underserved, 24 (4), 48-60.
185.Castejon AM, Calderon JL, Perez A, Millar C, McLaughlin J, Sangasubana N, Alvarez G, Arce L, Hardigan P and Rabionet S (2013). A Community-Based Pilot Study of Diabetes Pharmacist Intervention in Latino: Impact on Weight and Hemoglobin A1c Journal of Health Care for the Poor and Underserved, 24 (4), 48-60.
186.Castejon AM, Calderon JL, Perez A, Millar C, McLaughlin J, Sangasubana N, Alvarez G, Arce L, Hardigan P and Rabionet S (2013). A Community-based pilot study of a diabetes pharmacist intervention in Latinos: Impact on weight and hemoglobin A1c. Journal of Health care for the Poor and Underserved, 24 (4), 48-60.
187.Castejon, A. Zollner, E., Tristano, A.G., Cubeddu, L.X. (2008). AT1 Receptors and Statins Withdrawal Pharmacologist, 50 (1), 58-59.
188.Castejon, A.M and Spaw, J.A. (2014). Autism and Oxidative Stress Interventions: Impact on Autistic Behavior Austin J of Pharmacol Ther , 2 (2), 6-11.
189.Castejon, A.M., Calderon, J.L., Pere,z A., Millar, C., McLaughlin, J., Sangasubana N., Alvarez G., Arce L., Hardigan P., & Rabionet S (2013). A Community-Based Pilot Study of a Diabetes Pharmacist Intervention in Latinos: Impact on Weight and Hemoglobin A1c. Journal of Health Care for the Poor and Undeserved, 24 (4), 48-60.
190.Chaitin C, Velasquez J, Khanfar NM, Chassange S, Torres RP, Pham NL, Rodriguez MM, & Hale GH (2018). Third-year pharmacy students propose an interprofessional prediabetes educational programme: PreDiaMe (Prediabetes + Me). Journal of Interprofessional Care, 32 (1), 118-122.[website]
191.Chamberlain, J.S., Grant, S.G., Reeves, A.A., Mullins, L.J., Stephenson, D.A., Hoffman, E.P., Monaco, A.P., Kunkel, L.M., Caskey, C.T., & Chapman, V.M (1987). Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome. Somatic Cell and Molecular Genetics, 13 (6), 671-678.
192.Chan L, Fine J, Khanfar NM, Mujtaba BG (2009). Rebrading Ethereal Cereals: Responsing To Health Diet Campaigns through Strategic Plannin, Partnering, and Human Relations. Journal of Case Research in Business and Economics, 1 (1), 1-10.
193.Chapman, V.M., Grant, S.G., Benz, R.A., Miller, D.R., & Stephenson, D.A. (1988). X-chromosome linked mutations affecting mosaic expression of the mouse X chromosome. Current Topics in Microbiology and Immunology, 137 ( ), 372-380.
194.Chavez B, Chavez-Brown M, Sopko MA, Rey JA. (2007). Atypical Antipsychotics in Children with Pervasive Developmental Disorders. Pediatric Drugs, 9 (4), 249-266.
195.Chavez, B., Chavez-Brown, M., Rey, J. A. (2006). Role of Risperidone in Children with Autism Spectrum Disorder. The Annals of Pharmacotherapy, 40 (5), 909-916.
196.Chi JL, Chi GC, Khanfar NM, Gao X, Kaifi BA (2020). The Impact of Innovative Executive Servant Leadership on Organizational Citizenship, and Organizational Cynicism. International Journal of Business and Public Administration, 17 (1), 1-31.
197.Cho JC, Crotty MP, White BP, Marylee V. Worley. (2017). What is Old is New Again: Delafloxacin, a Modern Fluoroquinolone. Pharmacotherapy, (), .[website]
198.Choi, Y.S., Lee, J.Y., Kwon, Y. M., Lee, W. K., Lee, S. J., Chung, C. P., Yang, V. C., & Park, Y. J. (2006). Enhanced Uptake of Antisense Oligonucleotides and Suppression of bcl-2 Gene Expression in Human Breast Cancer Cells Using Cell Permeable Peptide. Biomaterials Research, 10 (4), 212-217.
199.Choi, Y.S., Lee, J.Y., Suh, J. S., Kwon, Y.M., Lee, S. J., Chung, J. K., Lee, D. S., Yang, V.C., Chung, C.P. & Park, Y. J. (2010). The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials, 31 (6), 1429-43.
200.Chrisphonte Y, Borja-Hart NL (2010). Rabies Vaccination Update Journal of the American Pharmacists Association, 50 (1), 104-106.
201.Clark, M., Bing, B., Paul Gotschall, P. and Williams, J. (1995). Differential Effect of Cytokines on the Phenobarbital or 3-Methylcholanthrene Induction of P450 Mediated Monooxygenase Activity in Cultured Rat Hepatocytes. Biochemical Pharmacology , 49 (), 97-104.
202.Clark, M., Tran, H., and Nguyen, T (2011). Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes. ; Volume 45, pages: , 2011 Neuropeptides, 45 (), 329-335.
203.Clark, M.A. and Gonzalez, N. (2007). Src and Pyk2 Mediate Angiotensin II Effects in Cultured Rat Astrocytes Regulatory Peptide, 143 (), 47-55.
204.Clark, M.A. and Gonzalez, N. (2007). Angiotensin II Stimulates Rat Astrocyte Mitogen-Activated Protein Kinase Activity and Growth Through EGF and PDGF Receptor Transactivation Regulatory Peptide, 144 (), 115-122.
205.Clark, M.A., Diz, D., and Tallant, EA (2001). Angiotensin-(1-7) Downregulates the AT1 Receptor in Vascular Smooth Muscle Cells. Hypertension, 37 (), 1141-1146.
206.Clark, M.A., Gottschall, P., and Wecker, L (1996). Effects of Phenobarbital and Interleukin-6 on Cytochrome P4502B1 and 2B2 in Cultured Rat Hepatocytes Biochemical Pharmacology, 51 (), 701-706.
207.Clark, M.A., Guillaume, G., and Pierre-Louis, H.C. (2008). c-Jun N-terminal Kinase Mediates Angiotensin II Effects in Cultured Rat Astrocytes. Brain Research Bulletin , 75 (), 101-106.
208.Clark, M.A., Nguyen, C., and Tran, H. (2012). Angiotensin III induces c-Jun N-terminal Kinase leading to proliferation of Rat Astrocytes. Neurochemical Research, 37 (), 1475-1481.
209.Clark, M.A., Nguyen, C., and Tran, H. (2013). Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes. International Journal of Hypertension, 2013 (782861), doi:10.1155/2013/782.[website]
210.Clark, M.A., Tallant, E.A. and Diz, D.I. (2001). Downregulation of the AT1A Receptor by Pharmacological Concentrations of Angiotensin-(1-7). , Volume 37, pp. 437-448, 2001. J. of Cardiovascular Pharmacology, 37 (), 437-448.
211.Clark, M.A., Tommasi, E.N., Bosch, S.M., Tallant, E.A. and Diz, D.I. (2003). Angiotensin-(1-7) Downregulates AT1 Receptors in Kidney through a Cyclooxygenase Dependent Pathway. J. of Cardiovascular Pharmacology, 41 (), 276-283.
212.Clark, M.A., and Tallant, E.A. (2003). Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7). Hypertension, 42 (), 574-579.
213.Clark, MA., Gottshall, P., and Wecker, L. (1996). Effects of Phenobarbital and Interleukin-6 on Cytochrome P4502B1 and 2B2 in Cultured Rat Hepatocytes. Biochem. Pharmacol., 51 (), 701-706.
214.Clark., M.A., and Gonzalez, N. (2007). Src and Pyk2 Mediate Angiotensin II Effects in Cultured Rat Astrocytes. Regulatory Peptide, Volume 143, page 47-55, 2007 Regulatory Peptides, 143 (), 47-55.
215.Clark., M.A., and Gonzalez, N. (2007). Angiotensin II Stimulates Rat Astrocyte Mitogen-Activated Protein Kinase Activity and Growth Through EGF and PDGF Receptor Transactivation. Regulatory Peptide, 144 (), 115-122.
216.Clauson KA, Alkhateeb FM, Lugo KD, Khanfar NM (2011). E-Prescribing: attitudes and perceptions of community pharmacists in Puerto Rico. International Journal of Electronic Healthcare, 6 (1), 34-46.
217.Clauson KA, Elrod S, Fox BI, Hajar Z, Dzenowagis J. (2013). Opportunities for pharmacists in mobile health. American Journal of Health-System Pharmacy , 70 (15), 1348-1352 .
218.Clauson KA, Fass JA, Seamon MJ (2008). Legal Requirements for Drug Information Resources Maintained by Pharmacies Drug Information Journal, 32 (Nov/Dec), 569-82.
219.Clauson KA, Khanfar NM, Polen HH, Gibson FH (2009). Nurse prescribers’ interactions with and perceptions of pharmaceutical sales representatives. Journal of Clinical Nursing, 18 (2), 228-233.
220.Clauson KA, Marsh W, Polen H, Seamon MJ, Ortiz BI (2007). Clinical decision support tools: analysis of commercially available online drug information databases. BMC Medical Informatics and Decision Making, 7 ( ), 7.
221.Clauson KA, Polen HH, Joseph SA, Zapantis A. (2009). Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) for HIV prevention. Pharmacy Practice, 7 (1), 11-18.
222.Clauson KA, Polen HH, Peak AS, Marsh WA, DiScala S. (2008). Clinical decision support tools: personal digital assistant vs. online dietary supplement databases Annals of Pharmacotherapy, 42 (11), 1592-9.
223.Clauson KA, Seamon MJ, Fox BI (2010). Pharmacist’s Duty to Warn in the Age of Social Media American Journal of Health-System Pharmacists, 67 ( ), 1290-3.
224.Clauson KA, Veronin MA, Khanfar NM, Lou JQ (2008). Open-access publishing for pharmacy-focused journals. American Journal of Health-System Pharmacy, 65 (16), 1539-1554.
225.Clauson, K.A. (2006). Drug-Induced Diseases: Prevention, Detection, and Management [Book Review]. American Journal of Pharmaceutical Education, 70 (6), Article 148.
226.Clauson, K.A., Alkhateeb F, Singh-Franco D. (2012). Concurrent use of an audience response system at a multi-campus college of pharmacy. American Journal of Pharmaceutical Education, 76 (1), Article 6.[website]
227.Clauson, K.A., Alkhateeb, F.M., Lugo, K.D., Khanfar, N.M. (2011). E-prescribing: attitudes and perceptions of community pharmacists in Puerto Rico. International Journal of Electronic Healthcare , 6 (1), 34-46.
228.Clauson, K.A., Cauffield, J.S., Santamarina, M.L., Buettner, C.M. (2005). Evaluation of the absence or presence of aspirin-related warnings with willow bark products. Annals of Pharmacotherapy, 39 (7/8), 1234-7.
229.Clauson, K.A., Cauffield, J.S., Santamarina, M.L.. (2005). Clauson KA, Cauffield JS, Santamarina ML. Evaluation of the absence or presence of aspirin-related warnings with willow bark products [letter]. Annals of Pharmacotherapy, 39 (10), 1763-1764.
230.Clauson, K.A., Elkins, J., Goncz, C. (2010). The use of blogs by pharmacists. American Journal of Health-System Pharmacy, 67 (23), 2043-8.
231.Clauson, K.A., Elrod, S., Fox, B.I., Hajar, Z., Dzenowagis, J. (2013). Opportunities for pharmacists in mobile health. American Journal of Health-System Pharmacy, 70 (15), 1348-1352.
232.Clauson, K.A., Fass, J.A., Seamon, M.J. (2008). Legal requirements for drug information resources maintained by pharmacies. Drug Information Journal , 42 (6), 569-582.
233.Clauson, K.A., Khanfar, N.M., Polen, H.H., Gibson, F.H. (2009). Nurse prescribers’ interactions with and perceptions of pharmaceutical sales representatives. Journal of Clinical Nursing, 18 (2), 228-33.
234.Clauson, K.A., Marsh, W., Polen, H., Seamon, M.J., Ortiz B.I. (2007). Clinical decision support tools: analysis of commercially available online drug information databases. BMC Medical Informatics and Decision Making, 7 (1), Article 7.
235.Clauson, K.A., McQueen, C.E., Bryant, P.J. (2002). Summary Results of the Missouri Pharmacists Survey – Knowledge and Attitudes Towards Dietary Supplements. Missouri Pharmacist, 76 (1), .
236.Clauson, K.A., McQueen, C.E., Shields, K.M., Bryant, P.J. (2003). Knowledge and attitudes of pharmacists in a midwestern state regarding natural products: its impact on educational goals. American Journal of Pharmaceutical Education, 67 (2), Article 41.
237.Clauson, K.A., Peak, A.S., Marsh, W.A., DiScala, S., Bellinger, R.R. (2008). Clinical decision support tools: focus on dietary supplement databases. Alternative Therapies in Health and Medicine, 14 (3), 36-40.
238.Clauson, K.A., Polen, H.H., Marsh W.A. (2007). Clinical decision support tools: performance of online versus personal digital assistant drug information databases. Pharmacotherapy, 27 (12), 1651-1658.
239.Clauson, K.A., Polen, H.H., Boulos, M.K., Dzenowagis, J.H. (2008). Scope, completeness, and accuracy of drug information in Wikipedia. Annals of Pharmacotherapy, 42 (12), 1814-21.
240.Clauson, K.A., Polen, H.H., Joseph, S.A., Zapantis, A. (2009). Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) for HIV prevention Pharmacy Practice, 7 (1), 11-18.
241.Clauson, K.A., Santamarina, M.L., Rutledge, J.C. (2008). Clinically relevant safety issues associated with St. John's wort product labels. BMC Complementary and Alternative Medicine, 8 ( ), 42.
242.Clauson, K.A., Seamon, M.J., Clauson, A.S., Van, T.B. (2004). Evaluation of core and supplemental drug information databases for the Palm OS and PocketPC. American Journal of Health-System Pharmacy, 61 (10), 1015-24.
243.Clauson, K.A., Seamon, M.J., Fox, B.I. (2010). Pharmacists’ duty to warn in the age of social media. American Journal of Health-System Pharmacy, 67 (15), 1290-3.
244.Clauson, K.A., Shields, K.M., McQueen, C.E., Persad, N. (2008). Safety issues associated with commercially available energy drinks. Journal of the American Pharmacists Association, 48 (3), e55-e67.
245.Clauson, K.A., Singh-Franco D., Sircar-Ramsewak F, Joseph S, Sandars J. (2013). Social media use and educational preferences of students in a doctoral pharmacy program. Teaching and Learning in Medicine, 25 (2), 122-8.
246.Clauson, K.A., Veronin, M.A., Khanfar, N.M., Lou, J.Q. (2008). Open-access publishing for pharmacy-focused journals. American Journal of Health-System Pharmacy, 65 (16), 1539-54.
247.Clauson, K.A., Vidal, D. (2008). Overview of biomedical journal podcasts. American Journal of Health-System Pharmacy, 65 (22), 2155-8.
248.Clauson, K.A., Zeng-Treitler, Q., Kandula, S. (2010). Readability of patient and healthcare professional targeted dietary supplement leaflets used for diabetes and chronic fatigue syndrome. Journal of Alternative and Complementary Medicine , 16 (1), 119-24.
249.Clay, P.G., Clauson, K.A., Glaros, A. (2004). Complementary and alternative medicine use by patients visiting a free health clinic: a single-site, pilot study. Current Therapeutic Research Clinical and Experimental , 65 (6), 481-494.
250.Clay, P.G., Glaros, A., Clauson, K.A. (2006). Perceived efficacy, indications and information sources for dietary supplements in medically indigent patients and their healthcare providers. Annals of Pharmacotherapy, 40 (3), 427-432.
251.Clayton ENGLISH, Jose A. REY, Lauren S. SCHLESSELMAN. (2011). Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacy Pharmacy Practice, (), .
252.Collins, P.M., Auclair, M., Butler, E., Hush, M., Bernstein, B.J., Aguirre, F., Huston, M. (2000). Educating staff about pain management. American journal of Nursing, 100 (1), 59.
253.Colon C, Salas P, Diaz M, Cotto R, Martinez I, Hale GM, Khanfar NM (2020). Patient Assistance Programs and Technology in Medication Adherence INNOVATIONS in pharmacy, 11 (2), 1-5.[website]
254.Compton-Quintana, P.J.E., Jensen, R.H., Bigbee, W.L., Grant, S.G., Langlois, R.G., Smith, M.T., & Rappaport, S.M. (1993). Use of the glycophorin A human mutation assay to study workers exposed to styrene. Environmental Health Perspectives, 99 ( ), 297-301.
255.Constantiner, M., Sehgal, A.R., Humbert, L., Constantiner, D., Arce, L., Sedor, J.R., Schelling, J.R. (2008). A dipstick protein and specific gravity algorithm accurately predicts pathological proteinuria. American Journal of Kidney Diseases, 45 (5), 833-41.
256.Conte, N (2012). Pharmacists attitudes toward using the internet to satisfy their continuing education needs: An exploratory study. Currents in Pharmacy Teaching and Learning, 4 (3), 180-187.[website]
257.Conte, N (2012). First-time-users' impressions of continuing education using the internet. Quality Assurance in Education, 20 (4), 372-386.[website]
258.Contreras de Condado, M.C., Malave, A. and Rathinavelu, A. (2001). A Highly Sensitive Electrochemical Detection HPLC Assay for Estimating Cisapride Levels in Biological Samples. J. Association of Official Analytical Chemists, 84 (), 9-12.
259.D Mastropietro and H Omidian (2013). How Abuse-Resistant Are the Abuse-Deterrent Medications SOJ Pharmacy and Pharmaceutical Sciences, 1 (1), 01.
260.D Mastropietro, H Omidian (2012). Prevalence and Trends of Cellulosics in Pharmaceutical Dosage Forms Drug Development and Industrial Pharmacy, 39 (2), 382-392.
261.D Mastropietro, H Omidian (2016). Deterred Drug Abuse Using Superabsorbent Polymers. Expert Opinion on Drug Delivery, 13 (11), 1523-1531.
262.D Mastropietro, H Omidian (2014). Drug Tampering and Abuse Deterrence Journal of Developing Drugs, 3 (1), 119.
263.D Mastropietro, H Omidian (2014). Path to Deter Drug Abuse Austin Journal of Pharmacology and Therapeutics, 1 (1), 2.
264.D Mastropietro, H Omidian (2013). Commercial Abuse-Deterrent Dosage Forms, Clinical Status Journal of Developing Drugs, 2 (1), 103.
265.D Mastropietro, H Omidian (2012). Current Approaches in Tamper-Resistant and Abuse-Deterrent Formulations Drug Development and Industrial Pharmacy, 39 (5), 611-624.
266.D Mastropietro, H Omidian (2014). Abuse-Deterrent Formulations (ADFs)-Part 2: Commercial Products and Proprietary Technologies, Expert Opinion on Pharmacotherapy, 15 (18), .
267.D Mastropietro, H Omidian (2014). Abuse-Deterrent Formulations (ADFs)- Part 1: Development of a Formulation-Based Classification System, Expert Opinion on Drug Metabolism and Toxicology, 11 (2), .
268.D Mastropietro, H Omidian, K Park (2012). Drug Delivery Applications for Superporous Hydrogels. Expert Opinion on Drug Delivery, 9 (1), 71-89.
269.D Mastropietro, R Nimroozi, H Omidian (2013). Rheology in Pharmaceutical Formulations-A Perspective Journal of Developing Drugs, 2 (2), 108.
270.D Mastropietro, S Muppalaneni, H Omidian (2013). Shear-Thinning Rheology of the Abuse-Deterrent Dosage Form Extracts Journal of Developing Drugs, 2 (3), 114.
271.D Obaid, T Johnston, NM Khanfar (2020). Monetary Policy and House Price Index: A VAR Analysis for Saudi Arabia. Journal of Business Studies Quarterly, 17 (2), 12-21.
272.D Obaid, T Johnston, NM Khanfar (2020). Monetary Policy and House Price Index: A VAR Analysis for Saudi Arabia. Journal of Business Studies Quarterly, 10 (1), 12-21.[website]
273.D Obaid, T Johnston, NM Khanfar (2020). Monetary Policy and House Price Index: A VAR Analysis for Saudi Arabia. Journal of Business Studies Quarterly, 10 (1), 12-21.[website]
274.D Obaid, T Johnston, NM Khanfar (2020). Monetary Policy and House Price Index: A VAR Analysis for Saudi Arabia. Journal of Business Studies Quarterly, 17 (2), 12-21.
275.DIXIE J. KOO; DALE D. CHITWOOD; Jesus Sanchez (2007). Factors for Employment: A Case-Control Study of Fully Employed and Unemployed Heroin Users Substance Use & Misuse, 42 (), 1035-1054.
276.DJ Mastropietro, H Omidian (2015). Abuse-Deterrent Formulations (ADFs): Crush Resistance Journal of Pharma and Pharmaceutical Sciences, 1 (1), 1-4.[website]
277.Dabul, S., Bathgate-Siryk, A., Reyes Valero, T., Jafferjee, M., Sturchler, E., McDonald, P., Koch, W.J., Lymperopoulos, A. (2015). Suppression of adrenal barrestin1-dependent aldosterone production by ARBs: head-to-head comparison. Sci. Rep. , 5 (), 8116.
278.Dale D. Chitwoo; Mary Comerford; Kathi R. Kitner; Wilson Palacios; Jesus Sanchez (2001). A COMPARISON OF HIV RISK BEHAVIORS BETWEEN NEW AND LONG-TERM INJECTION DRUG USERS SUBSTANCE USE & MISUSE, 36 (1&2), 91-111.
279.Dale D. Chitwood , Mary Comerford, Jesús Sanchez (2003). Prevalence and Risk Factors for HIV Among Sniffers, Short-Term Injectors, and Long-Term Injectors of Heroin Journal of Psychoactive Drugs, 35 (4), 445-453.
280.Dale D. Chitwood; Jesus Sanchez; Mary Comerford; Clyde B. McCoy (2001). PRIMARY PREVENTIVE HEALTH CARE AMONG INJECTION DRUG USERS, OTHER SUSTAINED DRUG USERS, AND NON-USERS SUBSTANCE USE & MISUSE, 36 (6&7), 807-824.
281.Daniel KL, Borja NL. (2007). Gestational diabetes - a review for pharmacists. US Pharmacist, 32 (10), 17-20.
282.Daniel, K., Fabelo, A., Marsh, W. (2002). Value of pharmacist osteoporosis screening in a community pharmacy practice. Pharmacotherapy, 22 (), 427.
283.Daniel, K.L., Arneson, D.L. (2004). Assessment of remedial policy at Nova Southeastern University. American Journal of Pharmaceutical Education, 68 (2), 4.
284.Daniel, K.L., Metzner, M., Assa-Eley, M. (2004). Implementation of a public speaking component in communication skills course. American Journal of Pharmaceutical Education, 68 (2), 20-21.
285.Daniel, K.P. (2003). The great debate: an effective method of teaching contraception. American Journal of Pharmaceutical Education, 67 (3), 29.
286.Daniel, K.P., Krop, L. (1996). Piperacillin/tazobactam: A new beta-lactam/beta-lactamase inhibitor combination Pharmacotherapy, 16 (2), 149-162.
287.Daniel, K.P., Robinson, M. (1999). Update on sexually transmitted diseases US Pharmacist, 24 (), HS5-HS21.
288.David J. Lonneman, Jr.; Jose A. rey, MS, PharmD, BCPP; and Brian D. McKee, PharmD (2013). Phentermine/Topiramate Extended-Release Capsules (Qsymia) for Weight Loss Pharmacy & Therapeutics, (), .
289.DeMuro, P. (2009). The shortage of primary care providers and healthcare reform – what compliance officers should be prepared for. CCH Health Care Compliance, 12 (21), .
290.DeMuro, P. (2010). Community physicians participating in accountable care organizations through clinical integration. The Health Lawyer , 22 (6), .
291.DeMuro, P. (2011). Imaging and laboratory systems - not interoperable. AHLA HIT News, 14 (1), .
292.DeMuro, P. (2011). 7 strategies for success in governing an ACO. Healthcare Financial Management, 65 (5), 78-82.
293.DeMuro, P. (2012). Accountable care. The Health Lawyer , 24 (6), .
294.DeMuro, P. (2012). Linking information retrieval to the electronic health record. Electronic Healthcare Law Review, 2 (2), .
295.DeMuro, P. (2015). The changing nature of compliance under payment for quality and cost effectiveness. Compliance Today, (), .
296.DeMuro, P. (2015). Skilled nursing facilities: quality and reporting and value-based purchasing programs, Part 1. Compliance Today, (), .
297.DeMuro, P. (2015). Final rule for accountable care organization: enabling technologies, Part 1. Compliance Today, (), .
298.DeMuro, P. (2015). Skilled nursing facilities: quality and reporting and value-based purchasing programs, Part 2. Compliance Today, (), .
299.DeMuro, P. (2015). Final rule for accountable care organizations: enabling technologies, Part 2. Compliance Today, (), .
300.DeMuro, P. (2013). Risks to patient safety with emerging health information technologies (HIT). American Health Lawyers Association, 16 (1), .
301.DeMuro, P. (2013). Emerging healthcare information technologies and the legal challenges they present. The Wyoming Lawyer, (), .
302.DeMuro, P. (2013). E-prescribing and quality and cost benefit metrics. Electronic Healthcare Law Review, 3 (2), .
303.DeMuro, P. (2014). The changing face of consumer health informatics: mhealth and social media and what it means to attorneys. Health Lawyers Weekly, 12 (23), .
304.DeMuro, P. (2014). Social media - healthcare law and ethical issues. Electronic Healthcare Law Review, 4 (1), .
305.DeMuro, P. (2016). In-house counsel increasingly must focus on data analytics. American Health Lawyers Association, 22 (1), .[website]
306.DeMuro, P. (2010). Accountable care organizations and evolving integrated delivery systems - the new frontier in compliance challenges. CCH Aspen Journal of Health Care Compliance, (), .
307.DeMuro, P. (1989). Joint ventures for mobile equipment reduce hospital costs. Healthc Financ Manage, 43 (4), 52, 56, 58 passim..
308.DeMuro, P. (1989). Implications of hospital transfers to related corporations and joint ventures. Trustee, 42 (10), 16, 25.
309.DeMuro, P. (1990). Medicare funded depreciation: a plan for hospitals. Calif Hosp, 5 (5), 29-30.
310.DeMuro, P. (1994). Provider alliances; key to health care reform. Healthc Financ Manage, 48 (1), 26-32.
311.DeMuro, P. (1994). Management services organizations Top Health Care Financ, 20 (3), 19-27.
312.DeMuro, P. (1994). Ten steps for integrated delivery systems to maintain exempt status. Healthcare and Taxation: Tax-Exempt Integration, Compliance and Financing, 1 (1), .
313.DeMuro, P. (1995). Paying specialists and subspecialists on a capitated basis. Healthc Financ Manage, 49 (7), 32-35.
314.DeMuro, P. (1999). A review of key legal requirements affecting ambulatory surgical centers. The Health Lawyer, 11 (5), .
315.DeMuro, P. (2002). Telltale signs your board of directors may be providing ineffective governance. Healthcare Leadersh Manag Rep, 10 (11), 1-8.
316.DeMuro, P. (2003). The discount safe harbor. CCH Health Care Compliance, 6 (2), .
317.DeMuro, P. (2003). The discount safe harbor - part 2. CCH Health Care Compliance, 6 (3), .
318.DeMuro, P. (2003). The new face of corporate governance. CCH Health Care Compliance, 6 (14), .
319.DeMuro, P. (2005). Telltale signs your executive compensation system may be ineffective. CCH Health Care Compliance, 8 (6), .
320.DeMuro, P. (2007). The international health regulations - restricting travel in emergency health situations and issues healthcare providers should consider. The Health Lawyer, 19 (4), .
321.DeMuro, P. (2009). Financial meltdown: key legal issues for healthcare organizations. Healthc Financ Manage, 63 (5), 52-58.
322.DeMuro, P. (2009). Compliance efforts should not take a holiday in a recession. CCH Health Care Compliance, 12 (9), .
323.DeMuro, P. (Co-Author) (2009). Accountable care organizations - physician/hospital integration. The Health Lawyer, 21 (6), .
324.DeMuro, P., Fairley, D. (2004). Resolving corporate governance conflicts on executive compensation. CCH Health Care Compliance, 7 (14), .
325.DeMuro, P., Gabrysch, L. (2008). A survey of new developments in tax-exemption law: what compliance officers need to know (Part III). CCH Tax-Exempt Advisor, (406), Report 405.
326.DeMuro, P., Gabrysch, L. (2007). A survey of new developments in tax-exemption law: what compliance officers need to know (Part I). CCH Health Care Compliance, 10 (20), .
327.DeMuro, P., Gabrysch, L. (2007). A survey of new developments in tax-exemption law: what compliance officers need to know (Part II). CCH Health Care Compliance, 10 (21), .
328.DeMuro, P., Gabrysch, L. (2008). A survey of new developments in tax-exemption law: what compliance officers need to know (Part II). CCH Tax-Exempt Advisor, (404), Report 404.
329.DeMuro, P., Gantt III, A. (2001). HIPAA privacy standards raise complex implementation issues. Healthc Financ Manage, 55 (1), 42-47.
330.DeMuro, P., Jaeger-Lenz, A. (2008). How to conduct clinical trials in the EU and eastern europe; overview and comparison with the U.S. system. Journal of Health Care Compliance, HCCA, (), .
331.DeMuro, P., Keilty, G., & Harrigan, R. (2009). Eye of the storm - the government's focus on hospital-physician arrangements. The Health Lawyer, 21 (5), .
332.DeMuro, P., Lauer, K. (2006). Joint venture imaging center (Part (II): preferred structural and restructuring considerations. CCH Health Care Compliance, 9 (14), .
333.DeMuro, P., Lauer, K. (2006). Joint venture imaging centers, part I: identifying compliance issues. CCH Health Care Compliance, 9 (13), .
334.DeMuro, P., Lauer, K., Huston, B. (2010). Profiting from anesthesia services: an analysis of emerging compensation arrangements between ambulatory surgery centers and anesthesiologists. CCH Health Care Compliance, 13 (16), .
335.DeMuro, P., Little, J. (1991). Know your investigator: the basics of how to handle a medicare or medicaid audit, review or investigation. Homecare, (), .
336.DeMuro, P., Marder, J., & Levels, R. (2009). Recession opportunities: compliance with charity care obligations and maintaining tax-exempt status. CCH Health Care Compliance, 12 (8), .
337.DeMuro, P., Marder, J., & Levels, R. (2010). Recession opportunities: compliance with charity care, obligations and maintaining tax-exempt status (Part I). Tax-Exempt Advisor Exempt Organizations Reports, (425), .
338.DeMuro, P., Marder, J., & Levels, R. (2010). Recession opportunities: compliance with charity care, obligations and maintaining tax-exempt status (Part II). Tax-Exempt Advisor Exempt Organizations Reports, (426), .
339.DeMuro, P., Margolis, G. (1991). Crisis management can leave residual effects. Healthc Financ Manage, 45 (10), 46, 48, 50-2 passim..
340.DeMuro, P., Owens, J.F. (1994). Special medicare reimbursement and fraud and abuse considerations for management services organizations, medical foundations, and integrated delivery systems. Top Health Care Financ, 20 (3), 54-60.
341.DeMuro, P., Roth, J.C. (1993). Fraud and abuse compliance programs: their time has come. Healthc Financ Manage, 47 (3), 50-56.[website]
342.Degen, S.J.F., Schaefer, L.A., Jamison, C.S., Grant, S.G., Fitzgibbon, J.J., Pai, J.-A., Chapman, V.M., & Elliott, R.W. (1990). Characterization of the cDNA coding for mouse prothrombin and localization of the gene on mouse chromosome 2. DNA and Cell Biology, 9 (7), 487-498.
343.Del Valle, A., Arce, L., (2017). Skin Rash: What is the Cause? Mi Pediatra, 17 (), 14-15.
344.Delaney, J., Chiarello, R., Villar, D., Kandalam, U., Castejon, A., Clark, M.A. (2008). Regulation of c-fos, c-jun and c-myc Gene Expression by Angiotensin II in Primary Cultured Rat Astrocytes: Role of ERK1/2 MAP Kninases. Neurochem Res. , 33 (3), 545-50.
345.Delgado O, Riskin J, Zapantis A (2013). Extending student pharmacy practice experiences into patient-care areas. ASHP Pharmacy Practice Model Intitiative Case Studies, ( ), .[website]
346.Deloatch, K.H., Gannett, P.M., Hagemann, T.M., Law, A.V., Smith, C., Trang, D., & Reynolds, J.R. (2012). An Exploratory Qualitative Study to Examine Student Engagement in Professional Political Advocacy in Colleges/Schools of Pharmacy Current Pharmacy Teaching and Learning, 4 (), 1877-1897.
347.Desir DR, Khanfar NM, Harrington CA, Loudon D (2011). The Value of Patient Care in the New Economy. Journal of Management and Strategy, 2 (2), 23-27.
348.Deters, M.A., Laven, A., Castejon, A., Doucette, W.R., Slveira, L., Krass, I., Mehuys, E., Obarcanin E., Schwender, H., Laeer, S. (2017). Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components Annals of Pharmacotherapy, (), .
349.Deters, MA, Laven, A, Castejon, A, Doucette, WR, Slveira, L, Krass, I, Mehuys, E, Obarcanin E, Schwender, H, Laeer, S (2017). Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components Annals of Pharmacotherapy,, First (), .
350.Deters, MA, Laven, A, Castejon, A, Doucette, WR, Slveira, L, Krass, I, Mehuys, E, Obarcanin E, Schwender, H, Laeer, S (2017). Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components Annals of Pharmacotherapy, (), .
351.Deth R, Clarke A, Ni J, M.Trivedi (2016). Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of ?-casein: results from a randomized, cross-over clinical trial Nutr J., 15 (1), .
352.Deth R, Clarke A, Ni J, Trivedi M (2016). Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of ?-casein: results from a randomized, cross-over clinical trial. Nutrition Journal, 15 (1), 82.
353.Di Benedetto, L.M., Droege, M. (2006). Pharmacy Education: A Student's Perspective American Journal of Pharmaceutical Education, 70 (3), .
354.DiDomenico, R.J., Perez, A., Schumann, H.M., Fontana, D.R., Kondos, G.T., Schumock, G.T. (2008). Impact of Treatment Guidelines on Clinical and Economic Outcomes of Acute Decompensated Heart Failure. Annals of Pharmacotherapy, 42 (3), 327-33.
355.Dinger, M. K., Waigandt, A., Soto-Torres, B. (1996). Sexuality behaviors among college students: risky business. Missouri Journal of Health, Physical Education, Recreation and Dance, 6 (), 10-20.
356.Disteche, C.M., McConnell, G.K., Grant, S.G., Stephenson, D.A., Chapman, V.M., Gandy, S., & Adler, D.A. (1989). Comparison of the physical and recombination maps of the mouse X chromosome. Genomics, 5 (2), 177-184.
357.Dixie J. Koo, Dale D. Chitwood, and Jesus Sanchez (2007). A Critical Unresolved Issue AssociatedWith Contemporary Employment, Substance Use, and Intervention Substance Use & Misuse, 42 (), 1207-1215.
358.Dodda, B., Corry, D. Bondi, C.D., Hasan, M., Clafshenkel, W.P., Gallagher, K.M., Kotlarczyk, M.P., Sethi, S., Buszko, E., Latimer, J.J., Cline, J.M, Witt-Enderby, P.A. and , Davis, V.L. (2019). Co-administering Melatonin with an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-positive Breast Cancer Frontiers in Oncology, 9 (), 525.[website]
359.Domagala BM, Leung S, Regal RE (2004). Possible drug interactions among quinolones Am Fam Physician, 69 (3), 489.
360.Donovan, M., Miles, T.D., Latimer, J.J., Grant, S., Talbott, E., Sasco, A.J., and Davis, D.L. (2006). Association between biomarkers of environmental exposure and increased risk of breast cancer. Nature Reviews Cancer , 6 ( ), c1.
361.Droege, M. (2004). Evaluating the Instructional Design of a Web-enhanced Educational Program for the Practice of Pharmaceutical Care. Pharmacy Education, 4 (3/4), 129-136.
362.Droege, M. (2001). Is Social and Administrative Pharmacy a Science? [Editorial]. Journal of Social and Administrative Pharmacy, 18 (5), 159-160.
363.Droege, M. (2003). The Role of Reflective Practice in Pharmacy. Education for Health: Change in Learning and Practice (EfH), 16 (1), 68-74.
364.Droege, M., Arneson, D.L., Marsh, W.A. (2005). 2004 Florida Pharmacist Compensation and Labor Survey Florida Pharmacy Today, (June), 13-15.
365.Droege, M., Assa-Eley, M.T. (2005). Pharmacists as Care Providers: Personal Attributes of Recent Pharmacy Graduates American Journal of Pharmaceutical Education, 69 (3), 290-295.
366.Droege, M., Baldwin H.J. (2005). Have Things Changed in Pharmacy Education? Journal of Pharmacy Teaching, 12 (1), 5-9.
367.Drosatos, K., Bharadwaj. K.G., Lymperopoulos, A., Ikeda, S., Khan, R., Hu, Y., Agarwal, R., Yu, S., Jiang, H., Steinberg, S.F., Blaner, W.S., Koch (2011). Cardiomyocyte lipids impair {beta}-adrenergic receptor function via PKC activation. American Journal of Physiology: Endocrinology & Metabolism, 300 ( ), E489-E499 .
368.Drosatos, K., Lymperopoulos, A., Schulze, P.C.,Pollak, N., Goldberg, I.J. (2015). Cardiac septic shock: Driven by inflammation, energy mismanagement, or both? Current Heart Failure Reports, 12 (), 130-140.
369.DuPont, B.R., Grant, S.G., Oto, S.H., Bigbee, W.L., Jensen, R.H., & Langlois, R.G. (1995). Molecular characterization of glycophorin A transcripts in human erythroid cells using RT-PCR, allele-specific restriction, and sequencing. Vox Sanguinis, 68 (2), 121-129.
370.Dutta, S., Ting, C., Lai, L (1997). Prevalence, Etiology and Severity of Acute Pancreatitis in Patients Infected with Human Immunodeficiency Virus The American Journal of Gastroenterology, 92 (), 2044-2048.
371.Dutta, S., Ting, C., Lai, L. (1997). Prevalence, Etiology and Severity of Acute Pancreatitis in Patients Infected with Human Immunodeficiency Virus The American Journal of Gastroenterology, 92 ( ), 2044-2048.
372.Ehret, M.J., Levin, G.M., Narasimhan, M., Rathinavelu, A. (2007). Velnafaxine Induces P-glycoprotein in Human Caco-2 Cells. Human Psychopharmacology: Clinical Experimental, 22 (1), 49-53.
373.El-Malah Y, Nazzal S, Khanfar NM (2006). D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms. Drug Development and Industrial Pharmacy, 32 (10), 1207-1218.
374.Elias B Chahine, Jonathan C. Cho, and Marylee V. Worley, (2017). Bezlotoxumab for the Prevention of Clostridium difficile Recurrence. The Consultant Pharmacist, (), .
375.Elias B Chahine, Marylee Worley, Michelle D. Lese, Jessica Pokora, Hannah A. Morris (2015). Update on Immunizations for Children and Adolescents US Pharmacist, May (), 67-77.
376.Elizabeth Sherman, Marylee V. Worley, Nathan R. Unger, Timothy P. Gauthier, Jason J. Schafer (2015). Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection. Clinical Therapeutics, 37 (9), 1876-1893.
377.Elliott, R.W., Sparkes, R.S., Mohandas, T., Grant, S.G., & McGinnis, J.F. (1990). Localization of the rhodopsin gene to the distal half of mouse chromosome 6. Genomics, 6 (4), 635-644.
378.Eltaki S, Singh-Franco D, Leon D, Nguyen M, Wolowich WR. (2018). Allocation of faculty and curricular time to the teaching of transitions of care concepts by colleges of pharmacy. Currents in Pharmacy Teaching & Learning , 10 (6), 701-711.[website]
379.Eltaki S, Singh-Franco D., Leon D, Nguyen M, Wolowich WR. (2018). Allocation of faculty and curricular time to the teaching of transitions of care concepts by colleges of pharmacy. Currents in Pharmacy Teaching & Learning , 10 (6), 701-711.
380.Ettner, S.L., T. French, and I. Popovici (2010). Heavy drinking and health promotion activities. Social Sciences and Medicine , 71 (1), 134-142.
381.Evans CM, Vacca D, Khanfar NM, Harrington CA (2010). Conflict Resolution in a Retail Community Pharmacy: Drugmart Pharmacy Case. Journal of Business Studies Quarterly, 1 (3), 53-67.
382.Evans, J.V., Ammer, A.G., Jett, J.E., Martin, K.H., Culp, M.V., Gannett, P.M., & Weed, S.A. (2012). Src Binds Cortactin Through a Novel SH2 Domain Cystein-mediated Linkage Journal of Cell Science, 124 (), 6185-6197.
383.Evdokimova, V.E., McLoughlin, R.K., Wenger, S.L., & Grant, S.G. (2005). Use of the glycophorin A bone marrow somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype. American Journal of Medical Genetics A, 135 (1), 59-65.
384.F Narimani, MJ Zohuriaan-Mehr, K Kabiri, H Omidian, H Bouhendi (2012). Overentrant Swelling Behavior in Poly(potassium, 3-sulfopropyl acrylate-acrylic acid) Hydrogels Journal of Polymer Research, 19 (12), 1-8.
385.F. Afshar-Taromi, H. Omidian (1989). Electrically Conducting Polymers Iranian Journal of Polymer Science and Technology, 2 (2), 122-133.
386.F. Askari, S. Nafisi, H. Omidian, S.A. Hashemi (1993). Synthesis and Characterization of Acrylic-based Superabsorbents Journal of Applied Polymer Science, 50 ( ), 1851-1855.
387.Fakioglu, H., Gelvez, J., Torbati, D., Glover, M.L., Olarte, J.L., Camacho, M.T., Wolfsdorf, J. (2004). Aminophylline therapy during endotoxemia in anesthetized spontaneously breathing rats. Pharmacological Research, 49 (), 45-50.
388.Faria-Waziry, P.A., Puerta F., Rottaro, G., Castejon A.M., Cubeddu, L.X. (2017). Simvastatin and Oncolytic Vesicular Stomatitis Virus Actions on HeLa Cells Current Topics in Pharmacology, 21 (), 17-25.
389.Faria-Waziry, P.A., Puerta F., Rottaro, G., Castejon, A.M., Cubeddu, L.X. (2017). Simvastatin and Oncolytic Vesicular Stomatitis Virus Actions on HeLa Cells Current Topics in Pharmacology, 21 (), 17-25.
390.Fass J, Garcia AS (2011). In reply to: The US FDA joint collaborations:enhancing consumer access to health information technology and the pharmacists' role. Journal of American Pharmacists' Association, 51 (3), 328-330.
391.Fass JA, Fass AD, Garcia AS (2012). Synthetic cathinones (bath salts): legal statusand patterns of abuse. Annals of Pharmacotherapy, 46 (3), 436-441.
392.Fass, A.D., Gershman, J.A. (2013). Efficacy and safety of dipeptidyl peptidase-4 inhibitors in combination with metformin. Adv Ther, 30 (4), 337-353.
393.Fass, J., Fass, A. (2011). Physician-assisted suicide: Ongoing challenges for pharmacists. Am J Health-Syst Pharm, (68), 846-849.
394.Fass, J., Fass, A., Chun, P., Quansah, K. (2012). The role of the pharmacy profession. Drug disposal, 75 (4), 10-13.
395.Fass, J., Fass, A., Garcia, A.S., (2012). Synthetic cathinones (“bath salts”): legal status and patterns of abuse. Pharmacother, 43 (3), 436-441.
396.Feichtl, M.M., Clauson, K.A., Alkhateeb, F.M., Jamass, D.S., Polen, H.H. (2011). Community pharmacists’ use of language access services (LAS) in the United States. Journal of the American Pharmacists Association, 51 (3), 368-372.
397.Fernandez, Y., Ramakrishnan, R.G. and Rathinavelu, A (2000). Effect of Systemic Lupus Erythematosus (SLE) Treatment Drugs on GI-101A breast tumor cells. Life Sciences, 67 ( ), 567-575.
398.Fernandez, Y., Ramakrishnan, R.G. and Rathinavelu, A. (2000). Changes in PKC activity following chloroquine and prednisone treatment of GI-101A breast tumor cells. Life Sciences, 67 (), 567-575.
399.Ferris C., Morrison T., Iriah S., Kouranova I., M.Trivedi (2018). Evidence of neurobiological changes in the presymptomatic PINK1-/- KO rat Journal of Parkinson’s Disease, 8 (2), .
400.Ferris C., Morrison T., Iriah S., Kouranova I., Trivedi M. (2018). Evidence of neurobiological changes in the presymptomatic PINK1-/- KO rat Journal of Parkinson’s Disease, 8 (2), .
401.Flordellis, C., Papathanasopoulos, P., Lymperopoulos, A., Matsoukas, J., Paris, H. (2007). Emerging therapeutic approaches multi-targeting receptor tyrosine kinases and g protein-coupled receptors in cardiovascular disease. Cardiovasc. Hematol. Agents Med. Chem., 5 ( ), 133-145.
402.Flordellis, C., Paris, H., Karabinis, A., Lymperopoulos, A. (2004). Pharmacogenomics of adrenoceptors. Pharmacogenomics, 5 ( ), 803-817.
403.Fontánez-Nuin DE, Santini E, Quirk GJ and Porter J (2010). Memory for Fear Extinction Requires mGluR5-Mediated Activation of Infralimbic Neurons. Cerebral Cortex, 21 (3), 727-35.
404.Forlenza, M., Latimer, J., and Baum, A. (2000). The effects of stress on DNA repair capacity. Psychology and Health , 15 ( ), 881-891.
405.Fox, B.I., Flynn, A.J., Fortier, C.R., Clauson, K.A. (2011). Knowledge, skills, and resources for pharmacy informatics education. American Journal of Pharmaceutical Education. , 75 (5), Article 93.
406.Franck H, Potter J, Caballero J (2013). Venlafaxine and duloxetine: A comparison of efficacy and tolerability for the treatment of depression in elderly patients. The Mental Health Clinician, 3 (), 69.[website]
407.French, M.T. , J.F. Homer, I. Popovici, and P.K. Robins. (2015). What You Do in High School Matters: High School GPA, Educational Attainment, and Labor Market Earnings as a Young Adult. Eastern Economic Journal , 41 (3), 370-386.[website]
408.French, M.T., I. Popovici (2011). That Instrument is Lousy! In Search of Agreement When Using Instrumental Variables Estimation in Substance Use Research. Health Economics, 20 (2), 127-146.
409.French, M.T., I. Popovici, P.K. Robins, and J.F. Homer. (2014). Personal Traits, Cohabitation, and Marriage. Social Science Research , 45 (), 184-199.
410.French, M.T., I. Popovici, and L.M. Tapsell (2008). The Economic Costs of Substance Abuse Treatment: Updated Estimates and Cost Bands for Program Assessment and Reimbursement. Journal of Substance Abuse Treatment, 35 ( ), 462-469.
411.G. Bakhshandeh, H. Omidian, M. Vafaian (1990). Styrene-Butadiene Rubber Iranian Journal of Polymer Science and Technology, 3 (1), 29-38.
412.G. Salzano, G. Navarro, M. Trivedi, G. De Rosa, & V. Torchilin (2015). Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer. Mol Cancer Ther, 14 (4), 1075-1084.[website]
413.G. Vasiliver-Shamis, M. Tuen, T.W. Wu, T. Starr, T.O. Cameron, R. Thomson, G. Kaur, J. Liu, M.L. Visciano, H. Li, R. Kumar, R.A. Ansari, Dong P. Ha (2008). Hiv-1 enevlope gp120 induces a stop signal and virological synapse formation in non-infected CD4+ T-cells. J Virol, 82 (19), 9445-57.
414.GLENDA W JAMISON, ANDREA L LAZOWICK, AND JOSE A REY (1998). Abrupt Discontinuation of Fenfluramine and Dexfenfluramine May Cause Serotonin Withdrawal Syndrome JOURNAL OF PHARMACY TECHNOLOGY, (), .
415.Garcia AS (2010). Legistlative events:impacting student pharmacists. Florida Pharmacy Today Journal, 78 (11), 7-9.
416.Garcia DG, Caballero J (2011). Warfarin interactions with herbal supplements. Geriatric Education Center Channel (non-peer reviewed), 4 ( ), 5.
417.Gauther TP, Unger NR (2013). Antimicrobial stewardship programs: a review for the formulary decision maker. Formulary, 48 ( ), 7-18.
418.Gauthier TP, Lantz E, Heyliger A, Francis S, Smith L. (2013). Internet-based institutional antimicrobial stewardship program resources in leading US academic medical centers Clinical Infectious Diseases, ( ), .[website]
419.Gauthier TP, Moreira A, Chan C, Cabrera A, Toro M, Carrasquillo M, Corentin M, Sherman EM (2016). Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution J Am Pharm Assoc, 56 (6), 670-6.
420.Gauthier TP, Sherman EM, Unger NR (2015). An elective course on antimicrobial stewardship Am J Pharm Educ, 79 (10), 157.
421.Gauthier TP, Steinberg JG, Zapantis A, Aragon L (2015). Recognition of Advanced Pharmacy Practice Experience Student Participation Within Antimicrobial Stewardship Activities. Journal of Pharmacy Technology, 31 (1), 3-7.
422.Gauthier TP, Wasko J, Unger NR, Abbo LM, Fernandez M, & Aragon L (2016). Cost reduction of inhaled tobramycin by use of preservative-free intravenous tobramycin given via inhalation. Antibiotics, 5 (1), 1-8.[website]
423.Gauthier TP, Wolowich WR, Reddy A, Cano E, Abbo L, Smith LB (2012). Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrob Agents Chemother, 56 (5), 2392-6.
424.Gauthier TP, Worley M, Laboy V, Hernandez L, Unger NR, Sherman EM, Frederick C, Aragon L (2014). Clinical infectious diseases pharmacists in the United States: a problem of both supply and demand. Clinical Infectious Diseases , 60 (15), 826-827.
425.Gauthier,T.P.,Lantz,E.,Frederick, C.,Masmouei,H.,Ruiz-Serrano,L.,Wolowich,W.R.,Abbo,L.M. (2014). Variability within investigations of intravenous colistin: the scope of the problem. Clinical Infectious Diseases, 58 (9), 1340-42.
426.Geletko SM. , Poulakos MN (2002). Pharmaceutical Care Services in an HIV Clinic. AJHP, 59 (8), 709-713.
427.Gernant SA, Hale G, Joseph T, Jones, R.S., Alameddine S, Maravent S, Eltaki S, Lucibella R, & Seamon MJ (2017). Building partnerships between a college of pharmacy and ACOs: development of the ACORN SEED. American Journal of Accountable Care, 5 (3), 29-99.[website]
428.Gershman J, Fass A ( ). Medication safety and pharmacovigilance resources for the ambulatory care setting: enhancing patient safety. Hospital Pharmacy , ( ), .
429.Gershman, J., Fass, A. (2014). Medication safety and pharmacovigilance resources for the ambulatory care setting: enhancing patient safety. Hosp Pharm, 49 (4), 363-368.
430.Gershman, J., Fass, A., Gershman, J., and Popovici, I. (2014). Evaluation of Florida Physicians’ Knowledge and Attitudes toward Accessing the State Prescription Drug Monitoring Program as a Prescribing Tool. Pain Medicine , 15 (12), 2013-2019.
431.Gershman, J.A., Fass, A.D. (2013). Dextromethorphan abuse: a literature review. J Pharm Technol, 29 (), 66-71.
432.Gershman, J.A., Fass, A.D. (2012). Hydrocodone rescheduling amendment and pipeline products on the horizon P&T, 37 (7), 399-404.
433.Gershman, J.A., Fass, A.D. (2012). Synthetic cathinones (‘bath salts’) legal and health care challenges [editorial]. P&T, 37 (10), 571-572, 595.
434.Gershman, J.A., Fass, A.D., Trivieri, K. (2013). Florida pharmacist licensure: steps for the future pharmacist. Pharmacy Today, 76 (3), 12-13.
435.Gettman, D. A. (2001). Book Review, The Patient Self-Determination Act: Meeting the Challenges in Patient Care by Lawrence P Ulrich. Annals of Pharmacotherapy, 35 (February), 265.
436.Glover, M.L., Armayor, G.M. (2004). Expectations and orientation activities of first-year pharmacy practice faculty. American Journal of Pharmaceutical Education, 68 (), Article 87.
437.Glover, M.L., Armayor, G.M. (2006). An assessment of college of pharmacy promotion committees and criteria for promotion for pharmacy practice faculty. Pharmacy Education, 6 (), 275-280.
438.Goldman, R., Claycamp, H.G., Sweetland, M.A., Sedlev, A.V., Tyurin, V.A., Kisin, E.R., Tyurina, Y.Y., Ritov, V.B., Wenger, S.L., Grant, S.G., & Kagan, (1999). Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells. Free Radical Biology and Medicine, 27 (9-10), 1050-1063.
439.Goldstein B, M.Trivedi, Speth RC (2017). Alterations in Gene Expression of Components of the Renin-Angiotensin System and Its Related Enzymes in Lung Cancer Lung Cancer International, 2017 (), .
440.Goldstein B, Speth RC, M.Trivedi (2016). Renin–angiotensin system gene expression and neurodegenerative diseases J Renin Angiotensin Aldosterone Syst. , 17 (3), .
441.Gonsai NH, Amin VH, Mendpara CG, Robert C. Speth, & Hale GM (2018). Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure. Journal of Clinical Pharmacy and Therapeutics, 43 (1), 1-7.[website]
442.Gowrisankar, Y.V. and Clark, M.A. (2016). Regulation of Angiotensinogen Expression by Angiotensin II in Spontaneously Hypertensive Rat Primary Astrocyte Cultures. Brain Research, 1643 (), 51-58.
443.Gowrisankar, Y.V. and Clark, M.A. (2016). Angiotensin II Induces Interleukin-6 Expression in Astrocytes: Role of Reactive Oxygen Species and NFkB. Molecular and Cellular Endocrinology, 437 (), 130-141.
444.Gowrisankar, Y.V. and Clark, M.A. (2016). Angiotensin II Regulation of ACE and ACE2 in Spontaneously Hypertensive Rat Primary Astrocyte Cultures. Journal of Neurochemistry , 138 (), 74-85.
445.Grant, S.G. (2010). Tobacco smoke exposure and somatic mutations in newborns. Open Pediatric Medicine Journal, 4 ( ), 10-13.
446.Grant, S.G. (2001). Molecular epidemiology of human cancer: biomarkers of genotoxic exposure and susceptibility. Journal of Environmental Pathology, Toxicology and Oncology, 20 (4), 245-261.
447.Grant, S.G. (2005). The GPA in vivo somatic mutation assay. Methods in Molecular Biology, 291 ( ), 179-195.
448.Grant, S.G. (2005). Qualitatively and quantitatively similar effects of active and passive maternal tobacco smoke exposure on in utero mutagenesis at the HPRT locus. BMC Pediatrics, 5 ( ), 20.
449.Grant, S.G., & Bigbee, W.L. (1994). Bone marrow somatic mutation after genotoxic cancer therapy. The Lancet, 343 (8911), 1507-1508.
450.Grant, S.G., & Bigbee, W.L. (1993). In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus: phenotypic variation encompassing both gene-specific and chromosomal mechanisms. Mutation Research, 288 (1), 163-172.
451.Grant, S.G., & Chapman, V.M. (1991). Detailed genetic mapping of the A-raf proto-oncogene on the mouse X chromosome. Oncogene, 6 (3), 397-402.
452.Grant, S.G., & Chapman, V.M. (1988). Mechanisms of X-chromosome regulation. Annual Review of Genetics, 22 ( ), 199-233.
453.Grant, S.G., & Worton, R.G. (1989). Activation of the hprt gene on the inactive X chromosome in transformed diploid female Chinese hamster cells. Journal of Cell Science, 92 (4), 723-732.
454.Grant, S.G., & Worton, R.G. (1989). Differential activation of the hprt gene on the inactive X chromosome in primary and transformed Chinese hamster cells. Molecular and Cellular Biology, 9 (4), 1635-1641.
455.Grant, S.G., Bigbee, W.L., Langlois, R.G., & Jensen, R.H. (1991). Allele loss at the human GPA locus: a model for recessive oncogenesis with potential clinical application. Clinical Biotechnology, 3 ( ), 177-185.
456.Grant, S.G., Campbell, C.E., Duff, C., Toth, S.L., & Worton, R.G. (1989). Gene inactivation as a mechanism for the expression of recessive phenotypes. American Journal of Human Genetics, 45 (4), 619-634.
457.Grant, S.G., Das, R., Cerceo, C.M., Rubinstein, W.S., & Latimer, J.J. (2007). Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier. Pathology and Oncology Research , 13 (4), 276-283.
458.Grant, S.G., Mattei, M.-G., Galland, F., Stephenson, D.A., Keitz, B.T., Birnbaum, D., & Chapman, V.M. (1990). Localization of the mouse Mcf-2 (Dbl) protooncogene within a conserved linkage group on the mouse X chromosome. Cytogenetics and Cell Genetics, 54 (3-4), 175-181.
459.Grant, S.G., McLoughlin, R.K., & Wenger, S.L. (2005). Unusual pattern of bone marrow somatic mutation in pediatric patients referred for cytogenetic analysis. Balkan Journal of Medical Genetics, 8 (1&2), 45-51.
460.Grant, S.G., Melan, M.A., Latimer, J.J., & Witt-Enderby, P.A. (2009). Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. Expert Reviews in Molecular Medicine, 11 ( ), e5.
461.Grant, S.G., Reeger, W., & Wenger, S.L. (1998). Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. Genetic Testing, 1 (4), 261-267.
462.Grant, S.G., Swiatek, D.A., Benz, R.A., & Stephenson, D.A. (1988). Golden: a novel coat color mutant in the wild mouse Mus caroli. Journal of Heredity, 79 (3), 151-154.
463.Grant, S.G., Wenger, S.L., Latimer, J.J., Thull, D., & Burke, L.W. (2000). Analysis of genomic instability using multiple assays in a patient with Rothmund-Thomson syndrome. Clinical Genetics, 58 (3), 209-215.
464.Grant, S.G., Zhang, Y.P., Klopman, G., & Rosenkranz, H.S. (2000). Modeling the mouse lymphoma forward mutational assay: the Gene-Tox Program data base. Mutation Research, 465 (1-2), 201-229.
465.H Omidian, D Mastropietro (2013). Fighting a New Drug Epidemic, , 2(1):e120,2013 Journal of Developing Drugs, 2 (1), e120.
466.H Omidian, D Mastropietro, U Kandalam (2014). Swelling, Strength, and Biocompatibility of Superporous Hydrogel Hybrids Journal of Bioactive and Compatible Polymers, 29 (1), 66-80.
467.H Omidian, J G. Rocca, K Park (2005). Advances in Superporous Hydrogels Journal of Controlled Release, 102 (1), 3-12.
468.H. Omidian (2001). Superabsorbent Polymers Chemistry and Development, 2 (5), 44-47.
469.H. Omidian (1995). Critical Review of the Chemical Engineering Thermodynamics Iranian Journal of Chemistry, 8 (1), 59-61.
470.H. Omidian (1998). Superabsorbent Polymers Iranian Journal of Chemistry, 11 (1), 18-23.
471.H. Omidian (2000). Superabsorbents in Iran, From a Souvenir to Superabsorbent Technology Chemistry and Development, 1 (2), 32-36.
472.H. Omidian, C. Gavrilas, W. Han, G. Li and J.G. Rocca (2008). Very-Pure Superporous Hydrogels with Outstanding Swelling Properties. US Patent Application 2008-0206339, ( ), .[website]
473.H. Omidian, J G. Rocca (2008). Superporous Hydrogels for Heavy Duty Applications US Patent Application 2008-0089940, ( ), .[website]
474.H. Omidian, J.G. Rocca (2006). Formation of Strong Superporous Hydrogels US Patent 7,056,957, ( ), .[website]
475.H. Omidian, J.G. Rocca, K. Park (2006). Elastic Superporous Hydrogel Hybrid of Polyacrylamide and Sodium Alginate. Macromolecular Bioscience, 6 (9), 703-710.
476.H. Omidian, K. Park (2002). Experimental Design in the Synthesis of Polyacrylamide Superporous Hydrogels Journal of Bioactive and Compatible Polymers, 17 (6), .
477.H. Omidian, K. Park, J.G. Rocca (2007). Recent Developments in Superporous Hydrogels. Journal of Pharmacy and Pharmacology, 59 (3), 317-327.
478.H. Omidian, K. Park, and J.G. Rocca (2010). Experimental Design in Preparation of Modified HEMA-based Superporous Hydrogels in an Aqueous Medium. International Journal of Polymeric Materials, 59 (9), 693-709.
479.H. Omidian, K. Park, and J.G. Rocca (2010). Swelling and Mechanical Properties of Modified HEMA-based Superporous Hydrogels. Journal of Bioactive and Compatible Polymers, 25 (5), 483-497.
480.H. Omidian, K. Park. (2008). Swelling Agents and Devices in Oral Drug Delivery. Journal of Drug Delivery Science and Technology, 18 (2), 83-93.
481.H. Omidian, M.J. Zohuriaan-Mehr (2002). DSC Studies on Synthesis of Superabsorbent Hydrogels Polymer, 43 (2), 269-277.
482.H. Omidian, M.J. Zohuriaan-Mehr, H. Bouhendi (2003). Polymerization of Sodium Acrylate in Inverse-Suspension Stabilized by Sorbitan Fatty Esters. European Polymer Journal, 39 (5), 1013-1018.
483.H. Omidian, M.J. Zohuriaan-Mehr, H. Bouhendi, (2003). Aqueous Solution Polymerization of Neutralized Acrylic Acid using Na2S2O5/ (NH4)2S2O8 Redox Pair System under Atmospheric Conditions International Journal of Polymeric Materials, 52 (4), 307-321.
484.H. Omidian, M.J. Zohuriaan-Mehr, K. Kabiri, K. Shah (2004). Polymer Chemistry Attractiveness: Synthesis and Swelling Studies of Gluttonous Hydrogels in the Advanced Academic Laboratory Journal of Polymer Materials, 21 (3), 281-292.
485.H. Omidian, S.A. Hashemi, F. Askari, S. Nafisi (1994). Modifying Acrylic-based Superabsorbents II. (Modification of Process Nature) Journal of Applied Polymer Science, 54 ( ), 251-256.
486.H. Omidian, S.A. Hashemi, F. Askari, S. Nafisi (1994). Swelling and Crosslink Density Measurements for Hydrogels Iranian Journal of Polymer Science and Technology, 3 (2), 115-119.
487.H. Omidian, S.A. Hashemi, F. Askari, S. Nafisi (1994). Modifying Acrylic-based Superabsorbents I. (Modification of Crosslinker and Comonomer Nature) Journal of Applied Polymer Science, 54 ( ), 241-249.
488.H. Omidian, S.A. Hashemi, P.G. Sammes, I. Meldrum (1999). Modified Acrylic-based Superabsorbent Polymers (Dependence on Particle Size and Salinity). Polymer, 40 ( ), 1753-1761.
489.H. Omidian, S.A. Hashemi, P.G. Sammes, I. Meldrum (1998). A Model for the Swelling of Superabsorbent Polymers Polymer, 39 (26), 6697-6704.
490.H. Omidian, S.A. Hashemi, P.G. Sammes, I. Meldrum (1998). Modified Acrylic-based Superabsorbent Polymers: Effect of Temperature and Initiator Concentration Polymer, 39 (15), 3459-3466.
491.H. Omidian, Y. Qiu, D.J. Kim, S.C. Yang, H. Park, K. Park (2005). Hydrogels Having Enhanced Elasticity and Mechanical Strength Properties. US Patent 6,960,617, ( ), .[website]
492.Hale G, & Brenner M (2015). Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients. American Journal of Cardiovascular Drugs, 15 (5), 311-322.[website]
493.Hale G, Ebaugh S, & Brenner M (2015). A comparative evaluation of adverse drug reactions and the incidence of stroke amongst the target specific oral anticoagulants. Journal of Hematology & Thrombosis, 1 (2), 1-6.[website]
494.Hale G, Joseph T, Maravent S, Stern D, Alameddine S, Stultz K, Nieves A, Miller J, Scott K, Rodriguez MM, & Perez A (2018). Effect of interprofessional collaboration on quality of life in elderly patients with cardiovascular disease. Journal of Interprofessional Education & Practice, 12 (), 25-28.[website]
495.Hale GM, & Brenner M (2015). Atomoxetine for orthostatic hypotension in an elderly patient over 10 weeks: a case report. Pharmacotherapy, 35 (9), e141-e148.[website]
496.Hale GM, Hassan SL, Hummel SL, Lewis C, Ratz D, & Brenner M (2017). Impact of a pharmacist-managed heart failure post-discharge (bridge) clinic for Veterans. Annals of Pharmacotherapy, 51 (7), 555-562.[website]
497.Hale GM, Joseph T, Moreau, C., Prados Y, Gernant S, Schneller M, Jones, R.S., Seamon MJ, & Rodriguez H (2018). Establishment of outpatient rounds by an interprofessional chronic care management team. American Journal of Health-System Pharmacy, 75 (10), 598-601.[website]
498.Hale GM, Kane-Gill SL, Groetzinger L, & Smithburger PL (2016). An evaluation of adverse drug reactions associated With antipsychotic use for the treatment of delirium in the intensive care unit. Journal of Pharmacy Practice, 29 (4), 355-360.[website]
499.Hale GM, Valdes J, & Brenner M (2017). The treatment of primary orthostatic hypotension. Annals of Pharmacotherapy, 51 (5), 417-428.[website]
500.Hall, P.D., Fish, H., McBane, S., Mercer, J., Moreau, C., Owen, J., Policastri, A., Rattinger, G.B., Srivastava, S.B., Thomas, M.C., Bradley-Baker, L.R. (2019). The Report of the 2018-2019 Professional Affairs Standing Committee: The Role of Educators in Pharmacy Practice Transformation American Journal of Pharmaceutical Education, (), .[website]
501.Hamill-Ruth R & McGory R (1996). Magnesium Repletion and Its Effect on Potassium Homeostasis in Critically Ill Adults: Results of a Double-blind, Randomized, Controlled Trial. Crit Care Med, 24 (1), 38.
502.Hansen, R.A., Droege, M. (2005). Methodological Challenges Surrounding Direct-To-Consumer Advertising  The Measurement Conundrum. Research in Social and Administrative Pharmacy, 1 (2), 331-347.
503.Hardigan, P., Carvajal, M. and I. Popovici. (2015). Response rate, response time, and economic costs of survey research: a randomized trial of practicing pharmacists. Research in Social and Administrative Pharmacy, 12 (1), 141-148.
504.Hardigan, P., Lai, L., Arneson, D, Robeson, A. (2001). The Significance of Academic Merit, Test Scores and Interviews in the Admissions Process: A Case Study. American Journal of Pharmaceutical Education, 65 (Spring), 40-44.
505.Hardigan, P., Lai, L., Carvajal, M. (2001). The Influence of Positive and Negative Affectivity on Reported Job Satisfaction Among Practicing Pharmacists Journal of Pharmaceutical Marketing and Management, 13 (4), 57-71.
506.Harrington C, Anderson HH, Vacca DJ, Khanfar NM (2010). Opening a New Service Marketing Channel for Medical Products: How Pharmacists became Immunizers. Journal of Service Science, 3 (2), 25-32.
507.Harrington C, English C (2010). Tolerability of Paliperidone: A meta-analysis of randomized, controlled trials. IN PRESS International Clinical Psychopharmacology, ( ), .
508.Harrington C, Khanfar NM, Bond DR, Vila I. (2010). Utilizing the Medical Literature for Market Research: Finding New Approaches to Marketing Substance Abuse Treatment Clinics. Journal of Medical Marketing, 10 (4), 344-351.
509.Harrington CA, English C (2010). Tolerability of paliperidone: a meta-analysis of randomized, controlled trials. International Clinical Psychopharmacology, 25 ( ), 334-341.
510.Harrington CA, English C (2011). Adverse drug events related to ziprasidone: a meta-analysis of randomized, placebo-controlled trials. Pharmacotherapy, 31 (9), 840-849.
511.Harrington CA, Garcia AS, Sircar F (2011). Evaluation of Adverse Drug Event Information in US Manufacturer Labels. Current Drug Safety, 6 ( ), 30-35.
512.Harris JR, Hale GM, Dasari TW, & Schwier NC (2016). Pharmacotherapy of vasospastic angina. Journal of Cardiovascular Pharmacology and Therapeutics, 21 (5), 439-451.[website]
513.Hart-Borja N, Douglas S, Marino J, Garcia AS, Anderson-Worts P (2011). Preparation for a medical mission. West Indian Medical Journal, 60 (2), 199-202.
514.Harvey, A.N., Nguyen, K., Lymperopoulos, A. (2011). GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting. Current Molecular Pharmacology, Epub ( ), .
515.Haspula. D. and Clark, M.A. (2016). Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats. Journal of Neurochemistry, 139 (), 523-536.
516.Hass T, Khanfar NM, Kaifi BA (2016). DirecTV Consumer Contract: A Case Study Journal of Business Studies Quarterly (JBSQ), 8 (2), 90-101.
517.Hassanzadah, M, Bitar, Adib H, Khanfar NM, Khasawneh FT Lutfy K, Shankar G (2019). A retrospective cohort study of the prevalence of anxiety and agitation in schizophrenic smokers and the unmet needs of smoking cessation programs. Medicine, 98 (40), 1-5.[website]
518.He H., Sheng J., David A. E., Kwon Y. M., Zhang J., Huang Y., Wang J., Yang V. C. (2013). The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption. Biomaterials, 34 (31), 7733-43.
519.He H., Ye J., Wang Y., Liu Q., Chung H. S., Kwon Y. M., Shin M. C., Lee K., Yang V. C. (2014). Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. Journal of Controlled Release, 176 (), 123-32.
520.Hedges, J.R., Soliman, K., D'Amour,G., Liang,D., Rodriguez-Diaz,C., Thompson,K., Rabionet, S. (2018). Academic Response to Storm-Related Natural Disasters-Lessons Learned. International Journal of Environmental Research and Public Health, 15 (8), 1768.
521.Henry, B., Grant, S.G., Klopman, G., & Rosenkranz, H.S. (1998). Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms. Mutation Research, 397 (2), 313-335.
522.Hong, K.A., Yancey, K., Battistella, L., Williams, R., Hickey, K., Bostick, C., Gannett, P. & Sooter, L. (2015). Selection of Single-Stranded DNA Molecular Recognition Elements Against Exotoxin A using A Novel Decoy-SELEX Method and Sensitive Detection of Exotoxin A in Human Serum. BioMed Research International, (), 417641.[website]
523.Huang HF.,Lai, L., Rivera HJ. (2012). Effective Mathematics Strategies for Pre-School Children with Autism. Australian Primary Mathematics Classroom, 17 (2), 25-30.
524.Huang, Y., Park, Y.S., Wang, J., Moon, C., Kwon, Y.M., Chung, H.S., Park, Y.J., & Yang, V. C. (2010). ATTEMPTS System: A Macromolecular Prodrug Strategy for Cancer Drug Delivery. Current Pharmaceutical Design, 16 (), 2369-76.
525.Hunter, T.S., Droege, M., Marsh, W.A., Droege, W. (2005). Hunter, T.S., Droege, M., Marsh, W.A., Droege, W. (2005) Effectively Managing Pharmaceutical Returns and Waste Drug Topics, (January), .
526.Husain K, Ferder L, Ansari RA, Lalla J (2011). Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats Hum Exp Toxicol, ( ), .
527.Husain K., Hernandez W., Ansari, R.A. & Ferder L (2015). Inflammation, oxidative stress and renin angiotensin system in atherosclerosis World Journal of Biological Chemistry, 6 (3), 209-217.
528.Husain, Ansari, R.A., and Leon Ferder (2010). Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication Ind. J. Exp. Biol, 48 (7), 642-650.
529.Ibrahim, O. As Sobeai, H.M., Grant, S.G., Latimer, J.J. (2018). Nucleotide excision repair as a predictor of early relapse in pediatric acute lymphoblastic leukemia BMC Medical Genomics, 11 (), 95.[website]
530.Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T & Lake J (1997). Retransplantation of Patients with Severe Posttransplant Hepatitis B in the First Allograft. Transplantation, 64 (3), 410.
531.J. B. Park, Y. M. Kwon, T. Y. Lee, R. Brim, M. C. Ko, R. Sunahara, J. H. Woods, V. C. Yang (2010). PEGylation of Bacterial Cocaine Esterase for Protection against Protease Digestion and Immunogenicity. Journal of Controlled Release, 142 (2), 174-9.
532.J. Czerwinska (1987). Computer simulation of experimental Zeeman-effect patterns of forbidden lines of BiI and BiII and estimation of electric-quadrupole admixture in mixed-type radiation. Journal of Optical Society of America, B (4), 1349-1357.
533.J. Czerwinska, S. Mrozowski (1991). Further computer simulation studies of experimental Zeeman-effect patterns of miced second-order radiation of BiI. Journal of Optical Society of America, B (8), 940-945.
534.J.G. Rocca, H. Omidian, K. Shah (2005). Gastric Retention Technologies: Commercial Status of Gastric Retention Technologies Drug Delivery Technology, 5 (4), 40-46.
535.J.G. Rocca, H. Omidian, K. Shah (2003). Progresses in Gastroretentive Drug Delivery Systems. Business Briefing, PharmaTech, ( ), 152-6.
536.J.G. Rocca, K. Shah, H. Omidian (2004). Superporous Hydrogels containing Solid and Semi-solid Carriers Gattefosse Technical Bulletin, 97 ( ), 73-84.
537.Jacobi J, McGory R, McCoy H & Matzke G (1983). Hemodialysis Clearance of Total and Unbound Lidocaine. Clinical Pharmacy, 1 ( ), 54.
538.Jacobs RJ, Lou JQ, Ownby RL, Caballero J. (2014). A systematic review of eHealth interventions to improve health literacy. Health Informatics Journal [June epub ahead of print], (), .[website]
539.Jacobs RJ, Ruff H, Chipon-Schoepp N, Caballero J, Kane MN, Russell A (2011). The association between religious affiliation and beliefs about end of life care. Journal of Social Work in End-of-Life and Palliative Care, ( ), (Submitted).
540.Jafferjee, M., Valero, T.R., Marrero, C., McCrink, K.A., Brill, A., Lymperopoulos, A. (2016). GRK2 up-regulation creates a positive feedback loop for catecholamine production in chromaffin cells. Mol. Endocrinol., 30 (), 372-381.
541.Jaisri, G., Rathinavelu, A. and Isom, G.E. (1992). Interaction of Cadmium with Atrial Natriuretic Peptide Receptors: Implications for Toxicity. Toxicology, 75 (), 133-243.
542.Jan Bakos, Zuzana Bacova, Stephen G. Grant, Castejon, A.M. Daniela Ostatnikova. (2015). Are Molecules Involved in Neuritogenesis and Axon Guidance Related to Autism Pathogenesis? Neuromol Med , 10.10 (), .
543.Jasmin, J.F., Rengo, G., Lymperopoulos, A., Gupta, R., Eaton, G.J., Quann, K., Gonzales, D.M., Mercier, I., Koch, W.J., Lisanti, M.P. (2011). Caveolin-1 Deficiency Exacerbates Cardiac Dysfunction and Reduces Survival in Mice with Myocardial Infarction American Journal of Physiology: Heart and Circulatory Physiology, 300 ( ), H1274-H1281.
544.Jayalakshmi Sridha, Nagaraju Akula, Dhakshamamurthy Sivanesan, Appu Rathinavelu and Nagarajan Pattabhiraman (2005). Inhibition of Novel Angiogenesis Factors. Bioorganic and Medicinal Chemistry Letters, 15 ( ), 4125-4129.
545.Jell, J, Ramakrishnan. R. and Rathinavelu, A (2002). Regulation of expression of mdm2 mRNA in human breast tumor derived GI-101A cells. Life Sciences, 71 ( ), 2331-2339.
546.Jenkins J, Khanfar NM, Kaifi BA (2017). Coping with Changing Business Models in Medicine: A Case Study. Journal of Business Studies Quarterly (JBSQ), 8 (4), 123-131.
547.Jennings DL, Horn ET, Lyster H, Panos AL, Teuteberg JJ, Lehmkuhl HB, Perez A, Shullo MA. (2016). Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: An international survey. ASAIO, 62 (1), 28-32.
548.Jensen, R.H., Bigbee, W.L., Langlois, R.G., Grant, S.G., Pleshanov, P.G., Chirkov, A.Y., & Pilinskaya, M.A. (1991). Laser-based flow cytometric analysis of genotoxicity of humans exposed to ionizing radiation during the Chernobyl accident. SPIE Proceedings, 1403 ( ), 372-380.
549.Jensen, R.H., Grant, S.G., Langlois, R.G., & Bigbee, W.L. (1991). Somatic cell genotoxicity at the glycophorin A locus in humans. Progress in Clinical and Biological Research, 372 ( ), 329-339.
550.Jensen, R.H., Langlois, R.G., Bigbee, W.L., Grant, S.G., Moore, D., II, Pilinskaya, M., Vorobtsova, I., & Pleshanov, P. (1995). Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiation Research, 141 (2), 129-135.
551.Jensen, R.H., Reynolds, J.C., Robbins, J., Bigbee, W.L., Grant, S.G., Langlois, R.G., Pineda, J.D., Lee, T., & Barker, W.C. (1997). Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131. Radiation Research, 147 (6), 474-752.
552.Jesus Sanchez (2014). Self-medication practices among a sample of Latino migrant workers in South Florida Frontiers in Public Health, 2 (109), 1-7.
553.Jesus Sanchez (2015). Alcohol use among Latino migrant workers in South Florida Drug and Alcohol Dependence, 151 (), 241-249.
554.Jesus Sanchez; Claudia A. Serna; Mario de la Rosa (2012). Project Salud: Using community-based participatory research to culturally adapt an HIV prevention intervention in the Latino migrant worker community International Public Health Journal, 4 (3), 301-308.
555.Jesus Sanchez; Dale D. Chitwood; Dixie J. Koo (2006). Risk Factors Associated with the Transition from Heroin Sniffing to Heroin Injection: A Street Addict Role Perspective Journal of Urban Health, 83 (5), 896-910.
556.Jesus Sanchez; Georgina Silva-Suarez; Claudia Serna; Mario de la Rosa (2012). The Latino Migrant Worker HIV Prevention Program Building a Community Partnership Through a Community Health Worker Training Program Family & Community Health, 35 (2), 139-146.
557.Jesus Sanchez; J. B. Page; D. D. Chitwood; D. C. McBride; K.R. Kitner; M. Comerford (2000). First injection and current risk factors for HIV among new and long-term injection drug users AIDS Care, 12 (3), 313-320.
558.Jesus Sanchez; Mario de la Rosa; Claudia A. Serna (2013). PROJECT SALUD: EFFICACY OF A COMMUNITY-BASED HIV PREVENTION INTERVENTION FOR HISPANIC MIGRANT WORKERS IN SOUTH FLORIDA AIDS Education and Prevention, 25 (5), 363-375.
559.Jesus Snchez; M. Comerford; D. D. Chitwood; M. I. Fernandez; C.B. McCoy (2002). High risk sexual behaviours among heroin sniffers who have no history of injection drug use: Implications for HIV risk reduction AIDS Care, 14 (3), 391-398.
560.Jett, J.E., Lederman, D., Wollenberg, L.A., Li, D., Flora, D.R., Bostick, C.D., Tracy, T.S., & Gannett, P.M. (2013). Measurement of Electron Transfer through Cytochrome P450 Protein on Nanopillars and the Effect of Bound Substrates Journal of the American Chemical Society, 135 (), 3834-3840.
561.Jimmy Delaney, Roselynn Chiarello, David Villar, Umadevi Kandalam, Ana Maria Castejon and (2008). Regulation of c-fos, c-jun and c-myc Gene Expression by Angiotensin II in Primary Cultured Rat Astrocytes: Effect of ERK1/2 MAP Kinases. Volume 33(3) pages: 545-550, 2008. Neurochemical Research, 33 (3), 545-550.
562.Joseph T, Hale GM, Eltaki SM, Prados Y, Jones, R.S., Seamon MJ, Moreau, C., & Gernant SA (2017). Integration strategies of pharmacists in primary care-based accountable care organizations: a report from the Accountable Care Organization Research Network, Services, and Education. Journal of Managed Care and Specialty Pharmacy, 23 (5), 541-548.[website]
563.Joseph T., Barros RA., Kim, E., Shah B., (2018). Evaluation of Early Versus Late Postdischarge Medication Reconciliation on Readmission Rates and Emergency Department Visits Journal of Pharmacy Practice, 31 (3), 279-81.
564.Joshi, N., & Grant, S.G. (2005). DNA double strand break damage and repair assessed by pulsed-field gel electrophoresis. Methods in Molecular Biology, 291 ( ), 121-129.
565.Juni, K; Nieves, E.A.; Perrin, J.H (1983). Novel Observations of a Drug (Indoprofen) Albumin Interactions Biopharmaceutics & Drug Disposition, 4 (1), 1-7.
566.K Kabiri, H Omidian, MJ Zohuriaan-Mehr, S Doroudiani (2011). Superabsorbent Hydrogel Nanocomposites Polymer Composites, 32 (2), 277-289.
567.K Kabiri, S Hesarian, MJ Zohuriaan-Mehr, A Jamshidi, H Bouhendi, MR Pourheravi, SA Hashemi, H Omidian, S Fathollahi (2011). Superabsorbent Polymer Composites, Does Clay Always Improve Properties? Journal of Materials Science, 46 (20), 6718-6725.
568.K Kabiri, SM Jebeli, H Omidian, HR Motesadizadeh, DJ Mastropietro (2017). Surface Crosslinked Super-absorbent Hydrogels with Improved Swollen Gel Strength Using Diols Macromolecular Research, (), Submitted.
569.K. Husain and R.A. Ansari (1990). Effectiveness of certain drugs in acute malathion intoxication in rats. J. Ecotoxicology and Environmental Safety, 19 (), 271-275.
570.K. Husain and R.A. Ansari (1988). Influence of cholinergic and adrenergic blocking drugs on hyperglycemia and brain glycogenolysis in diazinon-treated animals Canadian Journal of Physiology and Pharmacology, 66 (), 1144-1147.
571.K. Husain, M. Vazquez, R.A. Ansari, M.P. Malafa and J. Lalla (2008). Chronic alcohol-induced oxidative endothelial injury relates to angiotensin II levels in rat Mol. Cell. Biochem, 307 (1-2), 51-58.
572.K. Husain, R.A. Ansari and Leon Ferder (2010). Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication Ind. J. Exp. Biol, 48 (7), 642-650.
573.K. Kabiri, H. Omidian, M.J. Zohuriaan-Mehr (2003). Novel Approach to Highly Porous Superabsorbent Hydrogels: Synergistic Effect of Progens on Porosity and Swelling Rate Polymer International, 52 ( ), 1158-1164.
574.K. Kabiri, H. Omidian, S.A. Hashemi, M.J. Zohuriaan-Mehr (2003). Synthesis of Fast-Swelling Superabsorbent Hydrogels: Effect of Crosslinker Type and Concentration on Porosity and Absorption Rate. European Polymer Journal, 39 ( ), 1341-8.
575.K. Kabiri, H. Omidian, S.A. Hashemi, M.J. Zohuriaan-Mehr (2003). Concise Synthesis of Fast-Swelling Superabsorbent Hydrogels: Effect of Initiator Concentration on Porosity and Absorption Rate Journal of Polymer Materials, 20 (1), 17-22.
576.K. Russel, A. Miller, J. Czerwinska (1995). Epidemiology for Community Health Nursing: An Interactive Computer Assisted Instruction Program. Computers in Nursing, 12 (2), 98-105.
577.K.W. Sinkevicius, T.R. Morrison, P. Kulkarni, M.K.C. Cagliostro, S. Iriah, S. Malmberg, J. Sabrick, J.A. Honeycutt, K.L. Askew, M. Trivedi, & C.F. Ferris. (2018). RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory Disease models & mechanisms, (), .[website]
578.Kabiri, K., Omidian, H., Zohuriaan, M. J., Doroudiani, S. (2010). Superabsorbent Hydrogel Nanocomposites. Polymer Composites, Accep ( ), .
579.Kaifi BA, Khanfar NM, Noor AO, Poluka L (2014). . International Business Students’ Understanding, Perception, and Commitment to Corporate Social Responsibility: A Study Based Upon Gender, Generational Affiliation, and Culture. Journal of Business and Management Research, 3 (3), 34-42.
580.Kaifi BA, Khanfar NM, Kaifi MM, Nafei WA (2013). The Need for Human Resource Managers to Understand and Prepare for Future Employees: A Study on the Perceptions of Business Students on Job Performance. Journal of Management and Sustainability, 3 (4), 103-109.[website]
581.Kaifi BA, Khanfar NM, Swigart PM (2017). Executive Interview: Learning from a General Manager of Ford: Tooran Popal Shares His Leadership Experiences, Strategies, and Ambitions. Journal of Applied Management and Entrepreneurship, 22 (3), 76-80.
582.Kaifi BA, Nafei WA, Khanfar NM, Kaifi MM (2012). A Multi-Generational Workforce: Managing and Understanding Millennials. International Journal of Business and Management, 7 (24), 88-93.
583.Kaifi BA, Noor AO, Nguyen NL, Aslami N, Khanfar NM (2014). The Importance of Situational Leadership in the Workforce: A Study Based on Gender, Place of Birth, and Generational Affiliation. Journal of Contemporary Management, 3 (2), 29-40.
584.Kandalam, U. and Clark, M.A. (2010). Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes. Regulatory Peptide, 159 (), 110-116.
585.Kandalam, U., Sarmiento, N., and Giridhar, D.H., and Clark, M.A. (2014). Angiotensin III induces signal transducer and activator of transcription 3and IL-6 mRNA expression in cultured rat astrocytes. Journal of the Renin Angiotensin Aldosterone System, 16 (), 758-767.
586.Kandalam, U.,Palanisamy, P., and Clark, M.A. (2012). Angiotensin II induces cell growth and IL-6 mRNA expression through the JAK2/STAT3 pathway in rat cerebellar astrocytes. JAK-STAT , 1 (), 83-89.
587.Kandalam, U.D., Omidian, H., Mirza, M.A., Cabel, A.M.I. (2014). Comparative Assessment of Growth Supporting Potential of Different Alginic Acid Salts International Journal of Biomaterials, (), .
588.Karkoulias, G., Mastrogianni, O., Ilias, I., Lymperopoulos, A., Taraviras, S., Tsopanoglou, N., Sitaras, N., Flordellis, C.S. (2006). Alpha 2-adrenergic receptors decrease DNA replication and cell proliferation and induce neurite outgrowth in transfected rat pheochromocytoma cells. Ann. N. Y. Acad. Sci., 1088 ( ), 335-345.
589.Karkoulias, G., Mastrogianni, O., Lymperopoulos, A., Paris, H., Flordellis, C. (2006). alpha(2)-Adrenergic receptors activate MAPK and Akt through a pathway involving arachidonic acid metabolism by cytochrome P450-dependent epoxygenase, matrix metalloproteinase activation and subtype-specific transactivation of EGFR. Cell. Signal., 18 ( ), 729-739.
590.Kasabdji, D. Shanmugam, V. and Rathinavelu, A. (1996). The effect of emesis inducing anticancer drugs on dopamine release from PC12 cell experimental model. Life Sciences, 59 (), 1793-1801 .
591.Kassimatis, T.I., Nomikos, A., Giannopoulou, I., Lymperopoulos, A., Moutzouris, D.A., Varakis, I., Nakopoulou, L. (2010). Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury. Renal Failure, 32 ( ), 243-253 .
592.Kawaguchi-Suzuki M, Hogue MD, Khanfar NM, Lahoz MR, Law MG, Parekh J, Zairina E, Hong J, Robles YR, Thang VV (2019). Cultural Sensitivity and Global Pharmacy Engagement in Asia: India, Indonesia, Malaysia, Philippines, and Vietnam. American Journal of Pharmacy Education, 83 (4), 651-664.[website]
593.Kazim Husain, R.A. Ansari, Leon Ferder (2014). Alcohol-induced hypertension: Mechanism and prevention World Journal of Cardiology, 26 (5), 245-252.
594.Kazim, S., Ansari, R. A., Husain, K. (2016). ALCOHOLIC BEVERAGES-INDUCED HYPERTENSION AND ITS MANAGEMENT World Journal of Pharmaceutical and Life Sciences, 2 (5), 311-338.
595.Kennedy D, Magboo M, Ruby C, Twersky J (2002). Underutilization of cardiac medication therapy in diabetic elderly outpatients at a Veterans Affairs Medical Center The Consultant Pharmacist, 17 (7), 580-586.
596.Kennedy D.H, Ward C.T, Metzner MC (2003). Distance education: using compressed interactive video technology for an entry-level Doctor of Pharmacy program American Journal of Pharmaceutical Education, 67 (4), article 118.
597.Kennedy DH (2001). Improving diagnosis and treatment of older people with depression. Pharmacy Times, 67 (10), 65-77.
598.Kennedy MJ, Phan H, Benavides S, Potts A, Sorensen S (2011). The Pediatric Pharmacy Advocacy Group (PPAG) Position Statement: The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children. Journal of Pediatric Pharmacology and Therapeutics, 16 (2), 118-122.[website]
599.Kennedy, D.H., Fanning, K.D. (2001). Recommendations for the monitoring and management of tardive dyskinesia The Consultant Pharmacist, 16 (6), 555-558.
600.Kennedy, D.H., Ward C.T., & Salvig B. (2005). Retrospective review of megestrol use in an elderly veteran population for non-HIV/non-cancer cachexia or anorexia. The Consultant Pharmacist, 20 (4), 301-305.
601.Kenney M, Daniels DM, Khanfar NM (2013). Entrepreneurship Education As a Method of Stimulating Bioenergy Ventures and Technology Transfer: A Propositional Model. Journal of Teaching and Education, 2 (4), 41-47.
602.Kenney M, Khanfar NM (2009). Antecedents of Repurchase Intention: Propositions Towards Using Marketing Strategy To Mitigate The Attrition of Online Students. Services Marketing Quarterly, 30 (3), 270-286.
603.Kenney M, Khanfar NM (2009). The Case of Rhode Island Latino Youth Entrepreneurship Program: How local institutions can adapt segmentation strategies to effectively service culturally diverse students. Journal of Asian Business Management, 1 (2), 301-304.
604.Kenney M, Khanfar NM, Kizer LE. (2010). Practitioner Perspectives of Information Technology Industry Intrapreneurship: An Exploratory Study. International Journal of Management & Information Systems, 14 (1), 35-39.
605.Kenney M, Khanfar NM, Mujtaba BG. (2010). The Value of Creating, Maintaining and Sustaining an Intrapreneurial Culture: A Case Analysis of 3M’s Strategic Positioning. International Journal of Arts and Sciences, 3 (13), 332-346.
606.Kenney M, Khanfar NM. (2011). How Best Buy Implements the Five Forces Model to Build Market Share and Customer Loyalty. International Journal of Arts and Sciences, 4 (22), 159-164.
607.Keohavong, P., Xi, L., & Grant, S.G. (2005). Molecular analysis of mutations in the human HPRT gene. Methods in Molecular Biology, 291 ( ), 161-170.
608.Keohavong, P., Xi, L., Day, R.D., Zhang, L., Grant, S.G., Day, B.W., Ness, R.B., & Bigbee, W.L. (2005). HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy. Mutation Research, 572 (1-2), 156-166.
609.Kern JK, Geier DA, Deth RC, Sykes LK, Hooker BS, Love JM, Bjørklund G, Chaigneau CG, Haley BE, Geier MR (2017). Systematic Assessment of Research on Autism Spectrum Disorder (ASD) and Mercury Reveals Conflicts of Interest and the Need for Transparency in Autism Research. Sci Eng Ethics, Nov 8 (), Epub ahead of print].
610.Kernodle AR, Frail CK, Gernant SA, Pater KS, Doebbeling BN, Snyder ME. (). Patients' Experiences Using a Brief Screening Tool for Medication-Related Problems in a Community Pharmacy Setting: A Qualitative Study. J Pharm Pract, (), .
611.Kerstein M.D, Gemmen E, Harrington C et al. (2001). Cost and Cost Effectiveness of Venous and Pressure Ulcer Protocols of Care Disease Management & Health Outcomes, 9 (11), 651-663.
612.Khanfar NM (2008). Mind Over Matter: Why Intellectual Capital Is the Chief Source of Wealth. Journal of Applied Management and Entrepreneurship, 13 (3), 114-116.
613.Khanfar NM Harrington CA, Alkhateeb FM, Kaifi BA (2013). Cultural Differences in Leadership Styles of Pharmacist Preceptors. Business and Management Research, 2 (1), 1-17.[website]
614.Khanfar NM, Adams M (2006). How do CEOS perceive certain mechanisms that build strategic flexibility and its impact on organizational profit: exploratory study. International Journal of Business and Public Administration, 3 (2), 75-88.
615.Khanfar NM, Adams, M. (2006). How do CEOS perceive certain mechanisms that build strategic flexibility and its impact on organizational profit: exploratory study. International Journal of Business and Public Administration, 3 (2), 75-88.
616.Khanfar NM, Alshare K, Chowdhury M I (2008). Consumer Perception of Television Direct-To-Consumer Advertising (DTCA) of Prescription Drugs: An Exploratory Study International Journal of Business, Marketing, and Decision Sciences, 1 (1), 116-135.
617.Khanfar NM, Alshare K, Miller DS (2008). Student Performance in an Interactive Video Conference Teaching Mode: An Empirical Study. The International Journal of Education Research, 14 (7), 109-119.
618.Khanfar NM, Clauson KA, Polen HH, Shields KM (2008). Self-Reported Influence of Television-Based Direct-to-Consumer Advertising on Patient Seasonal Allergy and Asthma Medication Use: An Internet Survey Current Therapeutic Research Clinical and Experimental, 6 (2), 130-141.
619.Khanfar NM, Loudon D (2008). Adams Jewelry. Journal of the International Academy For Case Studies, 14 (7), 109-119.
620.Khanfar NM, Loudon D (2008). Dr. Talal’s Honda Journal of the International Academy For Case Studies, 14 (3), 121-126.
621.Khanfar NM, Loudon D, Alkhateeb FM (2011). Dr. Abdul-Aziz: The Case of Management Principles Within a Small Pediatric Medical Practice. Journal of Business Studies Quarterly (JBSQ), 2 (2), 139-153.
622.Khanfar NM, Loudon D, Mujtaba BG (2010). Santorini Restaurant: One Entrepreneur’s Start-Up Adventure. Journal of Business Studies Quarterly, 1 (2), 70-74.
623.Khanfar NM, Loudon D, Sircar-Ramsewak F (2007). FDA-Direct-to Consumer Advertising for Prescription Drugs: What Are Consumer Preferences and Response Tendencies? Journal of Health Marketing Quarterly, 24 (1/2), 77-91.
624.Khanfar NM, Polen HH, Clauson KA (2009). Influence on Consumer Behavior: The Impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder. Journal of Health Communication, 14 (5), 451-460.
625.Khanfar NM, Swaidan Z, Mujtaba BG (2009). A Study in Relationship Orientation and Prioritization of Alumni Association Preferences with College Seniors in Higher Education. Contemporary Issues in Education Research journal, 2 (2), 15-21.
626.Khanfar NM, Zapantis A, Alkateeb FM, Clauson KA, Beckey C (2013). Patient attitudes toward community pharmacist attire. Journal of Pharmacy Practice, 26 (4), 442-447.
627.Khanfar SM, Khanfar NM, Loudon D (2010). Adventure Travel International: Market Segmentation and Opportunity Assessment. International Journal of Marketing Issues and Trade Policy, 2 (1-2), 351-367.
628.Khanfar, N.M., Clauson, K.A., Shields, K.M., Polen, H.H. (2008). Self-reported influence of television-based direct-to-consumer advertising on patient seasonal allergy and asthma medication use: an Internet survey. Current Therapeutic Research Clinical and Experimental, 69 (2), 130-41.
629.Khanfar, N.M., Polen, H.H., Clauson, K.A. (2009). Influence on consumer behavior: the impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder. Journal of Health Communication. , 14 (5), 451-60.
630.Khanfar, N.M., Zapantis, A., Alkhateeb, F.M., Clauson, K,A., Beckey, C. (2013). Patient attitudes towards community pharmacist attire. Journal of Pharmacy Practice, 26 (4), 442-447.
631.Khanfar, N.M., Zapantis, A., Alkhateeb, F.M., Clauson, K.A., Beckey, C. (2013). Patient attitudes towards community pharmacist attire. Journal of Pharmacy Practice, 26 (4), 442-447.
632.Kisgen J, Mansour H, Unger NR, Childs LM (2014). Tedizolid: a new second generation oxazolidinone antimicrobial. American Journal of Health-System Pharmacists , 71 (8), 621-633.
633.Kiyasu P, Ishitani M, McGory R, Gaffey M, Dickson R, Caldwell S, Stevenson W & Pruett T (1994). Prevention of Hepatitis B "Rerecurrence" after a Second Liver Transplant - The Role of Maintenance Polyclonal HBIG Therapy. Transplantation, 58 ( ), 954.
634.Kizer LE, Khanfar NM, Loudon D (2009). Nationwide Telecom: A Case of Downsizing or Discrimination? International Journal of Business Management Economics and Information Technology, 1 (2), 393.
635.Klein A, Cofer J, Pruett T, Thuluvath P, McGory R, Uber L, Stevenson W, Baliga P & Burdick J (1996). Prostaglandin E1 Administration Following Orthotopic Liver Transplantation : A Randomized Prospective Multicenter Trial. Gastroenterology, 111 ( ), 710.
636.Kozak MA, Melton JR, Gernant SA, Snyder ME. (2015). A needs assessment of unused and expired medication disposal practices: A study from the Medication Safety Research Network of Indiana. Res Social Adm Pharm, (), .
637.Kozak, M. A., Melton, J. R., Gernant, S.A., Snyder, M. E. (2015). A needs assessment of unused and expired medication disposal practices: A study from the Medication Safety Research Network of Indiana. Res Social Adm Pharm, (), .
638.Kozusko, F., Chen, P.-H., Grant, S.G., Day, B.W., & Panetta, J.C. (2001). A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A. Mathematical Biosciences, 170 (1), 1-16.
639.Krishnaiah YSR, Al-Saidan SM (2008). Transdermal Permeation of Trimetazidine from Nerodilol-based HPMC Gel Drug Reservoir System across Rat Epidermis. Medical Principles and Practice, 17 ( ), 37-42.
640.Krishnaiah YSR, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. (2005). Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. Journal of Controlled Release , 106 ( ), 111-122.
641.Krishnaiah YSR, Al-Saidan SM, Jayaram B (2006). Effect of nerodilol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride. Die Pharmazie , 61 (1), 46-53.
642.Krishnaiah YSR, Chandrasekhar DV, Rama B, Al-Saidan SM (2006). Effect of Nerodilol and Carvone on In Vitro Permeation of Nicorandil across Excised Rat Skin. Drug Development and Industrial Pharmacy, 32 ( ), 423-435.
643.Krishnaiah YSR, Chandrasekhar DV, Satyanarayana V, Al-Saidan SM (2006). Controlled in vivo release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers. Drug Delivery , 13 ( ), 69-77.
644.Krishnaiah YSR, Shiva Kumar M, Raju V, Lakshmi M, Rama B (2008). Penetration enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis. Drug Delivery , 15 ( ), 227-234.[website]
645.Krishnaiah, Y. S. R., Al-Saidan, S.M. (2008). Limonene enhances the in vitro and in vivo permeation of trimetazidine across a membrane-controlled transdermal therapeutic system. 5: 70-76. Current Drug Delivery , 5 ( ), 70-76.
646.Krishnaiah, Y. S. R., Raju, V., Shiva Kumar, M., Rama, B., Raghumurthy, V., Ramanamurthy, K.V. (2008). Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone and limonene as penetration enhancers. Pharmaceutical Development and Technology , 13 ( ), 177-185.[website]
647.Krishnaiah, Y. S. R., Rama, B., Raghumurthy, V., Ramanamurthy, K.V., Satyanarayana, V. (2009). Effect of PEG6000 on the in vivo and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes Pharmaceutical Development and Technology, 14 ( ), 50-61.[website]
648.Krishnaiah, Y. S. R., Srinivas, B. P. (2008). Effect of 5-Fluorouracil Pretreatment on the In Vitro Drug Release from Colon-targeted Guar Gum Matrix Tablets. The Open Drug Delivery Journal, 2 ( ), 71-76.
649.Kwon Y. M., & Kim, S. W. (2004). Biodegradable Triblock Copolymer Microspheres Based on Thermosensitive Sol-Gel Transition. Pharmaceutical Research, 21 (), 339-343.
650.Kwon, Y. M., & Kim, S. W. (2003). New Biodegradable Polymers for Delivery of Bioactive Agents. Macromolecular Symposia, 201 (), 179-186.
651.Kwon, Y. M., Baudys, M., Knutson, K., & Kim, S. W. (2001). Insulin Aggregation induced by water / organic solvent interface. Pharmaceutical Research, 18 (), 1754-1759.
652.Kwon, Y. M., Chung, H., Moon, C., Yockman, J., Park, Y. J., Gitlin, S., David, A., & Yang, V. C. (2009). L-Asparaginase Encapsulated Intact Erythrocytes for Treatment of Acute Lymphoblastic Leukemia (ALL). Journal of Controlled Release, 139 (), 182-9.
653.Kwon, Y. M., Li, Y. T., Liang, J. F., Park, Y. J., Chang, L. C., & Yang, V. C. (2008). PTD-modified ATTEMPTS system for enhanced asparaginase therapy: A proof-of-concept investigation. Journal of Controlled Release, 130 (3), 252-8.
654.Kwon, Y. M., Li, Y., Naik, S., Liang, J.F., Huang, Y., Park, Y.J., & Yang, V. C. (2008). The ATTEMPTS Delivery System for Macromolecular Drugs. Expert Opinions on Drug Delivery, 5 (), 1255-66.
655.L. Milane, M.S. Trivedi, A.M. Singh, M.V. Talekar, & M. Amiji (2015). Mitochondrial Biology, targets, Drug Delivery. Journal of Controlled Release, 207 (), 40-58.[website]
656.L.A. Felton, K. Shah, J. Yang, H. Omidian, J.G. Rocca (2007). A Rapid Technique to Evaluate the Oxidative Stability of a Model Drug. Drug Development and Industrial Pharmacy, 33 (6), 683-9.
657.Lacy MK, Klutman NE, Horvat RT, Zapantis A. (2004). Antibiograms: New NCCLS guidelines, development and clinical application Hospital Pharmacy, 39 (6), 542-553.
658.Lai L. (2005). Measuring Indirect Benefits of Pharmacy Services Program-An Economic Evaluation Using Human Capital Approach. Journal of Pharmaceutical Finance, Economics, and Policy, 14 (1), 3-16.
659.Lai L.., (2005). Novoa G. Hypertensive Disease Management Community Outreach Program in Hispanics. (Letter to Editor) Southern Medical Journal, 98 (7), 748-749.
660.Lai, L (1998). Assessing Data Quality For Decision Support - Emphasis on Secondary Analysis. Pharmacy Practice Manage Quarterly, (18), 46-51.
661.Lai, L (1999). A Statewide Survey of Pharmacist=s Knowledge of OTC Herbal Remedy. Florida Pharmacy Today, 60 (9), 12-15..
662.Lai, L (1999). Does Pharmaceutical Care Service Change the Utilization and Cost of Medicaid ? Pharmacy and Managed Care, 6 (1), 7-12.
663.Lai, L (1998). Effects of a Pharmaceutical Care Intervention in Primary Care Ambulatory Settings Among Medicaid Population Journal of Pharmaceutical Care, 2 (), 1-13.
664.Lai, L (1998). Cost Benefit Analysis of Pharmaceutical Care in Medicaid Population - From Budgetary Perspective Journal of Managed Care Pharmacy, 4 (), :303-308.
665.Lai, L. (2007). Community Pharmacy-Based Hypertension Disease Management Program in a Latino-American Population. Consultant Pharmacist , 22 (5), 411-416.
666.Lai, L. (1998). Assessing Data Quality For Decision Support - Emphasis on Secondary Analysis. Pharmacy Practice Manage Quarterly, 18 ( ), 46-51.
667.Lai, L. (1998). Effects of a Pharmaceutical Care Intervention in Primary Care Ambulatory Settings Among Medicaid Population. Journal of Pharmaceutical Care , 2 ( ), 1-13.
668.Lai, L. (1999). Does Pharmaceutical Care Service Change the Utilization and Cost of Medicaid ?. Pharmacy and Managed Care, 6 (1), 7-12.
669.Lai, L. (2005). Measuring Indirect Benefits of Pharmacy Services Program – An Economic Evaluation Using Human Capital Approach. Journal of Pharmaceutical Finance, Economics, and Policy, 14 ( ), 13-16.
670.Lai, L. Thian, L. (1999). A Statewide Survey of Pharmacists Knowledge of OTC Herbal Remedy. Florida Pharmacy Today, 60 (9), 12-15.
671.Lai, L., Alfaifi, A., Althemery, A. (2016). Healthcare Disparities in Hispanic Diabetes Care - A Propensity Score-Matched Study. Journal of Immigrant and Minority Health, 10 (), .
672.Lai, L., Alfred, L. (2001). Impacts of Consultant Pharmacist Intervention on Antibiotic Therapy For Nursing Home Facility Residents Aged 85 and Older. Consultant Pharmacist, 16 (2), 130-134.
673.Lai, L., Almasri D. Sanabria S. (2015). Undertreatment of Migraine in the United States– A Population Based Study. American Journal of Pharmacy & Health Research , 3 (3), .
674.Lai, L., Bleidt, B. A., Singh-Franco, D., Elusma, C., and Huh, G. (2015). Trends in benzodiazepine prescribing under Medicare Part D in USA: outpatient settings 2005–2009 Journal of Pharmaceutical Health Services Research, 2015 (6), 133-138.
675.Lai, L., Gharib, S. (2007). Analysis of Potential Drug-Drug Interactions on Angiotensin Converting Enzyme (ACE) Inhibitors in the United States Outpatient Settings. Journal of Pharmaceutical Finance, Economics, and Policy, 17 (1), .
676.Lai, L., Harrington, C., Armayor, G. (2013). The effects of Medicare Part D Drug Coverage on Prescription Drug Use for Elderly with Sleep Disorders in The United States. International Review of Business and Social Sciences, 2 (2), 1-11.
677.Lai, L., Nguyen T, Ting A, Yang T, Bai S. (2013). Nanomedicine: Economic Prospect and Public Safety. Journal of Developing Drugs , 2 (3), 1-2.
678.Lai, L., Poblet, M., Bello, C. (2000). Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primary care setting. Southern Medical Journal, 93 (3), 283-6.
679.Lai, L., Sorkin, A. (1998). Cost Benefit Analysis of Pharmaceutical Care in Medicaid Population - From Budgetary Perspective. Journal of Managed Care Pharmacy , 4 ( ), 303-308.
680.Lai, L., Tan, MH. (2011). Prevalence and Factors Associated with Off-Label Antidepressant Prescriptions for Insomnia Drug, Healthcare and Patient Safety, 3 ( ), 27-36.
681.Lai,L (1999). A Statewide Survey of Pharmacist's Knowledge of OTC Herbal Remedy Florida Pharmacy Today, 60 (9), 12-15.
682.Lai,L., Alfred, L., (2001). Impacts of Consultant Pharmacist Intervention on Antibiotic Therapy For Nursing Home Facility Residents Aged 85 and Older Consultant Pharmacist, 16 (2), 130-134.
683.Lai., Tan, MH. (2011). Prevalence and Factors Associated with Off-Label Antidepressant Prescriptions for Insomnia. Drug, Healthcare and Patient Safety, 3 ( ), 27-36.
684.Lai., Tan, MH. (2011). Prevalence and Factors Associated with Off-Label Antidepressant Prescriptions for Insomnia. Drug, Healthcare and Patient Safety, 3 ( ), 27-36.
685.Langlois, R.G., Akiyama, M., Kusonoki, Y., DuPont, B.R., Moore, D.H., II, Bigbee, W.L., Grant, S.G., & Jensen, R.H. (1993). Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: a comparative study of assay methods. Radiation Research, 136 (1), 111-117.
686.Latimer JJ, Johnson JM, Kelly CM, Miles TD, Beaudry-Rodgers KA, Lalanne NA., Vogel, V.A., Kanbour-Shakir, A., Kelley, J.L., Johnson, R.R., Grant. S.G. (2010). Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer. Proceedings of the National Academy of Sciences USA, 107 (50), 21725-21730.
687.Latimer, J.J. (2014). Analysis of actively transcribed DNA repair using a transfection-based system. Methods in Molecular Biology , 1105 (), 533-550.
688.Latimer, J.J. and Kelly, C.M. (2014). Unscheduled DNA synthesis: the clinical and functional assay for global genomic nucleotide excision repair. Methods in Molecular Biology , 1105 (), 511-532.
689.Latimer, J.J., Alhamed, A., Sveiven, S., Almutairy, A., Klimas, N., Abreu, M., Sullivan, K, and Grant, S.G. (2019). Preliminary Evidence for a Hormetic Effect on DNA Nucleotide Excision Repair in Veterans with Gulf War Illness J. Military Medicine, 10 (1), doi: 10.1093/milmed/.[website]
690.Latimer, J.J., Berger, F.G., and Baumann, H. (1990). Highly conserved upstream regions of the a1-antitrypsin gene in two mouse species govern liver-specific expression by different mechanisms. Molecular and Cellular Biology 10: 760—769. Molecular and Cellular Biology , 10 ( ), 760-769.
691.Latimer, J.J., Berger, F.G., and Baumann, H. (1987). Developmental expression, cellular localization, and testosterone regulation of a1-antitrypsin in Mus caroli kidney Journal of Biological Chemistry, 262 ( ), 12641—12646.
692.Latimer, J.J., Hultner, M.L., Cleaver, J.E. and Pedersen, R.A. (1996). Elevated DNA excision repair capacity in the extraembryonic mesoderm of the mid-gestation mouse embryo. Experimental Cell Research , 228 ( ), 10-28.
693.Latimer, J.J., Johnson, J.M., Kelly, C.M., Miles, T.D., Beaudry-Rodgers, K.A., Lalanne, N.A., Vogel, V.G., Kanbour-Shakir, A., Kelley, J.L., Johns (2008). Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures. Cell and Tissue Research , 333 ( ), 461-467.
694.Latimer, J.J., Johnson, J.M., Kelly, C.M., Miles, T.D., Beaudry-Rodgers, K.A., Lalanne, N.A., Vogel, V.G., Kanbour-Shakir, A., Kelley, J.L., Johnson, R.R., and Grant, S.G. (2010). Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer. Proceedings of the National Academy of Sciences (U.S.A.), 50 ( ), 21725-21730.
695.Latimer, J.J., Johnson, J.M., Miles, T.D., Dimsdale, J.M., Edwards, R.P., Kelley, J.L., & Grant, S.G. (2008). Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures. Cell and Tissue Research, 333 (3), 461-467.
696.Latimer, J.J., Majekwana, V.J., Pabón-Padín, Y.R., Pimpley, M.R., and Grant, S.G. (2015). Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis. Photochemistry and Photobiology , 91 (), 493-500.
697.Latimer, J.J., Nazir, T., Flowers, L.C., Forlenza, M.J., Beaudry-Rodgers, Kelly, C.M., Conte, J.A., Shestak, K., Kanbour-Shakir, A., & Grant, S.G. (2003). Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures. Experimental Cell Research, 291 (1), 111-121.
698.Latimer, J.J., Rubinstein, W.S., Johnson, J.M., Kanbour-Shakir, A., Vogel, V.G., & Grant, S.G. (2005). Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes. BMC Medical Genetics, 6 ( ), 26.
699.Lee, J.Y., Choi, Y.S., Suh, J.S., Kwon, Y.M., Yang, V.C., Lee, S.J., Chung, C.P., & Park, Y.J. (2011). Cell penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy. International Journal of Cancer, 128 (10), 2470-2480.
700.Lee. M., Nah, J. W., Kwon, Y., Koh, J. J., Ko, K. S., & Kim, S. W. (2001). Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery. Pharmaceutical Research, 18 (), 427-431.
701.Leonard, S.T. (2008). Assessment in pharmacy education Internet Journal of Allied Health Sciences and Practice, 6 (2), 16-17.
702.Leonard, S.T. & Dorfman, W.I. (1996). he role of the Minnesota Multiphasic Personality Inventory in the assessment of the sexual dysfunctions: A review. Clinical Psychology Review, 16 (4), 317-335.
703.Leonard, S.T., & Droege, M. (2008). The uses and benefits of cluster analysis in pharmacy research. Research in Social and Administrative Pharmacy, 4 (), 1-11.
704.Leonard, S.T., Blasik, K., Dilgen, A., Till, F. (2003). Advanced Placement programs as a means to narrowing the ERS Spectrum, 21 (2), 4-14.
705.Leonard, S.T., Droege, M. (2007). Pharmacist as first responder in disaster relief Drug Topics, 151 (19), 37-46.
706.Leonard, S.T., Interian, A., Dorfman, W.I., & Burns, W.J. (1997). Neuropsychological complaints and their relationship to the MMPI-A Content scales. The Clinical Neuropsychologist, 11 (3), 24-25.
707.Leonard. S.T., Dorfman, W.I., & Burns, W.J., & Interian, A. (1998). The frequency of neuropsychological complaints and the MMPI-A Clinical scales Archives of Clinical Neuropsychology, 13 (19), 54-55.
708.Leos, S.H., Bigbee, W.L., Jensen, R.H., & Grant, S.G. (1997). SfaNI polymorphism distinguishes the alleles of the glycophorin A locus that determine the MN blood group. Acta Haematologica, 98 (1), 51-53.
709.Leosco, D., Rengo, G., Iaccarino, G., Filippelli, A., Lymperopoulos, A., Zincarelli, C., Fortunato, F., Golino, L., Marchese, M., Esposito, G., Rapacc (2007). Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. Am. J. Physiol. Heart Circ. Physiol., 293 ( ), H1596-H1603.
710.Leung S, Bendayan R. (1999). Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs. Can J Physiol Pharmacol., 77 (8), 625-630.
711.Leung S, Bendayan R. (2001). Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line Can J Physiol Pharmacol, 79 (1), 59-66.
712.Leung S, Poulakos MN, Kernan W. (2007). Is the Drug Interaction Actual Between Posaconazole and Cyclosporine? Pharmacotherapy, 28 (1), 3e.
713.Leung S., Poulakos MN, Leira Ramirez-Ruiz. (2008). Comparing Unbound Plasma Posaconazole Levels to Fungal Minimal Inhibitory Concentrations (MICs) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients with Graft-Versus Host Disease (GVHD). Phamacotherapy, 28 (4), 83e-84e.
714.Li, D., Gannett, P.M., & Lederman, D. (2012). Myoglobin-based Single-Electron Transitors Nanotechnology, 23 (), 395705.
715.Li, Y. T., Kwon, Y. M., Spangrude, G. J., Liang, J. F., Chung, H., Park, Y. J., & Yang, V. C. (2009). Preliminary In Vivo Evaluation of the PTD-Modified ATTEMPTS Approach in Enhancing Asparaginase Therapy. Journal of Biomedical Materials Research: A, 91 (1), 209-20.
716.Liu, M., Grant, S.G., Macina, O.T., Klopman, G., & Rosenkranz, H.S. (1997). Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication (“malsegregation”) in the yeast Saccharomyces cerevisiae: relevance to human carcinogenesis and developmental toxicology. Mutation Research, 374 (2), 209-231.
717.Livingston, G.K., Jensen, R.H., Silberstein, E.B., Hinnefeld, J.D., Pratt, G., Bigbee, W.L., Langlois, R.G., Grant, S.G., & Shukla, R. (1997). Radiobiological evaluation of immigrants from the vicinity of Chernobyl. International Journal of Radiation Biology, 72 (6), 703-712.
718.Lopez P, Khanfar NM, Alameddine S, Harrington CA (2015). Banning Tobacco Sales at the Retail Pharmacy: Natural Evolution of Drug Store as Responsible Health Provider or Effective Marketing Strategy?. Health Marketing Quarterly, 32 (), 382-393.
719.Luque, C. A., Ehret, M. J., Rey, J. A. (2007). Rimonabant (Acomplia): The First Cannabinoid-1 Receptor Blocker for Obesity Pharmacy & Therapeutics, 32 (4), 209-213.
720.Luque, C.A., Marsh, W., Rey, J.A. (2003). Update on the Pharmacological Therapy of Obesity. California Journal of Health-System Pharmacists., 15 (3), .
721.Luque, C.A., Rey, J.A. (2002). The Discovery and Status of Sibutramine as an Anti-Obesity Drug. European Journal of Pharmacology., 440 (2-3), 119-28.
722.Lymperopoulos, A. (2012). Beta-arrestin Biased Agonism/Antagonism at Cardiovascular Seven Transmembrane- spanning Receptors. Current Pharmaceutical Design, 18 ( ), 192-198.
723.Lymperopoulos, A. (2011). GRK2 and beta-arrestins in cardiovascular disease: something old, something new. American Journal of Cardiovascular Disease, 1 ( ), 126-137.
724.Lymperopoulos, A. (2012). Ischemic Emergency?: Endothelial Cells Have Their Own "Adrenaline Shot" at Hand. Hypertension, 60 ( ), 12-14.
725.Lymperopoulos, A. (2016). Autonomic Dysfunction in Critical Illness: ObNOX(2)ious (Baro)reflex Upregulation of G Protein-Coupled Receptor Kinase-2 Lets the Heart Down. Crit. Care Med., 44 (), 1621-1623 .
726.Lymperopoulos, A. (2013). Physiology and pharmacology of the cardiovascular adrenergic system. Front. Physiology, 4 (), 240.
727.Lymperopoulos, A., Aukszi, B. (2017). Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy. World J. Cardiol. , 9 (), 200-206.
728.Lymperopoulos, A., Bathgate, A. (2012). Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown. Pharmacogenomics, 13 ( ), 323-341.
729.Lymperopoulos, A., Bathgate, A. (2013). Arrestins in the cardiovascular system. Prog. Mol. Biol. Transl. Sci. , 118 (), 297-334 .
730.Lymperopoulos, A., Brill, A., McCrink, K.A. (2016). GPCRs of Adrenal Chromaffin Cells & Catecholamines: The Plot Thickens. Int. J. Biochem. Cell Biol. , 77 (), 213-219.
731.Lymperopoulos, A., French, F. (2014). Pharmacogenomics of heart failure. Methods Mol. Biol. , 1175 (), 245-257.
732.Lymperopoulos, A., Garcia, D., Walklett, K. (2014). Pharmacogenetics of cardiac inotropy Pharmacogenomics. , 15 (), 1807-1821.
733.Lymperopoulos, A., Karkoulias, G., Koch, W.J., Flordellis, C.S. (2006). alpha(2)-Adrenergic receptor subtype-specific activation of NF-kappaB in PC12 cells. Neurosci. Lett., 402 ( ), 210-215.
734.Lymperopoulos, A., McCrink, K.A., Brill, A. (2016). Impact of CYP2D6 genetic variation on the response of the cardiovascular patient to carvedilol and metoprolol. Curr. Drug Metab. , 17 (), 30-36.
735.Lymperopoulos, A., Negussie, S. (2013). bArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or "Good Cop, Bad Cop"? Int. J. Mol. Sci., 14 (), 24726-24741 .
736.Lymperopoulos, A., Negussie, S., Walklett, K. (2013). Research Highlights: Adrenergic receptor pharmacogenetics in heart failure. Pharmacogenomics. , 14 (), 1545-1549 .
737.Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A.D., Koch, W.J. (2007). Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nature Medicine, 13 ( ), 315-323.
738.Lymperopoulos, A., Rengo, G., Gao, E., Ebert, S.N., Dorn, G.W. 2nd, Koch, W.J. (2010). Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. Journal of Biological Chemistry, 285 ( ), 16378-16386.
739.Lymperopoulos, A., Rengo, G., Koch, W.J. (2007). Adrenal adrenoceptors in heart failure: Fine-tuning cardiac stimulation. Tr. Mol. Med., 13 ( ), 503-511.
740.Lymperopoulos, A., Rengo, G., Koch, W.J. (2012). GRK2 Inhibition in Heart Failure: Something Old, Something New. Current Pharmaceutical Design, 18 ( ), 186-191.
741.Lymperopoulos, A., Rengo, G., Koch, W.J. (2013). Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy. Circulation Research, 113 (), 739-753 .
742.Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Koch, W.J. (2011). Adrenal ??arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. Journal of the American College of Cardiology, 57 ( ), 356-365.
743.Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Soltys, S., Koch W.J. (2009). An adrenal ß-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 106 ( ), 5825-5830.
744.Lymperopoulos, A., Rengo, G., Zincarelli, C., Soltys, S., Koch W.J. (2008). Modulation of Adrenal Catecholamine Secretion by In Vivo Gene Transfer and Manipulation of G Protein-Coupled Receptor Kinase-2 Activity. Mol. Ther., 16 ( ), 302-307.
745.Lymperopoulos, A., Sturchler, E., Rengo, G., McDonald, P., Koch, W.J. (2014). Different potencies of angiotensin receptor blockers at suppressing adrenal barrestin1-dependent post-myocardial infarction hyperaldosteronism Journal of the American College of Cardiology, 64 (), 2805-2806.
746.M Ashkani, K Kabiri, A Salimi, H Bouhendi, H Omidian (2018). Hybrid Hydrogel Based on Pre-Gelatinized Starch Modified with Glycidyl-Crosslinked Microgel Iranian Polymer Journal, 27 (3), 183-192.
747.M Mehmanchi, P Shokrollahi, M Atai, H Omidian, R Bagheri (2012). Supramolecular Polycaprolactone- Nanocomposites Based on Functionalized Hydroxyapatite Journal of Bioactive and Compatible Polymers, 27 (5), 467-480.
748.M. Barikani, H. Omidian (1992). Preparation and Optimization of Nitrile-Phenolic Structural Adhesives Iranian Journal of Polymer Science and Technology, 5 (1), 10-17.
749.M. Barikani, H. Omidian (1991). Honeycombs Iranian Journal of Polymer Science and Technology, 4 (1), 4-10.
750.M. Barikani, H. Omidian (1991). The Study of the Parameters Affecting the Choice of Adhesive in Sandwich Panels and Honeycombs Iranian Journal of Polymer Science and Technology, 4 (4), 28-38.
751.M. Isabel Fernández, Robin J. Jacobs, Jacob C. Warren,Jesus Sanchez, G. Stephen Bowen (2009). Drug Use and Hispanic Men Who Have Sex with Men in South Florida: Implications for Intervention Development AIDS Education and Prevention, 21 (Sup. B), 45-60.
752.M. S. Trivedi, E. Oltra, L. Sarria, N. Rose, V. Beljanski, M.A. Fletcher, & L. Nathanson (2018). Identification of myalgic encephalomyelitis/chronic fatigue syndrome-associated DNA methylation patterns PloS one, 13 (7), .[website]
753.M. Trivedi, M. Talekar, P. Shah, Q. Ouyang, & M. Amiji (2016). Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization. Oncogenesis., 5 (8), .[website]
754.M. Trivedi, M. Talekar, P. Shah, Q. Ouyang, A. Oka, S. Gandham, & M.M. Amiji (2016). Combination wt-p53 and MicroRNA-125b Transfection in a Genetically-Engineered Lung Cancer Model using Dual CD44/EGFR Targeting Nanoparticles. Mol Ther, 24 (4), 759-769.[website]
755.M. Trivedi, Y. Li, M. Lopez-Toledano, A. Clarke, & R. Deth (2016). Differential neurogenic effects of casein derived opioid peptides on Neuronal Stem Cells: Implications for redox based epigenetic changes. The Journal of Nutritional Biochemistry , 37 (), 39-46.[website]
756.M.J. Zohuriaan, H. Omidian, S. Doroudiani, K. Kabiri (2010). Non-Hygienic Applications of Superabsorbent Hydrogel Polymers Journal of Materials Science, 47 ( ), 5711-5735.
757.M.J. Zohuriaan-Mehr, H. Omidian (2000). Petroleum Resins: An Overview Journal of Macromolecular Science, Review in Macromolecular Chemistry and Physics, 40 (1), 23-49.
758.M.J. Zohuriaan-Mehr, M. Ghannadan, H. Omidian, (2003). Liquid Hydrocarbon-Absorbent 1: Preparation and Evaluation of Styrenic Absorbents for Liquid Aromatic Hydrocarbons International Journal of Polymeric Materials, 52 ( ), 153-161.
759.M.S. Schrier, M.S. Trivedi, & R.C. Deth (2017). Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4. Frontiers in Oncology, 7 (46), .[website]
760.M.S. Trivedi & R.C. Deth (2015). Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention. Frontiers in Neuroscience, (), .[website]
761.M.S. Trivedi, D. Holger, A.T. Bui, T.J.A. Craddock, J.L. Tartar (2017). Short-term sleep deprivation leads to decreased systemic redox metabolites and altered epigenetic status. PLoS ONE, 12 (7), .[website]
762.M.S. Trivedi, J.S. Shah, N.W. Hodgson, H.M. Byun, & R.C. Deth (2014). Morphine induces redox-based changes in global DNA methylation, LINE-1 retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake. Mol Pharmacol, 85 (5), 747-757.[website]
763.M.S. Trivedi, N.W. Hodgson, G.A. Trooskens, C.W. Van, & R.C. Deth (2015). Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutr Metab , 12 (54), .[website]
764.M.S. Trivedi, P.A. Shah, A. Singh, G.A. Pawar, M.V. Talekar, M. Amiji (2017). microRNA-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) growth by mediating Epigenetic and Transcriptional Control of Mitochondrial DNA. Scientific Reports, 7 (1), .[website]
765.M.S.Trivedi, M. Abreu (2018). Nucleic Acid Profiling in Tumor Exosomes Diagnostic and Therapeutic Applications of Exosomes in Cancer, (), 93-117.
766.M.T. French, I. Popovici, and J.C. Maclean (2008). Do Alcohol Consumers Exercise More? Findings from a National Survey. American Journal of Health Promotion , 24 (1), 2-10.
767.M.Trivedi, Hodgson NW, Trooskens GA, Van CW, Deth RC (2015). Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutrition and Metabolism, 12 (54), .
768.M.Trivedi, Holger D, Bui AT, Craddock TJA, Tartar JL (2017). Short-term sleep deprivation leads to decreased systemic redox metabolites and altered epigenetic status PLoS ONE, (), .
769.M.Trivedi, Li Y, Lopez-Toledano M, Clarke A, Deth R (2016). Differential neurogenic effects of casein derived opioid peptides on Neuronal Stem Cells: Implications for redox based epigenetic changes The Journal of Nutritional Biochemistry, (), 39-46.
770.M.Trivedi, Oltra, E., Sarria, L., Rose, N., Beljanski, V., Fletcher, M. A., & Nathanson, L. (2018). Identification of myalgic encephalomyelitis/chronic fatigue syndrome-associated DNA methylation patterns PloS one, 13 (7), .
771.M.Trivedi, Shah PA, Singh A, Pawar GA, Talekar MV, Amiji M (2017). microRNA-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) growth by mediating Epigenetic and Transcriptional Control of Mitochondrial DNA Scientific Reports, (), .
772.M.Trivedi, Talekar M, Shah P, Ouyang Q, Amiji M (2016). Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization Oncogenesis, 5 (8), .
773.M.Trivedi, Talekar M, Shah P, Ouyang Q, Oka A, Gandham S, Amiji MM (2016). Combination wt-p53 and MicroRNA-125b Transfection in a Genetically-Engineered Lung Cancer Model using Dual CD44/EGFR Targeting Nanoparticles Mol Ther., 24 (4), .
774.Machado C, Zapantis A, Singh-Franco D., Beckey C, Marsh W. (2008). Evaluation of faculty-mediated interventions on pharmacy students' decision to pursue post-graduate training. American Journal of Health-System Pharmacists, 65 ( ), 158-163.[website]
775.Macina, O.T., Sussman, N.B., Claycamp, H.G., & Grant, S.G. (2001). Physicochemical and graph theoretical descriptors in developmental toxicity SAR: a comparative study. SAR and QSAR in Environmental Research, 11 (5-6), 345-362.
776.Maclean, J.C., I. Popovici, and E. Stern. (2018). Health Insurance Expansions and Provider Behavior: Evidence from Substance Use Disorder Providers. Journal of Law & Economics, 61 (2), 279-310.
777.Maclean, J.C., Popovici, I., & French, M.T. (2016). Are Natural Disasters in Early Childhood Associated With Mental Health and Substance Use Disorders as an Adult? Social Science and Medicine, 151 (), 78–91.
778.Maclean, J.C., Popovici, and E. Stern. (2018). Health Insurance Expansions and Provider Behavior: Evidence from Substance Use Disorder Providers. Journal of Law & Economics, 61 (2), .
779.Madhusudhanan Narasimhan, Rajiv Rose, Muthusamy Karthikeyan and Appu Rathinavelu (2007). Detection of HDM2 and VEGF co-expression in cancer cell lines: novel effect of HDM2 antisense treatment on VEGF expression. Life Sciences, 81 ( ), 1362 - 1372.
780.Makary P, Parmar JR, Mims N, Khanfar NM, Freeman RA (2019). Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy, (), .[website]
781.Malcom, D.R., Farris, K., Feola, D.J., Gannett, P.M., Law, A.V., O’Neal, K.S., Salinitri, F.D., Tromp, K., White, A. (2020). Appropriateness of Term Limits for Administrative Academic Appointments. Am. J. Pharm. Educ, 84 (1), Article 7462.
782.Manchester, D.K., Nicklas, J.A., O’Neill, J.P., Lippert, M.J., Grant, S.G., Langlois, R.G., Moore, D.H., III, Jensen, R.H., Albertini, R.J., & Bigbee. (1995). Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environmental and Molecular Mutagenesis, 26 (3), 203-212.
783.Maning, J., Negussie, S., Clark, M.A., Lymperopoulos, A. (2017). Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy. Pharmacol. Res. , 125 (), 14-20.
784.Maniscalco M, Singh-Franco D., Torres-Colon R., Wolowich W.R. (2006). Solifenacin succinate for the treatment of symptoms of overactive bladder. Clinical Therapeutics, 28 (9), 1247-1272.[website]
785.Manolis, A.S., Patsouras, N., Ilias, I., Constantakopoulos, J., Pyriohou, A., Lymperopoulos, A., Spathas, D.H., Flordellis C.S. (2006). Lack of association between alpha2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation--preliminary report. Clin. Chem. Lab. Med., 44 ( ), 807-812.
786.Mansour H, Inge L, Ferreira J, Unger NR (2011). A review of commonly prescribed antiviral and antiretroviral agents. the Journal of Pharmacy Technology, 27 ( ), 99-110.
787.Marchione TM, Khanfar NM, Bahaudin MG, Loudon D (2020). “Daltexpharma”: A Case Addressing Potential Pharmaceutical Cargo Theft. INNOVATIONS in pharmacy, 11 (3), 1-7.[website]
788.Marchione, T. M., Khanfar, N. M., Mujtaba, B. G., Loudon, D. (2020). “Daltexpharma”: A Case Addressing Potential Pharmaceutical Cargo Theft INNOVATIONS in pharmacy, 11 (3), 1-7.
789.Marchione, T. M., Khanfar, N. M., Mujtaba, B. G., Loudon, D. (2020). “Daltexpharma”: A Case Addressing Potential Pharmaceutical Cargo Theft INNOVATIONS in pharmacy, 11 (3), 1-7.
790.Marchione, T. M., Khanfar, N. M., Mujtaba, B. G., & Loudon, D. (2020). “Daltexpharma”: A Case Addressing Potential Pharmaceutical Cargo Theft. INNOVATIONS in pharmacy, 11 (3), 1-7.
791.Marino J, Augsten A, Henry J. (2009). Postictal psychosis treated successfully treated with quetiapine: a case report. Annals of Pharmacotherapy, 43 ( ), 43.
792.Marino J, Caballero J (2008). Paliperidone extended release for the treatment of schizophrenia. Pharmacotherapy, 28 (10), 1283-1298.[website]
793.Marino J, Caballero J (2010). Iloperiodone for the treatment of schizophrenia. Annals of Pharmacotherapy, 44 (5), 863-870.[website]
794.Marino J, Caballero J, Llosent M, Hinkes R (2010). Differences in pharmacy interventions at a psychiatric hospital: Comparison of staff pharmacists, pharmacy faculty, and student pharmacists. Hospital Pharmacy , 45 (4), 314-319.
795.Marino J, English C, Caballero J, Harrington C. (2012). The role of paliperidone extended release for the treatment of bipolar disorder. Neuropsychiatric Disease and Treatment, 8 (), 181-189.
796.Marino J, Mascarenas CA, Saklad SR, Simpson J. (2007). Aripiprazole for the treatment of resistant obsessive compulsive disorder. Journal of College of Psychiatric and Neurologic Pharmacists, ( ), .[website]
797.Marsh WA, Rascati K (1999). Meta-analysis of the effectiveness of epo for end-stage renal disease and cancer Clinical Therapeutics, 21 (9), 1443-55.
798.Marsh WA, Rascati K (2000). Meta-analysis of the effectiveness for epo for end-stage renal disease and cancer [extended abstract] Focus on anaemia in cancer, 1 (1), 16-17.
799.Marylee V Worley, Eliza W Dollard, Laura Aragon, Kellie Henderson, Lilian Abbo, Patricia Byers (2017). Role of Ethanol Locks in Reducing Bloodstream Infections in Adults on Parenteral Nutrition infection control & hospital epidemiology, 38 (9), 1133-1134.
800.Marylee V. Worley, Eliza W. Dollard, Laura Aragon, Kellie Henderson, Lilian Abbo, Patricia Byers (2017). Role of Ethanol Locks in Reducing Bloodstream Infections in Adults on Parenteral Nutrition. infection control and hospital epidemiology, 38 (9), 1133-1134.
801.Marylee V. Worley, Sandy J. Estrada (2014). Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis Pharmacotherapy, 34 (11), 1187-1197.
802.Mastropietro, D., Omidian , H (2014). Abuse-Deterrent Formulations (ADFs)-Part 2: Commercial Products and Proprietary Technologies Expert Opinion on Pharmacotherap, (), .
803.Mastropietro, D., Omidian , H (). Abuse-Deterrent Formulations (ADFs)-Part 2: Commercial Products and Proprietary Technologies Expert Opinion on Pharmacotherapy, (), .
804.Matzke G, McGory R, Halverston C & Keane W (1984). Vancomycin Pharmacokinetics in Patients with Various Degrees of Renal Function; A Nomogram for Dosage. Antimicrobial Agents and Chemotherapy, 25 ( ), 433.
805.Mayo- Santana, R., Rabionet, S., Pena-Caro, L. and Serrano, A. E., (2016). Marvels and shadows: Science and education at the University of Puerto Rico School of Tropical Medicine under the auspices of Columbia University: An Introduction. Puerto Rico Health Sciences Journal, 35 (), 49-52.
806.Mayo-Santana, R., Pena- Caro, L., and Rabionet, S. (2016). The historical antecedents of the UPR School of Tropical Medicine. Puerto Rico Health Sciences Journal, 35 (), 53-61.
807.McCoy C, Badowski M, Sherman E, Crutchley R, Smith E, Chastain D (2017). Strength in amalgamation: Newer combination agents for HIV and implications for practice: Insights from the Society of Infectious Disease Pharmacists Pharmacotherapy, (), .[website]
808.McCoy C, Badowski M, Sherman E, Crutchley R, Smith E, Chastain D (2017). Newer combination agents for HIV: Implications for practice Society of Infectious Disease Pharmacists Newsletter, (Winter), .
809.McCrink KA, Brill A, Jafferjee M, Valero TR, Marrero C, Rodriguez MM, Hale GM, & Lymperopoulos A (2016). Beta 1-adrenoceptor Arg389Gly polymorphism confers differential beta-arrestin-binding tropism in cardiac myocytes. Pharmacogenomics, 17 (15), 1611-1620.[website]
810.McCrink, K.A., Brill, A., Lymperopoulos, A. (2015). Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure. World J. Cardiol., 7 (), 539-543.
811.McCrink, K.A., Lymperopoulos, A. (2015). Beta1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration. Pharmacogenomics, 16 (), 1035-1038.
812.McCrink, K.A., Maning, J., Vu, A., Jafferjee, M., Marrero, C., Brill, A., Bathgate-Siryk, A., Dabul, S., Koch, W.J., Lymperopoulos, A. (2017). Beta-Arrestin2 Improves Post-Myocardial Infarction Heart Failure via Sarco[endo]plasmic Reticulum Ca2+-ATPase-Dependent Positive Inotropy in Cardiomyocytes. Hypertension, 70 (), 972-981.
813.McCrink, K.A., Maning, J., Vu, A., Jafferjee, M., Marrero, C., Brill, A., Bathgate-Siryk, A., Dabul, S., Koch, W.J., Lymperopoulos, A. (2017). Cardiac barrestin2 Improves Contractility and Adverse Remodeling in Heart Failure, But Is Underexpressed in Humans. Journal of the American College of Cardiology, 70 (23), 2948-2949.
814.McGory R & Matzke G (1982). Evaluation of a Single-Point Method for Predicting Theophylline Dosage. Clinical Pharmacy, 1 ( ), 441.
815.McGory R, Ishitani M, Oliveira W, Stevenson W, McCullough C, Dickson R, Caldwell S & Pruett T (1996). Improved Outcome of Orthotopic Liver Transplantation for Chronic Hepatitis B Cirrhosis With Aggressive Passive Immunization. Transplantation, 61 (9), 1359.
816.McQuade DE, Khanfar NM (2010). Sprint Customer Service. Journal of Business Studies Quarterly (JBSQ), 2 (1), 106-114.
817.Merchant K, Kumi-Diaka J, Appu Rathinavelu, Esiobu N, Zoeller R, Hartmann J, and Johnson M (2011). Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells Journal of Functional Foods in Health and Disease, 1 (3), 91-105.
818.Merchant K, Kumi-Diaka J, Rathinavelu A, Esiobu N, Zoeller R, Hartmann J, and Johnson M (2011). Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells Functional Foods in Heals and Disease, 3 (), 91-105.
819.Merchant K, Kumi-Diaka J, Rathinavelu A, Esiobu N, Zoeller R, Hartmann J, and Johnson M (2011). Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells Functional Foods in Heals and Disease, 3 (), 91-105.
820.Merchant K, Kumi-Diaka J, Rathinavelu Appu, Esiobu N, Zoeller R, Hartmann J, and Johnson M (2011). Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells Functional Foods in Health and Disease, 3 (), 91-105.
821.Merchant K, Kumi-Diaka J, Rathinavelu Appu, Esiobu N, Zoeller R, Hartmann J, and Johnson M (2011). Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells Functional Foods in Heals and Disease, 3 (), 91-105.
822.Merchant, K., Kumi-Diaka, J., Appu Rathinavelu, Esiobu, N., Zoeller, R and Hormann, V. (2012). Genistein Modulation of Immune - Associated Genes in LNCaP Prostate Cancer Cell Line The Open Access Prostate Cancer Journal, 5 (), 1-7.
823.Metscher, D., Lowe, W., Barnes, F., Lai, L. (2011). Using Leadership Commitment for Civil Servants and Air Force Personnel in Times of Conflic. Air Force Journal of Logistics, XXXV (1 and 2), 125-133.
824.Metzner, M., Daniel, K. (1999). Case study: streamlining drug therapy. Lippincott's Primary Care Practice, 3 (3), 275-279.
825.Michael L. Weiss, Dale D. Chitwood, Jesús Sánchez (2008). Religiosity, Drug Use, and HIV-Related Risk Behaviors Among Heroin Injectors Journal of Drug Issues, 38 (), 883-910.
826.Michelle A. Clark, Bettye Bing, Paul Gotschall and Joseph Williams. (1995). Differential Effect of Cytokines on the Phenobarbital or 3-Methylcholanthrene Induction of P450 Mediated Monooxygenase Activity in Cultured Rat Hepatocytes. Biochem. Pharmacol., 49 ( ), 97-104.
827.Michelle A. Clark, Debra I. Diz, and E. Ann Tallant. (2001). Angiotensin-(1-7) Downregulates the AT1 Receptor in Vascular Smooth Muscle Cells. Hypertension, 37 ( ), 1141-1146.
828.Michelle A. Clark, Paul Gotschall and Lynn Wecker. (1996). Effects of Phenobarbital and Interleukin- 6 on Cytochrome P4502B1 and 2B2 in Cultured Rat Hepatocytes. Biochem. Pharmacol., 51 ( ), 701-706,.
829.Miroslav Gantar, Sivanesan Dhandayuthapani and Appu Rathinavelu (2012). Phycocyanin Induces Apoptosis and Enhances the Effect of Topotecan on Prostate Cell Line LNCaP, Journal of Medicinal Food, 15 (), 1091 - 1095..
830.Mobley, C. and Hochhaus, G. (2001). Methods to assess the pulmonary deposition and absorption for drugs for the treatment of respiratory disease. Drug Discovery Today, 6 (), 367-375.
831.Mody, R., Hernandez, Y., Lymperopoulos, A. (2017). Assays of adrenal GPCR signaling and regulation: Measuring adrenal beta-arrestin activity in vivo through plasma membrane recruitment. Methods Cell Biol. , 142 (), 79-87 .
832.Monique L Hart, Duc P Do, R.A. Ansarii and Syed A A Rizv (2013). Brief Overview of Various Approaches to Enhance Drug Solubility Journal of Developing Drugs, 2 (3), 115-122.
833.Moon, C., Kwon, Y. M., Lee, W. K., Park, Y. J., & Yang, V. C. (2007). In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. Journal of Controlled Release, 124 (), 43-50.
834.Moon, C., Kwon, Y. M., Lee, W. K., Park, Y. J., Chang, L. C., & Yang, V. C. (2008). A novel polyrotaxane-based intracellular delivery system for camptothecin: In vitro feasibility evaluation. Journal of Biomedical Materials Research: A, 84 (), 238-46.
835.Moreau, C., Hale, G.M., Joseph, T., Nieves Santiago, A.A., Maravent, S., Steinberg, J.G. (2019). Development and evaluation of physician-precepted advanced pharmacy practice experiences (APPEs) within an accountable care organization (ACO). Currents in Pharmacy Teaching and Learning, (), In press.
836.Moreau, C., Sando, K., Zambrano, D.H. (2017). Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study Annals of Pharmacotherapy, 51 (6), 473-478.[website]
837.Moreau, C., Wilson, D.L. (2015). Review of Continuing Education and Published Literature Related to Women's Health and Pharmacy Journal of Pharmacy Technology, 31 (2), 69-77.[website]
838.Moser, M.J., Oshima, J., Bigbee, W.L., Grant, S.G., Langlois, R.G., Jensen, R.H., & Monnat, R.J., Jr. (2000). Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Research, 60 (9), 2492-2496.
839.Mujtaba BG, Khanfar NM, Khanfar SM (2010). Leadership Tendencies of Government Employees in Oman: a Study of Task and Relationship based on Age and Gender. Public Organization Review, 10 (2), 173-190.
840.Mujtaba, B. G., McClelland, B., Williamson, P., Khanfar, NM. and Cavico, F. J. (2018). An Analysis of the Relationship between Regulatory Control and Corruption based on Product and Market Regulation and Corruption Perceptions Indices. Business Ethics and Leadership, 2 (3), 6-20.
841.Mullins, L.J., Grant, S.G., Stephenson, D.A., & Chapman, V.M. (1988). Multilocus molecular mapping of the mouse X chromosome. Genomics, 3 (3), 187-194.
842.Mullins, L.J., Stephenson, D.A., Grant, S.G., & Chapman, V.M. (1990). Efficient linkage of 10 loci in the proximal region of the mouse X chromosome. Genomics, 7 (1), 19-30.
843.N Moniri, K Kabiri, MJ Zohuriaan-Mehr, H Omidian, N Esmaeili (2017). Fine-Tuning of SAP Properties via Epoxy-Silane Surface Modification Polymers for Advanced Technologies, 28 (), 1132-1147.
844.Nada A H, KrishnaiahYSR, Zaghloul AA. (2010). Analysis of vitamin E in commercial cosmetic preparations by HPLC. Journal of Cosmetic Science , 61 ( ), 353-365.
845.Nada AH, Krishnaiah YSR, Zaghloul AA, Khattab, I. (2010). Analysis of vitamin E in commercial cosmetic preparations by HPLC. Journal of Cosmetic Science , 61 ( ), 353-365.
846.Nada, A.H., Krishnaiah, Y.S.R., Zaghloul, A.A., Khattab, I. (2010). Analysis of vitamin E in commercial cosmetic preparations by HPLC. Journal of Cosmetic Science , 61 ( ), 353-365.
847.Nafei WA, Kaifi BA (2012). Leadership Styles and Organizational Learning An Empirical Study on Saudi Banks in Al-Taif Governorate Kingdom of Saudi Arabia. Journal of Management and Strategy, ( ), .
848.Nafei WA, Kaifi BA, Khanfar NM (2012). Organizational Learning As An Approach To Achieve Outstanding Performance: An Applied Study On Al-Taif University, Kingdom Of Saudi Arabia Advances in Management and Applied Economics (AMAE), 2 (4), 13-40.[website]
849.Nafei WA, Khanfar NM, Kaifi BA (2012). Leadership Styles and Organizational Learning An Empirical Study on Saudi Banks in Al-Taif Governorate Kingdom of Saudi Arabia. Journal of Management and Strategy, 3 (1), 2-17.
850.Nagaraja, A., Clauson, K.A. (2009). Database coverage and impact factor of open access journals on pharmacy. Journal of Electronic Resources in Medical Libraries. , 6 (2), 138-145..
851.Nagaraja, A., Joseph, S.A., Polen, H.H., Clauson, K.A. (2011). Disappearing act: Persistence and attrition of uniform resource locators (URLs) in an open access medical journal Program: electronic library and information systems, 45 (1), 98-106.
852.Nakagawa N., Kusaba M., Ozaki F., Maekawa M., Matsuura M., Hisamichi K., Murai Y., Gershma J., Lai, L., Mano N. (2014). Comparison of Drug Information Practice Experience between Tohoku University Hospital Pharmacy in Japan and College of Pharmacy at Nova Southeastern University in the United States. Japanese Journal of Drug Information , 16 (3), 143-151.
853.Nakagawa N., Lai L., Mano N. (2013). Potential Changes to the Model Core Curriculum for Pharmaceutical Education in Japan based on Direct Observation of the Advanced Pharmacy Practice Experience at Nova Southeastern University in the United States. Japanese Journal of Pharmaceutical Health Care and Science, 39 (1), 25-32.
854.Nakagawa, N., Lai, L., Mano, N. (2013). Comparison of Pharmacy Practice training in Pharmaceutical Education for 6 years in Japan with Advanced Pharmacy Practice Experience at Nova Southeastern University in the United States. Japanese Journal of Pharmaceutical Health Care and Science , 39 (1), 25-32.
855.Nathan R. Unger, Marylee V. Worley, Jamie J. Kisgen, Elizabeth M. Sherman, Lindsey M. Childs-Kean (2016). Elvitegravir for the treatment of HIV Expert Opinion on Pharmacotherapy, 17 (17), 2359-2370.
856.Nemire R.E., Margulis L.., Shepherd E.F. (2004). Prescription for a Healthy Service-Learning Course American Journal Pharmacy Education, 68 (1), SL3.
857.Nemire, R.E., Meier, S.M. (2006). Educating Students for Practice: Educational Outcomes and Community Experience. AJPE, 70 (1), 20.
858.Netzer J., Clauson, K. A. (2005). Comparison of state requirements for preprinted prescriptions. American Journal of Health System Pharmacy, 62 (21), 2278-2282.
859.Netzer, J., Clauson, K.A. (2005). Comparison of state requirements for preprinted prescriptions. American Journal of Health System Pharmacy, 62 (21), 2278-2282.
860.Ng TMH, DiDomenico RJ, Ripley TL, Benge CD, Buckley LF, Campbell KB, Hale GM, Macaulay TE, Nappi JM, Pickworth KK, Short MR (2020). An opinion paper of the Cardiology Practice and Research Network of the American College of Clinical Pharmacy: Recommendations for training of cardiovascular pharmacy specialists in postgraduate year 2 residency programs. Journal of the American College of Clinical Pharmacy, 3 (), 95-108.[website]
861.Nguyen, K., Kassimatis, T., Lymperopoulos, A. (2011). Impaired desensitization of a human polymorphic alpha2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells. Cell Communication & Signaling, 9 ( ), 5.
862.Ogundele O, Ulku OY, Khanfar NM, Kaifi BA (2013). Management Decisions to Maximize Profits: The Case of a Retail Pharmacy Chain. Journal of Business Studies Quarterly (JBSQ), 4 (4), 166-175.
863.Ortiz, B.I., Clauson, K.A. (2006). Herbs and herbal product use by Hispanics in South Florida. Journal of the American Pharmacists Association, 46 (2), 161-167.
864.Ortiz, B.I., Clauson, K.A. (2006). Herbs and herbal product use by Hispanics in South Florida Journal of the American Pharmacists Association, 46 (2), 161-167.
865.Ortiz, B.I., Shields, K.M., Clauson, K.A., & Clay, P.G. (2007). Complementary and alternative medicine use among Hispanics in the United States. Annals of Pharmacotherapy, 41 (6), 994-1004.
866.Ortiz, B.I., Shields, K.M., Clauson, K.A., Clay, P.G. (2007). Complementary and alternative medicine use among Hispanics in the United States. Annals of Pharmacotherapy, 41 (6), 994-1004.
867.Ortiz-Giuliani, F., Arce, L.,Ortiz, B.I. (2006). Use of low molecular weight heparins in patients with renal insufficiency. Revista Farmacéutica. ACPE Program: 151-000-06-10-HO4., 65 (3), 38-47.
868.Ovnic, M., Tepperman, K., Medda, S., Elliott, R.W., Stephenson, D.A., Grant, S.G., & Ganschow, R.E. (1991). Characterization of a murine cDNA encoding a member of the carboxylesterase multigene family. Genomics, 9 (2), 344-354.
869.Ownby RL, Acevedo A, Jacobs RJ, Caballero J, Waldrop-Valverde D. (2014). Negative and positive beliefs related to mood and health. American Academy of Health Behavior, 38 (4), 586-597.[website]
870.Ownby RL, Acevedo A, Jacobs RJ, Caballero J, Waldrop-Valverde D. (2014). Quality of life, health status, and health service utilization related to a new measure of health literacy: FLIGHT/VIDAS. Patient Education and Counseling, 96 (3), 404-410.[website]
871.Ownby RL, Acevedo A, Waldrop-Valverde D, Jacobs RJ, Caballero J, Davenport R, Homs AM, Czaja SJ, Loewenstein D. (2013). Development and initial validation of a computer-administered health literacy assessment in Spanish and English: FLIGHT/VIDAS. Patient Related Outcome Measures, 4 (), 21-35.
872.Ownby RL, Acevedo A, Waldrop-Valverde D, Jacobs RJ, Caballero J. (2014). Abilities, skills, and knowledge in measures of health literacy. Patient Education and Counseling, 95 (2), 211-217.[website]
873.Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ. (2012). Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence. Neurobehavioral HIV Medicine, 4 (), 113-121.
874.Ownby RL, Waldrop-Valverde D, Hardigan P, Caballero J, Jacobs RJ, Acevedo A. (2013). Development and validation of a brief computer-administered HIV-related health literacy scale (HIV-HL). AIDS and Behavior, 17 (2), 710-718.
875.Ownby RL, Waldrop-Valverde D, Jacobs RJ, Acevedo A, Caballero J. (2013). Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence. BMC Medical Informatics and Decision Making, 13 (), 29.
876.O’Loughlin D, Chu V, Singh D (2000). Perindopril. Heart Disease , 2 (6), 446-455.[website]
877.P Park, J Caballero, H Omidian (2014). The Use of Serotonin Norepinephrine Reuptake Inhibitors in the Treatment of Attention Deficit Hyperactivity Disorder in Pediatrics Annals of Pharmacotherapy, 48 (1), 86-92.
878.P Shokrollahi, M Mehmanchi, M Atai, H Omidian, F Shokrolahi (2014). Effect of Interface on Mechanical Properties and Biodegradation of PCL HAp Supramolecular Nano-Composites Journal of Materials Science: Materials in Medicine, 25 ( ), 23-35.
879.Palanisamy Marimuthu, Kamal Kaur, Uma Kandalam, Vandana Jasani, Nidha Bukhari, Michelle Nguyen, Alleesa Abdul, Farheen F. Pervez and Appu Rathinavelu (2011). Treatment of Ovarian cancer cells with Nutlin - 3 and Resveratrol combination leads to apoptosis via Caspase activation Journal of Medicinal Food, 14 (1-2), 46-52.
880.Pape, Z., Hale, G, Joseph, T., Moreau, C., Wolowich, W.R. (2019). Impact of pharmacist-led heart failure tool kits on patient-reported self-care behaviors in a primary care based accountable care organization. Journal of the American Pharmacists Association (2003), 59 (6), 891-895.[website]
881.Parcheta N, Kaifi BA, Khanfar NM (2013). Gender Inequality of Women in the Workforce: A Human Resource Management Quandary. Journal of Business Studies Quarterly (JBSQ), 4 (3), 240-248.
882.Parise R.A, Shawaqfeh M.S., Egorin M.J., Beumer J.H. (2008). (Liquid chromatography–mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase. Journal of Chromatography B, 872 (1-2), 141-147.
883.Parise,R.A., Shawaqfeh,M.S., Egorin,M.J., Beumer,J.H. (2008). Liquid chromatography–mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase. Journal of Chromatography B, 872 (1-2), 141-147.
884.Park P, Caballero J, Omidian H. (2014). The use of serotonin norepinephrine reuptake inhibitors in the treatment of attention deficit hyperactivity disorder in pediatrics. Annals of Pharmacotherapy, 48 (1), 86-92.
885.Park, J. B., Kwon, Y. M., Lee, T. Y., Brim, R., Ko, M. C., Sunahara, R., Woods, J. H., & Yang, V. C. (2010). PEGylation of Bacterial Cocaine Esterase for Protection against Protease Digestion and Immunogenicity. Journal of Controlled Release, 142 (2), 174-9.
886.Park, J.-S., Lim, Y.-B., Kwon, Y.-M., Jeong, B., Choi, Y. H., & Kim, S. W. (1999). Liposome Fusion Induced by pH-Sensitive Copolymer: Poly(4-Vinylpyridine-co-N, N'-Diethylaminoethyl Methacrylate). Journal of Polymer Science: Part A, 37 (), 2305-09.
887.Parker ME, Gokkaya S, Khanfar NM (2009). Islamic Investment Vehicles: A Primer. Global Review of Business and Economic Research, 5 (2), 365-373.
888.Parrish RH, Benavides S, Malak JT, Potts AL, Guirguis M, Hagemann T. (2014). Optimizing effectiveness in electronic prescriptions for pediatric outpatients: A call for responsive action. Pharmacy, 2 (4), 260-269.[website]
889.Patel B, Benavides S (2011). Yoga for pediatric obesity. J Yoga Phys Therapy, 1 (), e105.[website]
890.Patel H, Simpson A, Palevoda G, & Hale GM (2018). Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults. Journal of Clinical Hypertension, 20 (4), 794-797.[website]
891.Patel, P. Hemmeger, H. Kozak, M. A. Gernant, S. A. Snyder, M. E. (2015). Community pharmacist participation in a practice-based research network: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet) J Am Pharm Assoc, 55 (6), 649-55.
892.Pavlakovic, G., Rathinavelu, A. and Isom, G.E. (1994). MK-801 Prevents Cyanide-Induced Changes of cFOS Levels in Rat Brain. Neurochem. Res., 19 (), 1287-1294.
893.Pazos M, Khanfar NM, Harrington C, Anderson HH. (2010). Prestigious and Punctual Physicians in Palm Beach. Journal of Business Studies Quarterly (JBSQ), 2 (1), 115-120.
894.Peer, C.J., Younis, I., Leonard, S.S., Gannett, P.M., Minarchick, V.C., Kenyon, A.J., & Callery, P.S. (2012). Glutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metabolite Xenobiotica, 42 (), 1170-1177.
895.Perez A, Elrod S, Sanchez J (2015). Differences in the use and quality of antidiabetic therapies in Mexican American and non-Hispanic whites with uncontrolled type 2 diabetes in the U.S.: NHANES 2003-2012. The Diabetes Educator, 41 (5), 582-91.
896.Perez A, Elrod S, Sanchez J. (2016). A comparison of the use and quality of antidiabetic medication regimens between non-Hispanic black and white adults with uncontrolled type 2 diabetes in the U.S.: NHANES 2003-2012 The Diabetes Educator, 42 (2), 234-42.
897.Perez A, Levin AD, Alam N (2016). A comparison of the use of clinical guideline recommended antihypertensive regimens in Mexican American, non-Hispanic black and white adults with type 2 diabetes and hypertension in the U.S.: NHANES 2003-2012 The Diabetes Editor, 142 (6), .
898.Perez, A, Bleidt, and Rabionet, S. (2016). Teaching Research Skills to Pharmacy Students in One Semester: Description and Assessment Of An Applied Research Elective American Journal of Pharmaceutical Education, 81 (1), 16.
899.Perez, A, Elrod, S., and Sanchez, J (2015). Differences in the use and quality of antidiabetic therapies in Mexican American and non-Hispanic whites with uncontrolled type 2 diabetes in the U.S.: NHANES 2003-2012 The Diabetes Educator , 41 (5), 582-591.
900.Perez, A. Wertheimer, A. (2018). What are we treating with antihyperglycemic drug therapy?. Journal of Pharmaceutical Health Services Research, 9 (), 173-4.
901.Perez, A., Doloresco, F., Hoffman, J., Meek, P.D., Touchette, D.R., Vermeulen, L.C. (2008). Economic Evaluations of Clinical Pharmacy Services:2001–2005. WHITE PAPER. Pharmacotherapy, 28 (11), 285e.
902.Perez, A., Elrod, S., and Sanchez, J. (2016). A Comparison of the Use and Quality of Antidiabetic Medication Regimens between Non-Hispanic Black and White Adults with Uncontrolled Type 2 Diabetes in the US NHANES 2003-2012. The Diabetes Educator , 42 (2), 234-242.
903.Perez, A., Touchette, D., DiDomenico, R.J., Stamos, T.D., Walton, S. (2011). Comparison of rate versus rhythm control for atrial fibrillation management with co-existing heart failure: A cost and effectiveness analysis. Pharmacotherapy , 31 (6), 552-65.[website]
904.Pescovitz M, Pruett T, Gonwa T, Brook B, McGory R, Kicker K, Griffy K, Robinson C & Jung D (1998). Oral Ganciclovir dosing in Transplant Recipients and Dialysis Patients Based on Renal Function. Transplantation, 66 (8), 1104.
905.Petersen C., DeMuro, P. (2015). Legal and regulatory considerations associated with use of patient-generated health data from social media and mobile health (mhealth) devices. Applied Clinical Informatics, 6 (1), 16-26.
906.Petersen C., DeMuro, P., Goodman K.W., Kaplan, B. (2013). Sorrell v. IMS Health: issues and opportunities for informaticians. J Am Med Inform Assoc, 20 (), 35-37.[website]
907.Petersen, C., Adams, S.A., DeMuro, P. (2015). mhealth: don’t forget all the stakeholders in the business case. Medicine 2.0, 4 (2), 1.[website]
908.Petrova M, Benavides S, Almaguer M (2010). Insulin glargine (Lantus) and cancer: Is there a connection? PrescRxiption Digest (Non peer-reviewed), 4 (1), 6-7.
909.Pimpley, M.R., Foley, M.L., Latimer, J.J. (2020). New Perspectives on Unscheduled DNA Synthesis: Functional Assay for Global Genomic DNA Nucleotide Excision Repair. Methods in Molecular Biology, in press, 2102 (), .[website]
910.Polen HH, Clauson KA, Thomson W, Zapantis A, Lou JQ (2009). Evaluation of nursing-specific drug information PDA databases used as clinical decision support tools. International Journal of Medical Informatics, 78 (10), 679-687.
911.Polen HH, Khanfar NM, Clauson KA (2009). Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Marketing Quarterly, 26 (1), 42-55.
912.Polen HH, Zapantis A, Clauson KA, Jebrock J, Paris M. (2008). Ability of online drug databases to assist in clinical decision-making with infectious disease therapies BMC Infectious Diseases, 8 (153), .[website]
913.Polen, H.H., Clauson, K.A., Thomson, W., Zapantis, A., Lou, J.Q. (2009). Evaluation of nursing-specific drug information PDA databases used as clinical decision support tools. International Journal of Medical Informatics, 78 (10), 679-687.
914.Polen, H.H., Khanfar, N.M., Clauson, K.A. (2009). Impact of direct-to-consumer-advertising (DTCA) on patient health-related behaviors. Health Marketing Quarterly , 26 (1), 42-55.
915.Polen, H.H., Zapantis, T., Clauson, K.A., Jebrock, J., Paris, M. (2008). Ability of online drug databases to assist in clinical decision-making with infectious disease therapies. BMC Infectious Diseases, 8 ( ), 153.
916.Polivka BJ, Elliott MB, Wolowich WR. (2002). Comparison of poison exposure data: NHIS and TESS data. J Toxicol Clin Toxicol, 40 (7), 839-45.
917.Polivka, B. J., Elliott, M.B., Wolowich, W.R. (2002). Comparison of poison exposure data: NHIS and TESS Data. Journal of Toxicology, Clinical Toxicology, 40 (4), 839-845.[website]
918.Popovici I, Maclean JC, Hijazi B, Radakrishnan S. (2018). The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment. Health Economics , 27 (2), 294-305.
919.Popovici, I., J.F. Homer, H. Fang, and M.T. French. (2012). Alcohol Use and Crime: Findings from a Longitudinal Sample of U.S. Adolescents and Young Adults. Alcoholism: Clinical and Experimental Research, 36 (3), 532-543.
920.Popovici, I., L. Lai and F. Lopez-Evangelio. (2013). Non-Medical Use of Prescription Drugs and Health Services Utilization. Journal of Developing Drugs, 2 (1), .[website]
921.Popovici, I., M.T. French (2013). Does Unemployment Lead to Greater Alcohol Consumption? Industrial Relations, 52 (2), 444-466.
922.Popovici, I., M.T. French, R.L. Pacula, J.C. Maclean, and O. Antonaccio. (2014). Cannabis Use and Antisocial Behavior among Youth. Sociological Inquiry , 84 (1), 131-162.
923.Popovici, I., M.T. French, and J. McKay (2008). Economic Evaluation of Continuing Care Interventions in the Treatment of Substance Abuse: Recommendations for Future Research. Evaluation Review, 32 (6), 547-568.
924.Popovici, I., M.T. French. (2013). Binge Drinking and Sleep Problems among Young Adults. Drug and Alcohol Dependence, 132 (1-2), 207-215.
925.Poulakos MN, Bui B (2002). Management of Allergic Rhinitis U.S. Pharmacist, 27 (10), 41-55.
926.Powell, J.M., Ebin, E., Borzak, S., Lymperopoulos, A., Hennekens, C.H. (2016). Hypothesis: Paroxetine, a G Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor Reduces Morbidity and Mortality in Patients With Heart Failure. J. Cardiovasc. Pharmacol. Ther., 22 (), 51-53.
927.Praneetha Muthumani, Karthikeyan Alagarsamy, Sivanesan Dhandayuthapani, Thiagarajan Venkatesan, Appu Rathinavelu (2014). Pro-angiogenic effects of MDM2 through HIF-1alpha and NF-?B mediated mechanisms in LNCaP prostate cancer cells Molecular Biol Reports, (), (DOI) 10.1007/s11033.
928.Q. Ye, M. Trivedi, Y. Zhang, M. Böhlke, H. Alsulimani, J. Chang, T. Maher, R. Deth, J. Kim (2018). Brain iron loading impairs DNA methylation and alters GABAergic function in mice. The FASEB Journal, (), .[website]
929.R Ahmad, S Alaei, H Omidian (2018). Safety and Performance of Abuse Deterrent Formulations Expert Opinion on Drug Metabolism and Toxicology, (), 17425255.2018.154628.
930.R Nimroozi, D Mastropietro, H Omidian (2014). Opioid Abuse and Deterrence: Buprenorphine Products Journal of Developing Drugs, 3 (1), 117.
931.R. A. Ansari, and J. Gandy (2007). Determining the Transrepression Activity of Xenoestrogen on Nuclear Factor-?B in Cos-1 cells by Estrogen Receptor-a Int. J. Toxicol, 26 (5), 441-449.
932.R. Deth, A. Clarke, J. Ni, & M. Trivedi (2016). Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of ?-casein: results from a randomized, cross-over clinical trial. Nutr J, 15 (1), .[website]
933.R.A. Ansari and J. Gandy (2007). Determining the Transrepression Activity of Xenoestrogen on Nuclear Factor-?B in Cos-1 Cells by Estrogen Receptor-? International Journal of Toxicology, 26 (), 441–449.
934.R.A. Ansari and P.K. Gupta (1983). Influence of Endosulfan on male Gonads: Biochemical Study Advances in Biosciences, 2 (1), 61-67.
935.R.A. Ansari and P.K. Gupta (1982). Effect of Endosulfan on production and maturation of sperms of Gonads in Rale Rats Journal of Veterinary Physiology and Allied Sciences, 1 (), 43-47.
936.R.A. Ansari, B.S. Aswal, R. Chander, B.N. Dhawan, N.K. Garg, N.K. Kapoor, D.K. Kulshreshtha, H. Mehdi, B.N. Mehrotra, G.K. Patnaik and S.K. Sharma (1988). Hepatoprotective activity of Kutkin-the iridoid glycoside mixture of Picrorhiza kurrooa Indian Journal of Medical Research, 87 (), 401-404.
937.R.A. Ansari, Chunbiao Li, Ziming Yu, Dinesh Shah (2000). Definitive Molecular Evidence of Renin-Angiotensin System in Human Uterine Decidual Cells Hypertension, 36 (), 159-164.
938.R.A. Ansari, K. Husain and P.K. Gupta (1987). Endosulfan Toxicity Influences on Biogenic amines of Rat Brain Journal of Environmental Biology, 8 (3), 229-236.
939.R.A. Ansari, M.K.J. Siddiqui and P.K. Gupta (1984). Toxicity of Endosulfan: Distribution of alpha and beta isomers of racemic endosulfan following oral administration in rats Toxicology Letters, 21 (), 29-33.
940.R.A. Ansari, R.S. Thakran and W.O. Berndt (1990). Effects of Mercuric Chloride on Transport by Brush Border and Basolateral vesicles isolated from rat kidney Toxicology Applied Pharmacology, 106 (), 145-153.
941.R.A. Ansari, R.S. Thakran and W.O. Berndt (1991). Effect of Mercuric Chloride on Renal Plasma Membrane Function after Depletion or elevation of renal glutathione Toxicology Applied Pharmacology, 111 (), 364-372.
942.R.A. Ansari, S.C. Tripathi, G.K. Patnaik and B.N. Dhawan (1991). Antihepatotoxic properties of Picroliv: the active fraction from rhizomes of Picrorhiza Kurooa. Journal of Ethnopharmacoly, 106 (), 145-153.
943.Rabionet S., Santiago, L., Zorrilla C. (2009). A Multifaceted Mentoring Model for Minority Researchers to Address HIV Health Disparities. American Journal of Public Health, 99 (S1), 65-70.
944.Rabionet, S. (2011). How I Learned to Design and Conduct Semi-structured Interviews: An Ongoing and Continuous Journey. Qualitative Report, 16 (2), 563-566.
945.Rabionet, S. (2009). How I learned to design and conduct semi-structured interviews: An ongoing and continuous journey. The Weekly Qualitative Report, 2 (35), 203-206.
946.Rabionet, S. (2014). Edward Bliss Emerson: The blazing star of a complex constellation. The Qualitative Report, 19 (15), 22-40.
947.Rabionet, S. (2009). Self-Reflection, Politics, Art, and Qualitative Research: A Review of Denzin and Lincoln’s Third Edition of Collecting and Interpreting Qualitative Materials. The Weekly Qualitative Report, 2 (35), 203-206.
948.Rabionet, S., (2016). The Educational Legacy of the UPR School of Tropical Medicine: Curricula, Faculty, Students (1926-1949). Puerto Rico Health Sciences Journal, 35 (), 125-133.
949.Rabionet, S., Zorilla, C., Rivera-Vinas, J. (2018). Pregnancy and Zika: The quest for quality care and reproductive justice. Puerto Rico Health Sciences Journal, 37 (), .
950.Rachid, O.M., Rawas-Qalaji, M.M., Simons, F.E.R., Simons, K.J. (2011). Dissolution Testing of Sublingual Tablets: A Novel Apparatus and Method (Times Cited: 4). AAPS PhamSciTech (Impact Factor 1.9), 12 (2), 544-552.[website]
951.Rachid, O.M., Rawas-Qalaji, M.M., Simons, F.E.R., Simons, K.J. (2013). Epinephrine (Adrenaline) Absorption from New-Generation, Taste-Masked Sublingual Tablets: A Preclinical Study (Times Cited: 2). J Allergy Clin Immunol (Impact Factor 12), 131 (1), 236-238.[website]
952.Rachid, O.M., Rawas-Qalaji, M.M., Simons, F.E.R., Simons, K.J. (2012). Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development (Times Cited: 5). Eur J Pharm Biopharm (Impact Factor 4.7), 82 (3), 598-604.[website]
953.Rachid, O.M., Simons, F.E.R., Rawas-Qalaji, M.M., Simons, K.J. (2010). An Electronic Tongue: Evaluation of the Masking Efficacy of Sweetening and/or Flavoring Agents on the Bitter Taste of Epinephrine (Times Cited: 19). AAPS PhamSciTech (Impact Factor 1.9), 11 (2), 550-557.[website]
954.Rajiv Rose, Madhusudhanan Narasimhan and Appu Rathinavelu (2008). Identification of HDM2 as a Regulator of VEGF Expression in Cancer Cells. Life Sciences, 82 ( ), 1231-1241.
955.Ramirez MA, Borja NL (2008). Epalrestat: An aldose reductase inhibitor for the treatment of diabetic neuropathy Pharmacotherapy, 28 (5), 646-655.
956.Ramugounder, R., Zell, J., Malave and Rathinavelu, A. (2000). Expression of Vascular Endothelial Growth Facot mRNA in GI-101A and HL-60 cell lines. Biochem. Biophys. Res. Commun., 270 (), 709-713.
957.Rathinavelu Appu, Levy A, Sivanesan D, Murugan R, Jornadal J, Quinonez Y, Jaffe M, Gossell-Williams M, (2013). Cytotoxic effects of Pumpkin (Curcurbita pepo) Seed Extracts in LNCaP Prostate Cancer Cells is mediated through Oxidative Stress, Mitochondrial Depolarization and PARP Cleavage Current Topics in Nutraceutical Research, 11 (), 137-144.
958.Rathinavelu, A, Sridhar; Jayalakshmi; Dakshanamurthy, Sivanesan; Pattabiraman, Nagarajan; (2008). VASCULAR ENDOTHELIAL RECEPTOR SPECIFIC INHIBITORS. United States Patents Office Publication, ( ), #20070249575.
959.Rathinavelu, A. and Isom, G.E. (1993). Lysosomal Delivery of ANP Receptors Following Internalization in PC12 Cells. Life Sci.,, 53 (), 1007-1014.
960.Rathinavelu, A. and Isom, G.E. (1988). High Affinity Receptors for Atrial Natriuretic Peptide. Biochem. Biophys. Res. Commun., 156 , 78-85, 156 (), 78-85.
961.Rathinavelu, A. and Isom, G.E. (1989). Production of Monoclonal Antibody Against C Terminus of Atrial Natriuretic Factor by In Vitro Immunization. Biochem. Biophys. Res. Commun., 162 (), 634-638.
962.Rathinavelu, A. and Isom, G.E. (1991). Differential Internalization and Processing of ANF B and C Receptors in PC12 cells. Biochem. J., 276 (), 493-497.
963.Rathinavelu, A. and Isom, G.E. (1991). Modification of ANF Receptor Internalization : Involvement of Extracellular Calcium. Biochem. Biophys. Res. Commun., 175 , 1017-1022, 175 (), 1017-1022.
964.Rathinavelu, A. and Malave, A. (1995). An Electrochemical Detection Assay for the Determination of Prazosin in Serum Samples. J. Chromatograpy B: Biomedical applications, 670 (), 177-182.
965.Rathinavelu, A. and Shanmugasundaram, K.R. and Shanmugasundaram, E.R.B. (1986). Studies on Rat Liver Hexokinase During Cyclopiazonic Acid Induced Toxicosis. Ind. J. Exptl. Biol., 24 (), 179-181.
966.Rathinavelu, A. and Shanmugasundaram, K.R. and Shanmugasundaram, E.R.B. (1984). Simple colorimetric Estimation of Cyclopiazonic Acid in Contaminated Foods and Feeds. Journal of Assoc. Offic. Anal. Chem., 67 , 38-40, 67 (), 38-40.
967.Rathinavelu, A., Pavlakovic. G., Sun, P-W. and Isom, G.E. (1994). Potassium Cyanide Induces Translocation of PKC to the plasma membrane Through NMDA Receptors in Rat brain Slices. J. Biochem. Toxicol., 9 (), 235-240.
968.Rathinavelu, P., Malave, A., Raney, S., Hurst, J. Roberson, C.T. and Rathinavelu, A. (1999). Expression of mdm2 Oncoprotein in the Primary and metastatic Sites of mammary Tumor (GI-101) Implanted Athymic Nude Mice. Cancer Biochemistry and Biophysics, 17 (), 133-146.
969.Rawas-Qalaji, M.M. (2013). Treatment of anaphylaxis: where is the future? J Develop Drugs, 2 (1), 118.[website]
970.Rawas-Qalaji, M.M. (2017). List of All Peer-Reviewed Articles (hyperlinked to original source). Pub-Med Indexed Journals, (), .
971.Rawas-Qalaji, M.M., Rachid, O.M., Simons, K.J., Simons, E.R. (2013). Long-Term Stability of Epinephrine Sublingual Tablets for the Potential First-Aid Treatment of Anaphylaxis. Ann Allergy Asthma Immunol (Impact Factor 3.4), 111 (6), 568-570.[website]
972.Rawas-Qalaji, M.M., Simons, E.R., Simons, K.J. (2006). Sublingual Epinephrine Tablets Versus Intramuscular Injection of Epinephrine: Dose Equivalence for Potential Treatment of Anaphylaxis (Times Cited: 49). J Allergy Clin Immunol (Impact Factor 12), 117 (2), 398-403.[website]
973.Rawas-Qalaji, M.M., Simons, E.R., Simons, K.J. (2009). Long-Term Stability of Epinephrine Dispensed in Unsealed Syringes for the First-Aid Treatment of Anaphylaxis (Times Cited: 17). Ann Allergy Asthma Immunol (Impact Factor 3.4), 102 (6), 500-503.[website]
974.Rawas-Qalaji, M.M., Simons, E.R., Simons, K.J. (2007). Fast-Disintegrating Sublingual Tablets: Effect of Tablet Dimensions on Tablet Characteristics (Times Cited: 11). Drug Dev Ind Pharm (Impact Factor 1.6), 23 (5), 523-530.[website]
975.Rawas-Qalaji, M.M., Simons, E.R., Simons, K.J. (2006). Epinephrine for the Treatment of Anaphylaxis: Do all 40 mg Sublingual Epinephrine Tablet Formulations with Similar In Vitro Characteristics have the Same Bioavailability? (Times Cited: 11). Biopharm Drug Dispos (Impact Factor 2.1), 27 (9), 427-435.[website]
976.Rawas-Qalaji, M.M., Simons, E.R., Simons, K.J. (2006). Fast-Disintegrating Sublingual Tablets: Effect of Epinephrine Load on Tablet characteristics (Times Cited: 56). AAPS PharmSciTech (Impact Factor 1.9), 7 (2), E72-E78.[website]
977.Rawas-Qalaji, M.M., Williams, C. (2012). Advances in Ocular Drug Delivery (Times Cited: 7). Current Eye Research (Impact Factor 1.7), 37 (5), 345–356.[website]
978.Rengo, G., Leosco, D., Zincarelli, C., Marchese, M., Corbi, G., Liccardo, D., Ferrara, N., Lisanti, M.P., Koch, W.J., Lymperopoulos, A. (2010). Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. American Journal of Physiology: Heart & Circulatory Physiology, 298 ( ), H2032-H2038 .
979.Rengo, G., Lymperopoulos, A., Koch W.J. (2009). Future G-protein coupled receptor targets for treatment of heart failure. Curr. Treat. Options Cardiovasc. Med., 11 ( ), 328-338.
980.Rengo, G., Lymperopoulos, A., Leosco, D., Koch, W.J. (2011). GRK2 as a novel gene therapy target in heart failure. Journal of Molecular and Cellular Cardiology, 50 ( ), 785-792.
981.Rengo, G., Lymperopoulos, A., Zincarelli, C., Donniacuo, M., Soltys, S., Rabinowitz, J.E., Koch W.J. (2009). Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation, 119 ( ), 89-98.
982.Rengo, G., Lymperopoulos, A., Zincarelli, C., Femminella, G.D., Liccardo, D., Pagano, G., de Lucia, C., Cannavo, A., Gargiulo, P., Ferrara, N. (2012). Blockade of ß-adrenoceptors restores the GRK2-mediated adrenal a(2) -adrenoceptor-catecholamine production axis in heart failure. British Journal of Pharmacology, 166 ( ), 2430-2440.
983.Rengo, G., Perrone-Filardi, P., Femminella, G.D., Liccardo, D., Zincarelli, C., de Lucia, C., Pagano, G., Marsico, F., Lymperopoulos, A., Leosco, D (2012). Targeting the ß-Adrenergic Receptor System Through G-Protein-Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure: From Bench to Bedside. Circulation: Heart Failure, 5 ( ), 385-391.
984.Rengo, G., Zincarelli, C., Femminella, G.D.,Ferrara, N., Lymperopoulos, A., Koch, W.J., Leosco, D. (2012). Myocardial ß(2)-adrenergic receptor gene delivery promotes coordinated cardiac adaptive remodeling and angiogenesis in heart failure. British Journal of Pharmacology, 166 ( ), 2348-2361.
985.Rey JA (2002). Antipsychotic Therapy: A Pharmacoeconomic Perspective AJHP, (), .
986.Rey JA (2017). Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women. Pharmacy & Therapeutics. 2017;42(4):237-241. Pharmacy and Therapeutics, (), .
987.Rey, J. A. (2006). The Interface of Multiculturalism and Psychopharmacology. Journal of Pharmacy Practice, 19 (6), 379-385.
988.Rey, J.A. (2002). Antipsychotic Therapy: A Pharmacoeconomic Perspective. American Journal of Health-System Pharmacy., 59 (Suppl.8), 5-9.
989.Rey, J.A., Rivas-Vazquez, R.A. (2002). Weight Gain and Metabolic Disturbances Associated with the Atypical Antipsychotics. Professional Psychology: Research and Practice., 33 (4), 341-344.
990.Richard A. Anderson, Charles Joyce, Matthew Davis, Jerry Reagan, Michelle Clark, Gregory (1998). Two Forms of Acyl CoA: Cholesterol acyltransferase Address Different Intracellular Compartments in Primate Liver. J. Biol. Chem., 273 ( ), 26747-26754.
991.Rigau-Perez, J.G., Rabionet, S., Ramirez de Arellano, A.B., Geigel, W.A., Mayo-Santana, R., and Simounet, A. (2014). The Edward Bliss Emerson Journal Project: Qualitative research by a non-hierarchical team. The Qualitative Report, 19 (14), 1-9.
992.Robert C. Speth (2017). Please refer to other scholarship activities tab for PDFs of my publications from 2013 to 2017 , (), .
993.Robinson RF, Griffith JR, Wolowich WR, Nahata MC. (2002). Intoxication with sodium monofluoroacetate (compound 1080). Vet Hum Toxicol, 44 (2), 93-95.
994.Robles G, Singh-Franco D. (2009). A review of exenatide as adjunctive therapy in patients with type 2 diabetes. Drug Design, Development and Therapy, 3 ( ), 219-240.[website]
995.Robles G, Singh-Franco D., Ghin HL. (2008). A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Clinical Therapeutics, 30 (5), 800-812.[website]
996.Rojas, M., Ortiz, B., & Soto-Torres, B. (2007). Knowledge, beliefs, and dietary supplement use among personal trainers and health food store employees [Abstract]. Journal of the American Pharmacists Association, 47 (2), 243.
997.Romo A, Benavides S (2008). Treatment options in insulin resistance obesity-related acanthosis nigricans. Annals of Pharmacotherapy, 42 (7), 1090-4.[website]
998.Rosenkranz, H.S., Cunningham, A.R., Zhang, Y.P., Claycamp, H.G., Macina, O.T., Sussman, N.B., Grant, S.G., & Klopman, G. (1999). Development, characterization and application of predictive-toxicology models. SAR and QSAR in Environmental Research, 10 (2-3), 277-298.
999.Roy,Y; Closs,S; Mathis, N; Nieves, E (2004). Thermal Effusivity as a Process Analytical Technology to Optimize, Monitor and Control Fluid Bed Drying Pharmaceutical Technology , 28 (9), 21-28.
1000.Rubinstein, W.S., Latimer, J.J., Sumkin, J.H., Huerbin, M.B., Grant, S.G., & Vogel, V.G. (2006). Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high risk women. BMC Women’s Health , 6 ( ), 10.
1001.Ruby CM, Kennedy DH (2001). Psychopharmacologic medication use in nursing home care: Indicators for surveyor assessment of the performance of drug regimen reviews; recommendations for monitoring and non-pharmacologic alternatives. Clinics in Family Practice, 3 (3), 577-598.
1002.S Mirzaei, H Mobedi, H Gourabi, M H Sanati, S Khezli, M Ighaei, H Omidian (2018). Investigation of increasing human Growth Hormone stability by Tris (hydroxymethyl) aminomethane-HCl, using Molecular Docking Modeling and experimental analysis for determination of Interactions , (), In submission.
1003.S Mirzaei, H Mobedi, H Gourabi, M H Sanati, S Khezli, S Sadrai, H Omidian (2018). Investigation of Poly (ethylene glycol) dimethyl ether and Tris(hydroxymethyl)aminomethane effects on human Growth Hormone stability and release mechanisms in PLGA-based in situ forming implant systems: in vitro and in vivo study , (), In submission.
1004.S Muppalaneni, DJ Mastropietro, H Omidian (2016). Crush Resistance and Insufflation Potential of Poly(ethylene oxide)-Based Abuse-Deterrent Formulations. Expert Opinion on Drug Delivery, 13 (10), 1375-1382.[website]
1005.S Muppalaneni, H Omidian (2013). Polyvinyl Alcohol in Medicine and Pharmacy Journal of Developing Drugs, 2 (3), 112.
1006.S Shahi, MJ Zohuriaan-Mehr, H Omidian (2017). Antibacterial Superabsorbing Hydrogels with High Saline-Swelling Properties without Gel Blockage-Towards Ideal Superabsorbents for Hygiene Applications Journal of Bioactive and Compatible Polymers, 32 (2), 128-145.
1007.S Shaneh, F Shokrollahi, P Shokrollahi, H Yeganeh, E Seyedjafari, AA Lajimi, H Omidian (2015). Improved Immobilization of Gelatin on a Modified Polyurethane Urea, Journal of Bioactive and Compatible Polymers, 30 (), .
1008.S Shaneh, F Shokrollahi, P Shokrollahi, H Yeganeh, H Omidian (2018). Structural Engineering to Control Density, Configuration, and Bioactivity of the PEG-Grafted Polyurethane Urea (PUU) Scaffolds Journal of Bioactive and Compatible Polymers, (), in Press.
1009.S. Doroudiani and H. Omidian (2010). Environmental,Health and Safety Concerns of Decorative Moldings Made of Expanded Polystyrene. Building and Environment, 46 ( ), 647-654.
1010.S. Essex, G. Navarro, P. Sabhachandani, A. Chordia, M.S. Trivedi, S. Movassaghian, & V. Torchilin (2015). Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multi-drug resistant tumors. Gene Therapy, 22 (3), 257-266.[website]
1011.S. Mrozowski, J. Czerwinska, R. Drozdowski (1993). Study of Zeeman effect in second-order mixed radiation of SbI. Journal of Optical Society of America, B (10), 607-612.
1012.Saghir, S.A, Ansari, R.A., and Dorato, M.A. (2020). Rethinking toxicity testing: Influence of aging on the outcome of long-term toxicity testing and possible remediation Food and Chemical Toxicology, 141 (), 111327-37.
1013.Sajithlal, G.S., Rothermund, K., Zhang, F., Dabbs, D.J., Latimer, J.J., Grant, S.G., & Prochownik, E.V. (2010). Permanently blocked stem cells derived from breast cancer cell lines. Stem Cells, 28 (6), 1008-1018.
1014.Salazar, N.C., Vallejos, X., Gao, E., Leosco, D., Koch, W.J., Lymperopoulos, A. (2013). GRK2 blockade with betaARKct is essential for cardiac beta2-adrenergic receptor signaling towards increased contractility Cell Commun. Signal. , 11 (), 64.
1015.Samra Kazim, R.A. Ansari, Wilfredo Hernandez, Leon Ferder and Kazim Husain (2018). Therapeutic Intervention of Human Pancreatic Cancer Annals of Clinical Pharmacology and Therapeutics, 1 (1), 1-6.
1016.Santini E & Porter JT (2010). M-type potassium channels modulate the intrinsic excitability of infralimbic neurons and regulate fear expression and extinction. The Journal of Neuroscience, 15 (30 (37)), 12379-86..
1017.Santini E, Quirk GJ and Porter J (2008). Fear conditioning and extinction differentially modify the intrinsic excitability of infralimbic neurons. The Journal of Neuroscience, 28 ( ), 4028-4036.
1018.Santini E. Sepulveda M. and Porter J. (2012). Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction. Neuropsychopharmacology , ( ), .
1019.Santos, R.M., Weinstock-Guttman, B., Tamaño-Blanco, M., Badgett, D., Pachner, A., Zivadinov,R., Justin, T., (2006). Dynamics of Interferon-b Modulated mRNA Biomarkers in Multiple Sclerosis Patients with Anti-Interferon-b Neutralizing Antibodies. Journal of Neuroimmunology, 176 (), 125-133.
1020.Sarat C. Chattaraj, Rathinavelu, A. and Sudip K. Das. (1999). Biodegradable Microparticles of Influenza Viral Vaccine: Comparison of the Effects of Routes of Administration on the in vivo Immune Response in Mice. Journal of Controlled Release, 58 (), 223-232.
1021.Sawyer R, McGory R, Gaffey M, Shephard B, McCullough C, Houlgrave C, Ryan T, Kuhns M, McNamara A, Caldwell S, Abdulkareem A & Pruett T. (1998). Improved Clinical Outcomes with Liver Transplantation for Hepatitis B Induced Chronic Liver Failure Using Passive Immunization. Transplantation, 66 (8), 1104.
1022.Schaak, S., Cayla, C., Lymperopoulos, A., Flordellis, C., Cussac, D., Denis, C., and Paris, H. (2000). Transcriptional down-regulation of the human a2C-adrenergic receptor by cAMP. Mol. Pharmacol., 58 ( ), 821-827.
1023.Schafer JJ, Gill TK, Sherman EM, McNicholl IR (2016). ASHP guidelines on pharmacist involvement in HIV care Am J Health Syst Pharm, 73 (7), 468-94.
1024.Schrier MS, M.Trivedi, Deth RC (2017). Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4 Frontiers in Oncology, (), .
1025.Schrier MS, Trivedi MS, Deth RC (2017). Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4. Front Oncol. , 7 (), 46.
1026.Schwenzer K, Vega H & McGory R (1994). Intravenous Ketorolac for Patients in Intensive Care Units. Anesth Review, 21 (4), 125.
1027.Schwier NC, Hale GM, & Davies ML (2017). Treatment of adults with idiopathic recurrent pericarditis: novel use of immunotherapy. Pharmacotherapy, 37 (3), 305-318.[website]
1028.Seamon MJ (2010). Antitrust and the Biopharmaceutical Industry: Lessons from Hatch-Waxman and an Early Evaluation of the Biologics Price Competition and Innovation Act Nova Law Review, 34 ( ), 629-78.
1029.Seamon MJ (2011). Counterfeit Drugs Pharmacy Law Column / Drug Store News Pharmacy Practice , (June), .
1030.Seamon MJ (2011). Medical Marijuana Pharmacy Law Column / Drug Store News Pharmacy Practice , (July), .
1031.Seamon MJ (2011). Active Pharmaceutical Ingredients and the Globalization of Pharmaceutical Manufactures: Contributors to US Drug Recalls and Shortages Pharmacy Law Column / Drug Store News Pharmacy Practice , (August), .
1032.Seamon MJ (2011). Pharmaceutical Life-Cycles: Patents, Exclusivities, and Evergreening Strategies Pharmacy Law Column / Drug Store News Pharmacy Practice , (September), .
1033.Seamon MJ (2011). Direct to Consumer Prescription Drug Advertising and Regulation Pharmacy Law Column / Drug Store News Pharmacy Practice , (October), .
1034.Seamon MJ (2011). The safe harbor of pharmacy compounding; avoiding pharmaceutical manufacturing provisions Pharmacy Law Column / Drug Store News Pharmacy Practice , (November), .
1035.Seamon MJ (2011). Managing Medical Marijuana in the Health-System Pharmacy Pharmacy Purchasing & Products, (November), .
1036.Seamon MJ (2010). Medical Marijuana, an Evolving Landscape Medscape Pharmacists, (February), .
1037.Seamon, M. J., Clauson, K. A. (2005). Ephedra: Yesterday, DSHEA, and Tomorrow. A Ten Year Perspective on the Dietary Supplement Health and Education Act of 1994. Journal of Herbal Pharmacotherapy, 5 (3), 65-83.
1038.Seamon, M.J., Clauson, K.A. (2005). Ephedra: yesterday, DSHEA, and tomorrow. A ten year perspective on the Dietary Supplement Health and Education Act of 1994. Journal of Herbal Pharmacotherapy, 5 (3), 65-83.
1039.Sepers CE, Fawcett SB, Lipman R, Schultz J, Colie-Akers V, Perez A (2015). Measuring the implementation and effects of a coordinated care model featuring diabetes self-management education within four patient-centered medical homes. The Diabetes Educator, 41 (3), 328-42.
1040.Shaeer K, Sherman EM, Shafiq S, Hardigan P (2014). Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis J Am Pharm Assoc, 54 (6), 610-7.
1041.Shahzad, Y.; Khan, I. U.; Hussain, T.; Alamgeer.; Serra, C. A.; Rizvi, S, A. A.; Gerber, M.; Plessis, J. D. (2014). Bioactive albumin-based carriers for tumour chemotherapy/1568009614666141028100640. Current Cancer Drug Targets, 14 (), 752-763.
1042.Shamus E, Garcia AS (2011). Editorial: Identifying risk factors for osteoporosis in young women. Internet Journal of Allied Health Sciences and Practice, 9 (4), .
1043.Shatnawi A, Khanfar NM, Latif D, Shaer M (2019). A comparative study of the depth, breadth, and perception of pharmacogenomics instruction in a subgroup of US pharmacy curricula. Currents in Pharmacy Teaching and Learning, 11 (5), 476-484.[website]
1044.Shehadeh, N., Attonito, J., Rubens, M. and Sanchez, J. (2018). The Impact of Depression and Acculturation on Injection Drug Use among Male Latino Injection Drug Users Journal of HIV and AIDS, 4 (1), 1-6.
1045.Shehadeh, N., Sanchez, J., and Rubens, M. (2019). Latina Injection Drug Users: A Descriptive Analysis of an Overlooked Population in South Florida. HIV and Sexual Health , 1 (1), 1-6.
1046.Sherman E (2011). Coping with ADAP cuts: clinic organizes new service to help patients (non-peer reviewed). HIV Specialist, (Spring), 14-15.
1047.Sherman E, Cocohoba J, Neff S, Dong B (2011). Healthcare provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Annals of Pharmacotherapy, 45 (12), 1499-1505.
1048.Sherman E, Elrod S, Allen D, Eckardt P (2014). Pharmacist testers expand point-of-care HIV testing program. J Pharm Pract, 27 (6), 578-81.
1049.Sherman E, Elrod S, Eckardt P (2012). Baseline transmitted V106V/I/M non-nucleoside reverse transcriptase inhibitor resistance in HIV-1 subtype B infection. BMJ Case Reports, Dec ( ), .
1050.Sherman EM, Clauson K, Elrod S, Eckardt P, Alkhateeb F, Jacobs R (2018). Patient perceptions of text messaging to improve antiretroviral therapy adherence: a qualitative study of patients in a Ryan White clinic J Int Assoc Provid AIDS Care, (), .
1051.Sherman EM, Steinberg JG (2011). Heat-stable ritonavir tablets: a new formulation of a pharmacokinetic enhancer for HIV. Expert Opinion on Pharmacotherapy, 12 (1), 141-148.
1052.Sherman EM, Worley MV, Unger NR, Gauthier TP, Schafer JJ (2015). Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection. Clinical Therapeutics, 37 (9), 1876-1893.[website]
1053.Sherman, E. M., Cocohoba, J. M., Dong B.J. (2011). Raltegravir Intensification Therapy in Two Human Immunodeficiency Virus–Infected Patients with Undetectable Viremia and Discordant CD4+ Response Pharmacotherapy, 31 (5), 525.
1054.Sherwood, D. A., Rey, J. A. (2006). Pharmacological Agents for the Treatment of Adult Attention Deficit Hyperactivity Disorder: A Review of the Literature. Journal of Pharmacy Practice, 19 (6), 336-341.
1055.Shewood, D. A., Rey, J. A. (2007). Ramelteon (Rozerem): A Novel Treatment Option for Patients with Insomnia Pharmacy & Therapeutics, 32 (8), 427-431.
1056.Shin M. C., Zhang J., David A. E., Trommer W. E., Kwon Y. M., Min K. A., Kim J. H., Yang V. C. (2013). Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. Journal of Controlled Release, 172 (1), 169-78.
1057.Shukla BS, Gautheir TP, Correa R, Smith L, Abbo L (2013). Treatment considerations in vancomycin-resistant bacteremia: daptomycin or linezolid? A review. International Journal of Clinical Pharmacy, ( ), ePub Ahead of Print.
1058.Shukla BS, Gauthier TP, Correa R, Smith L, Abbo L (2013). Treatment considerations in vancomycin-resistant bacteremia: daptomycin or linezolid?. International Journal of Clinical Pharmacy, ( ), Epub ahead of print.
1059.Shyale S, Chowdary KPR, Krishnaiah YSR, Bhat NK (2006). Pharmacokinetic evaluation and studies on the clinical efficacy of guar gum-based oral drug delivery systems of albendazole and albendazole-ß-cyclodextrin for colon-targeting in human volunteers. Drug Development Research , 67 ( ), 154-165.
1060.Shyale S, Chowdhary KPR, Krishnaiah YSR (2005). Development of colon-targeted albendazole-ß-cyclodextrin-complex drug delivery systems. Drug Development Research , 65 ( ), 76-83.
1061.Silva-Suarez, G., Bastida, E., Rabionet, S., Beck-Saque, C., Febo, I., and Zorrilla, C. (2015). That's True Love Lives experiences of Puerto Rican Perinatally HIV-infected Youth within their Families' Context. International Journal of Enviromental Research and Public Health , 12 (), .
1062.Silva-Suárez, G., Rabionet, S., & Zorrilla, C. D. (2017). HIV normalization message and its implication on the lives of perinatally HIV-infected youth in Puerto Rico. Journal of Pharmaceutical Health Services Research, 8 (4), 241-246.
1063.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1064.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (2019). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, 0 (0), 0.
1065.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (2019). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1066.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (2019). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1067.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1068.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1069.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S. E., Medina, P., Lozada, R. & Ortiz, B. (). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1070.Silva?Suárez, G., Alvarado, Y., Rodriguez-Figueroa, L., Rivera-Ortiz, N., Vargas-Loyselle, J., Rabionet, S., Medina, P., Lozada, R. & Ortiz, B. (2019). Assessment of experiences and impact of Hurricane Maria in the academic performance of student pharmacists American Journal of Pharmaceutical Education, (), .
1071.Silvia Lakatosova, Sheinberg Nurit, Pivovarciova Anna, Husarova Veronika, Rozenfeld Irina, Ostatnikova Daniela, Castejon, A.M. (2014). Oxytocin but Not Testosterone Modulates Behavioral Patterns in Autism Spectrum Disorders Open Journal of Medical Psychology, 3 (1), 48-53.
1072.Sing D., Lai L.et.al (2005). Role of Clinical Pharmacist in a heart failure patients. Hospital Pharmacy, 40 (), 890-896.
1073.Singh D, Kennedy DH (2003). The use of gabapentin for the treatment of postherpetic neuralgia. Clinical Therapeutics, 25 (3), 852-89.[website]
1074.Singh-Franco D. (2015). Potential for dipeptidyl peptidase-4 inhibitor and sodium glucose cotransporter 2 inhibitor singlepill combinations. Expert Review of Endocrinology & Metabolism, 10 (3), 305-317.
1075.Singh-Franco D., Elrod S., Harrington CA, McLaughlin-Middlekauf J. (2012). Response Letter to the Editor. Diabetes, Obesity & Metabolism, 14 ( ), 1056-1057.[website]
1076.Singh-Franco D., Ghin HL, Robles GI, Borja-Hart NL, & Perez A (2009). Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria Clinical Therapeutics, 31 (8), 1664-1687.[website]
1077.Singh-Franco D., Hale GM, & Jacobs RJ. (2018). Oral anticoagulation therapy upon discharge in hospitalized patients with nonvalvular atrial fibrillation: a retrospective cohort study. Hospital Practice, 46 (1), 22-29.[website]
1078.Singh-Franco D., Harrington C., Tellez-Corrales E. (2016). An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease. SAGE Open Medicine, 4 (), 1-16.
1079.Singh-Franco D., Lai, L., Hannah, S., Diamond, M. (2005). Role of clinical pharmacist in a heart failure clinic. Hospital Pharmacy, 40 ( ), 890-896.
1080.Singh-Franco D., Machado C, Tuteja S, Zapantis A. (2005). Trospium chloride for the treatment of overactive bladder with urge incontinence. Clinical Therapeutics, 27 (5), 511-530.[website]
1081.Singh-Franco D., McLaughlin-Middlekauf J, Elrod S., Harrington CA (2012). The effect of linagliptin on glycemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes, Obesity & Metabolism, 14 (8), 694-708.[website]
1082.Singh-Franco D., Perez A, Wolowich W.R. (2013). Improvement in surrogate endpoints by a multidisciplinary team in a mobile clinic serving a low-income, immigrant minority population in South Florida. Journal of Healthcare for the Poor and Underserved, 24 ( 1), 67-77.
1083.Singh-Franco D., Perez, A., Harrington, C. (2011). The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis.(original work) Diabetes, Obesity and Metabolism, 13 (2), 169-80.[website]
1084.Singh-Franco D., Robles G, Gazze D (2007). Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Clinical Therapeutics, 29 (4), 535-562.[website]
1085.Singh-Franco, D., Jacobs RJ. (2017). Patient perspectives on peripheral neuropathic pain experience within the community. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11S (), S243–S246.
1086.Sinkevicius, K.W., Morrison, T.R., Kulkarni, P., Cagliostro, M.K.C., Iriah, S., Malmberg, S., Sabrick, J., Honeycutt, J.A., Askew, K.L., M.Trivedi and Ferris, C.F. (2018). RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory Disease models & mechanisms, 2018 (11), .
1087.Sircar, F., Clauson, K.A., Duffy, M., Joseph, S. (2012). Thematic analysis of pharmacy students’ perceptions of Web 2.0 tools and preferences for integration in educational delivery. Future Learning, 1 (1), 65-77.
1088.Siryk-Bathgate, A., Dabul, S., Lymperopoulos, A. (2013). Current and future G protein-coupled receptor signaling targets for heart failure therapy. Drug Des. Devel. Ther. , 7 (), 1209-1222 .
1089.Sivanesan Dhandayuthapani, Hasan Azad and Appu Rathinavelu (2015). Apoptosis induction in LNCaP prostate cancer cell lines by Ocimum sanctum (holy basil) extract Journal of Medicinal Food, 18 (7), 776-785.
1090.Sivanesan Dhandayuthapani, Palanisamy Marimuthu, Vanessa Hörmann, James Kumi-Diaka and Appu Rathinavelu (2013). Induction of Apoptosis in HeLa cells via Caspase activation by Resveratrol and Genistein. Journal of Medicinal Food , 16 (), 139 - 146.
1091.Sizemore EN, Rivas KM, Valdes J, Caballero J. (2012). Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea. British Medical Journal Case Reports, 27 (), .
1092.Skrabal, M.Z., Kahaleh, A.A., Nemire, R.E.,Boxer, H., Zachariah, B., Harris, M., Cardello, C. (2006). Preceptors' Perpectives on Benefits of Precepting Student Pharmacists to Students, Preceptors and the Profession Journal of the American Pharmacists Association, 46 (5), 605-612.
1093.Snyder RL, Kizer LE, Mujtaba BG, Khanfar NM (2009). Comparing and Managing the Relative Importance and Ranking of Reasons for Selecting the Masters’ of Business Administration Program. American Journal of Business Education, 2 (4), 55-63.
1094.Sonya Collins (2013). Psychopharmacologist lends expertise to law. Pharmacy Today, (), .
1095.Sorbera, M., Joseph, T., Digregorio RV (2017). Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report Journal of Pharmacy Practice, 30 (3), 567-70.
1096.Soto-Torres, B. (1992). Reflexion sobre el Modelo de Razonamiento en la Educacion en Salud (Reflection on the Reasoning Model of the Health Education Profession). Bayoan, 2 (1), 15-16,30.
1097.Soto-Torres, B., & Ortiz, B. I. (2006). Alcanzando competencia cultural en la atencion farmaceutica (Achieving cultural competence in pharmaceutical care) Revista Farmaceutica, ACPE Program # 151-999-06-01-H04, 65 (2), 34-41.
1098.Soto-Torres, B., & Ortiz, B. I. (2006). El rol del farmaceutico ante la violencia domestica en la mujer (Pharmacist's role on domestic violence against women). Revista Farmaceutica, ACPE Program # 151-000-06-31-H04, 65 (4), 38,40-42,44-47.
1099.Sridhar J. Akula N. Sivanesan D. Narasimhan M. Rathinavelu A, Pattabiraman N. (2005). Identification of novel angiogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters., 15 (18), 4125-4129.
1100.Stallings A, Borja-Hart N, Fass J (2010). Developing an interactive group journal club activity for pharmacy students on Advanced Pharmacy Practice Rotations: A guide for reinventing journal club. American Journal of Health-System Pharmacy, ( ), .
1101.Stein B, Ward T, Hale G, Lyver E. (2019). Safety of high-intensity statins in the Veteran population: Atorvastatin 40-80 mg compared to rosuvastatin 20-40 mg. Annals of Pharmacotherapy, 54 (5), 405-413.
1102.Steinberg JG, Machado C, Clarke H, Marsh W, Kelly G (2008). Impact of pharmacy-generated recommendations on antibiotic therapy in a community hospital. Hospital Pharmacy, 43 (12), 988-993.
1103.Stephenson, D.A., Elliott, R.W., Chapman, V.M., & Grant, S.G. (1988). Identification of an X-linked member of the Odc gene family in the mouse. Nucleic Acids Research, 16 (4), 1642.
1104.Stephenson, D.A., Grant, S.G., Mullins, L.J., Scolese, A.E., O’Reilly, A.J., & Chapman, V.M. (1988). X-chromosome gene order in different Mus species crosses. Current Topics in Microbiology and Immunology, 137 ( ), 183-190.
1105.Stephenson, D.A., Keitz, B., Grant, S.G., Mullins, L.J., & Chapman, V.M. (1990). Linkage analysis of the X-linked gene involved in the initiation of transition from G1 to S phase of the cell cycle. Mouse Genome, 86 ( ), 255.
1106.Su, HF., Lai, L., Rivera, H. (2010). Using an Exploratory Approach to Help Autistic Children Learn Mathematics. Creative Education, 3 ( ), 149-153.
1107.Suarez Conejero, J., Godue, C., Garcia Gutierrez, J.F., Magana Valladares, L., Rabionet, S., Concha, J., et al (2013). Competencias esenciales en Salud Publica: Un marco regional para las Americas [Core competencies in public health: a regional framework for the Americas]. TECHNICAL REPORT Rev Panam Salud Publica, 34 (1), 47-53.
1108.Sussman, N.B., Macina, O.T., Claycamp, H.G., Grant, S.G., & Rosenkranz, H.S. (1999). The utility of multiple random sampling in the development of SAR models. AAAI Technical Report, 9901 ( ), 45-48.
1109.Swaidan Z, Khanfar NM, Venneman S (2008). Moral Ideologies and Academic Dishonesty Review and Hypothesis European Journal of Management, 8 (4), 160-164.
1110.Syed A. A. Rizvi (2011). Relationship between Surface Tension and Surface Coverage Langmuir, 27 (23), 13975–13977.
1111.Syed A. A. Rizvi (2016). What’s Causing This Intensely Itchy Rash on a Woman’s Lower Extremities? Consultant, 56 (3), 261.[website]
1112.Syed A. A. Rizvi (2016). Multiple Myeloma Consultant, 56 (2), 190.[website]
1113.Syed A. A. Rizvi (2016). Novel anticancer compound [trifluoromethyl-substituted pyrazole N-nucleoside] inhibits FLT3 activity to induce differentiation in acute myeloid leukemia cells. Cancer Letters, 375 (2), 199-208.[website]
1114.Syed A. A. Rizvi (2016). A Woman With Seventh Nerve Palsy: Presentation and Management. Consultant, 56 (4), 354-356.[website]
1115.Syed A. A. Rizvi (190). Multiple Myeloma Consultant, 56 (2), .[website]
1116.Syed A. A. Rizvi (2016). Neurocysticercosis: A Case Report and Brief Review. Asian Pacific Journal of Tropical Medicine, (), .[website]
1117.Syed A. A. Rizvi (2015). Patience with Patients: A Medical Student’s Perspective on Helping Patients Be Adherent. Consultant, 55 (11), 938-940.[website]
1118.Syed A. A. Rizvi (2015). Sulfasalazine in Ionic Liquid Form with Improved Solubility and Exposure Medicinal Chemical Communications, 6 (), 1837-1841.
1119.Syed A. A. Rizvi (2006). Cryoetch and Cryo-planing for Low Temperature HRSEM SE-I Imaging of Hydrated Multicellular Microbial and Bioorganic Systems Microscopy and Microanalysis, 12 (S02), 1120-1121.
1120.Syed A. A. Rizvi (2015). Antiproliferative activity of the isoindigo 5'-Br in HL-60 cells is mediated by apoptosis, dysregulation of mitochondrial functions and arresting cell cycle at G0/G1 phase Cancer letters, 361 (2), 251-261.[website]
1121.Syed A. A. Rizvi (2011). Fundamentals of Micellar Electrokinetic Chromatography (MEKC) European Journal of Chemistry, 2 (2), 276-281.[website]
1122.Syed A. A. Rizvi (2011). Novel Approach for Preparing Nontoxic Stealth Microspheres for Drug Delivery European Journal of Chemistry, 2 (2), 125-129.[website]
1123.Syed A. A. Rizvi (2011). Reply to “Should the Gibbs Analysis Be Revised?” Langmuir, 27 (12), 7963–7965.[website]
1124.Syed A. A. Rizvi (2011). Liposome Fusion Rates Depend Upon the Conformation of Polycation Catalysts Journal of the American Chemical Society, 133 (9), 2881-3.[website]
1125.Syed A. A. Rizvi (2010). Cationic gemini surfactants as pseudostationary phases in micellar electrokinetic chromatography. Part I: Effect of head group Journal of Chromatography A, 217 (32), 5279-87.[website]
1126.Syed A. A. Rizvi (2010). Self-assembling systems. Mining a rich vein Journal of Colloid and Interface Science, 344 (2), 241–246.[website]
1127.Syed A. A. Rizvi (2010). Additional Support for a Revised Gibbs Analysis Langmuir, 26 (3), 1588–1589.[website]
1128.Syed A. A. Rizvi (2010). Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy International Journal of Pharmaceutics, 386 (1), 114–121.[website]
1129.Syed A. A. Rizvi (2009). Re-evaluating the Gibbs Analysis of Surface Tension at the Air/Water Interface Journal of the American Chemical Society, 131 (30), 10380–10381.[website]
1130.Syed A. A. Rizvi (2009). The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome Crystal Engineering Communications, 11 (), 418-426.[website]
1131.Syed A. A. Rizvi (2008). Unusual Aqueous-Phase Behavior of Cationic Amphiphiles with Hydrogen-Bonding Headgroups Langmuir, 24 (3), 673-7.[website]
1132.Syed A. A. Rizvi (2007). Polymeric alkenoxy amino acid surfactants: V. Comparison of carboxylate and sulfate head group polymeric surfactants for enantioseparation in MEKC Electrophoresis, 28 (11), 1762-78..[website]
1133.Syed A. A. Rizvi (2007). Simultaneous chiral separation and determination of ephedrine alkaloids by MEKC-ESI-MS using polymeric surfactant I: method development. Electrophoresis, 28 (9), 1352-63..[website]
1134.Syed A. A. Rizvi (2007). Polymeric Sulfated Amino Acid Surfactants: A Class of Versatile Chiral Selectors for Micellar Electrokinetic Chromatography (MEKC) and MEKC-MS Analytical Chemistry, 79 (3), 879–898..[website]
1135.Syed A. A. Rizvi (2016). Chiari Malformation Type I Consultant, 56 (5), 473-474.[website]
1136.Syed A. A. Rizvi (2016). Bullous Pemphigoid Consultant, 56 (5), 476.[website]
1137.Syed A. A. Rizvi (2007). Photopolymerized Sol-Gel Monolithic Column for Capillary Electrochromatography (CEC) and CEC Coupled to Atmospheric Pressure Photoionization Mass Spectrometry Journal of Liquid Chromatography & Related Technologies, 30 (1), 43-57.[website]
1138.Syed A. A. Rizvi (2006). Capillary electrochromatography-mass spectrometry of cationic surfactants Electrophoresis, 27 (21), 4273-87.[website]
1139.Syed A. A. Rizvi (2006). Synthesis, Characterization, and Application of Chiral Ionic Liquids and Their Polymers in Micellar Electrokinetic Chromatography Analytical Chemistry, 78 (19), 7061–7069.[website]
1140.Syed A. A. Rizvi (2006). Application of polymeric surfactants in micellar electrokinetic chromatography electrospray ionization mass spectrometry of benzodiazepines and benzoxazocine chiral drugs Electrophoresis, 27 (5), 1263-75..[website]
1141.Syed A. A. Rizvi (2005). Polymeric alkenoxy amino acid surfactants: IV. Effects of hydrophobic chain length and degree of polymerization of molecular micelles on chiral separation of ?-blockers Electrophoresis, 26 (21), 4172-86.[website]
1142.Syed A. A. Rizvi (2005). Glycine-based polymeric surfactants with varied polar head group: I. Synthesis, characterization, and application in micellar electrokinetic chromatography Electrophoresis, 26 (21), 4127-37..[website]
1143.Syed A. A. Rizvi (2005). Simultaneous Enantioseparation and Tandem UV-MS Detection of Eight b-Blockers in Micellar Electrokinetic Chromatography Using a Chiral Molecular Micelle Analytical Chemistry, 77 (6), 1672–1683.[website]
1144.Syed A. A. Rizvi (2004). Chiral separations in microemulsion electrokinetic chromatography Use of micelle polymers and microemulsion polymers Journal of Chromatography A, 1043 (2), 291-302.[website]
1145.Syed A. A. Rizvi (2004). Polymeric alkenoxy amino acid surfactants: III. Chiral separations of binaphthyl derivatives Electrophoresis, 25 (4), 712-22..[website]
1146.Syed A. A. Rizvi (2004). Polymeric alkenoxy amino acid surfactants: II. Chiral separations of b-blockers with multiple stereogenic centers Electrophoresis, 25 (6), 853-60..[website]
1147.Syed A. A. Rizvi (2003). Polymeric alkenoxy amino acid surfactants: I. Highly selective class of molecular micelles for chiral separation of b-blockers Electrophoresis, 24 (15), 2514-26.[website]
1148.Syed A. A. Rizvi (2014). An unusual case of Neurocysticercosis in Asian American Female in the United States Consultant, 54 (10), 810.[website]
1149.Syed A. A. Rizvi (2014). Bioactive albumin-based carriers for tumour chemotherapy Current Cancer Drug Targets, 14 (8), 752-63.[website]
1150.Syed A. A. Rizvi (2014). End-Stage Renal Disease with Atrial Fibrillation: Uncharted Territory in the Modern World of Anti-Coagulants Expert Opinion on Pharmacotherapy, 15 (12), 1639-42.[website]
1151.Syed A. A. Rizvi (2014). In vitro cytotoxicity of Artemisia vulgaris L. essential oil is mediated by a mitochondria-dependent apoptosis in the human acute promyelocytic leukemia cell line HL-60 BMC Complementary and Alternative Medicine, 14 (), 226.[website]
1152.Syed A. A. Rizvi (2014). Formulation Development and In Vitro Evaluation of Oral Extended-release Capsules containing Biodegradable Microspheres Journal of Nanomedicine & Nanotechnology, 5 (3), 208.[website]
1153.Syed A. A. Rizvi (2013). Formulation and Evaluation of Drug-loaded Targeted Magnetic Microspheres for Cancer Therapy International Journal of Nanomedicine, 8 (1), 1393—1402.[website]
1154.Syed A. A. Rizvi (2013). Formulation development of albumin based theragnostic nanoparticles as a potential tumor targeting and delivery system Journal of Drug Targeting, 21 (1), 77-86.[website]
1155.Syed A. A. Rizvi (2013). An Essay on Scientific Writing Education, 3 (2), 130-133.[website]
1156.Syed A. A. Rizvi (2012). Pharmaceutical Cocrystals of Nitrofurantoin: Screening, characterization and crystal structure analysis CrystEngComm, 14 (), 5078-5088.
1157.Syed A. A. Rizvi, Rais Ansari (2013). Brief Overview of Various Approaches to Enhance Drug Solubility Journal of Developing Drugs, 2 (3), 115.[website]
1158.T-L. Chang, M.G. Kramer, R.A. Ansari and S.A. Khan (2000). Role of individual monomers of a dimeric initiator protein in the initiation and termination of plasmid rolling circle replication J. Biol. Chem, 275 (18), 13529-13534.
1159.TP Gauthier (2013). Rifampicin plus colistin in the era of extensively resistant Acinetobacter baumannii infections Clinical Infectious Diseases, TBD (TBD), TBD.[website]
1160.TP Gauthier, C Morrison (2012). Comment on "an advanced clinical track within a doctor of pharmacy program". American Journal of Pharmaceutical Education, 76 (5), Article 95.
1161.TP Gauthier, L Smith (2012). Tips for the first trainee in a new pharmacy residency program. American Journal of Health-System Pharmacy, 69 (April 15th), 644,646,649.
1162.TP Gauthier, NR Unger (2013). Antimicrobial stewardship programs: a review for the formulary decision maker. Formulary, 48 (January), 7,8,15-18.
1163.TP Gauthier, V Price-Goodnow (2011). From resident to peer: practicing where you trained. American Journal of Health-System Pharmacy, 68 (June 1), 980,982.
1164.TP Gauthier, WR Wolowich, A Reddy, E Cano, L Abbo, L Smith (2012). Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrobial Agents and Chemotherapy, 56 (5), 2392-2396.
1165.Talon, B., Perez, A., Touchette, D. (2019). A Systematic Review of Economic Evaluations of Clinical Pharmacy Services in the United States: 2011-2017. Journal of the American College of Clinical Pharmacy , (), .
1166.Taraviras, S., Olli-Lahdesmaki, T., Lymperopoulos, A., Charitonidou, D., Mavroidis, E., Kallio, J., Scheinin, M., Flordellis, C. (2002). a2-adrenergic receptor subtypes regulate neuronal differentiation of transfected PC12 cells through MAPK activation. Eur. J. Cell Biol., 81 ( ), 363-374.
1167.Tenam-Zamach, M., Kirchgessner, M., Pecore, J., Lai, L. (2014). Development of an Innovative Method for Analyzing the Presence of Environmental Sustainability Themes and an Ecological Paradigm in Science Content Standards. Studies in Educational Evaluation , 41 (), 133-142.
1168.Terhune TD, Deth R. (2015). A role for impaired regulatory T cell function in adverse responses to aluminum adjuvant-containing vaccines in genetically susceptible individual. Vaccine, 32 (40), 5149-55.
1169.Terrault N, Zhou S, McGory R, Pruett T, Lake J, Roberts J, Ascher N & Wright T (1998). Incidence and Clinical Consequences of Surface and Polymerase Gene Mutations in Liver Transplant Recipients on Hepatitis B Immunoglobulin. Hepatology, 28 ( ), 555.
1170.Thiagarajan Venkatesana, Aiyavu Chinnaiyanb, Sivanesan Dhandayuthapani, Appu Rathinavelu (2015). Analysis of angiogenesis related gene expression in MDM2 transfected prostate cancer cells using PCR array, Molecular Biology Reports , (Submitted), .
1171.Thomas JE, Caballero J. (2012). Impact of pharmacists in mental health over the past decade. The Mental Health Clinician (editor reviewed article), 1 (10), 17.[website]
1172.Thomas, C.A., Grant, S.G., Pflug, B.R., Getzenberg, R.H., & Day, B.W. (2008). (Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells. Urologic Oncology, 26 (4), 378-385.
1173.Timothy P. Gauthier, Marylee Worley, Vanesa Laboy, Luis Hernandez, Nathan R. Unger, Elizabeth M. Sherman, Corey Frederick, Laura Aragon (2015). Clinical Infectious Diseases Pharmacists in the United States: A Problem of Both Supply and Demand. Clinical Infectious Diseases, 60 (5), 826-827.
1174.Torres-Colón, R., Frontera-Zayas, F., Maniscalco-Feichtl, M., (2007). Thrombolytic Therapy in Pregnant Women US Pharmacist, 32 (9), 12-15.
1175.Touchette D, Doloresco F, Suda K, Perez A, Turner S, Jalundhwala Y, Tangonan M, Hoffman J (2014). Economic Evaluations of Clinical Pharmacy Services: 2006-2010. Pharmacotherapy , 34 (8), 771-93.
1176.Train, B.C., Bilgesu, S.A., Despeaux, E.C., Vongsutilers, V. & Gannett, P.M. (2014). Single C8-Arylguanine Modifications Render Oligonucleotides in the Z-DNA Conformation under Physiological Conditions Chemical Research in Toxicology, 27 (), 1176-1186.
1177.Trivedi M, Zhang Y, Lopez-Toledano M, Clarke A, Deth R. (2016). Differential neurogenic effects of casein-derived opioid peptides on neuronal stem cells: implications for redox-based epigenetic changes. J Nutr Biochem. , 37 (), 39-46.
1178.Trivedi MS, Deth RC (2015). Redox-based Epigenetic status in Drug Addiction: Potential mediator of drug-induced gene priming phenomenon and use of metabolic intervention for symptomatic treatment in drug addiction. Frontiers in Neuroscience, 8 (), 444.
1179.Trivedi MS, Hodgson NW, Walker SJ, Trooskens G, Nair V, Deth RC (2015). Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutr Metab (Lond), 12 (), 54.
1180.Trivedi, M. S., Oltra, E., Sarria, L., Rose, N., Beljanski, V., Fletcher, M. A., & Nathanson, L. (2018). Identification of myalgic encephalomyelitis/chronic fatigue syndrome-associated DNA methylation patterns. PloS one, 13 (7), .
1181.Tuteja S, Pyrsopoulos NT, Wolowich WR, Khanmoradi K, Levi DM, Selvaggi G, (2008). Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation. Pharmacotherapy, 28 (9), 1188-93.
1182.Tuteja, S., Prysopoulos, N., Wolowich, W.R., Khamoradi, K., Levi, D., Selvaggi, G., Weisbaum, G., Tzakis, A.G., Schiff, E.R. (2008). Simvastatin/Ezetimibe (Vytorin) Induced Hepatic Failure Necessitating Liver Transplantation. Pharmacotherapy, 28 (9), 1188-1193.
1183.UD Kandalam, AMI Cabel, H Omidian, EJ Stelnicki (2012). Viability of Human Umbilical Cord-Derived Mesenchymal Stem Cells in G-rich and M-rich Sodium Alginates Journal of Bioactive and Compatible Polymers, 27 (2), 174-182.
1184.UD Kandalam, H Omidian, MA Mirza, and AMI Cabel (2016). Comparative Assessment of Growth Supporting Potential of Different Alginic Acid Salts International Journal of Polymeric Materials, 67 (1), 47-53.
1185.Unger NR, Campbell K. (2010). Use of angiotensin-converting enzyme inhibitors and angiotension receptor blockers in chronic kidney disease. The Journal of the Florida Osteopathic Medical Association, (Winter), 13-16.
1186.Unger NR, Gauthier TP, Cheung LW (2013). Penicillin skin testing: implications for antimicrobial stewardship programs. Pharmacotherapy, 33 (8), 856–867.
1187.Unger NR, Osiyemi OO, Richardson RM, Menajovsky J, Kuretski J. (2014). Ceftaroline and gentamicin for the treatment of Daptomycin-non-susceptible methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis in a pregnant patient. JMM Case Reports, 1 (2), .[website]
1188.Unger NR, Ritter E, Borrego R, Goodman J, Osiyemi OO (2014). Antibiotic susceptibilities of bacteria isolated within the oral flora of Florida blacktip sharks: guidance for empiric antibiotic therapy. PLoS One, 9 (8), .[website]
1189.Unger NR, Stein B (2014). Effectiveness of preoperative cefazolin in obese patients. Surgical Infections , 15 (4), 412-6.
1190.Unger NR, Worley MV, Kisgen JJ, Sherman EM, Childs-Kean LM (2016). Elvitegravir for the treatment of HIV Expert Opin Pharmacother, 17 (17), 2359-70.
1191.V Najafi, F Ziaee, E Ahmadi, H Sedaghat, H Omidian (2018). Polyaniline-modified TiO2, a highly effective photo-catalyst for solid-phase photocatalytic degradation of PVC Journal of Polymers and Environment, (), submitted.
1192.V Najafi, K Kabiri, F Ziaee, H Omidian, MJ Zohuriaan-Mehr, H Bouhendi (2012). Synthesis and Characterization of Alcogels Based on (Ethylene Glycol Methyl Ether Methacrylate-Vinyl Phosphonic Acid) Copolymers Journal of Polymer Research, 19 (6), 1-7.
1193.Valero, T.R., Sturchler, E., Jafferjee, M., Rengo, G., Magafa, V., Cordopatis, P., McDonald, P., Koch, W.J., Lymperopoulos, A. (2016). Structure–activity relationship study of angiotensin II analogs in terms of beta-arrestin-dependent signaling to aldosterone production. Pharmacol. Res. Perspect. , 4 (), e00226.
1194.Vallejos X, Benavides S. (2013). The Patient Protection and Affordable Care Act: Implications for pediatric pharmacy practice. Ann Pharmacother, 47 (7-8), 1075-1078.[website]
1195.Van M, Bello C (1999). Osteoarthritis. Florida Pharmacy Today, 64 (2), 10-13,24.
1196.Van M, Chang A, Bello C (1999). Rosiglitazone-Avandia. The Practice News, 3 (5), 2-3.
1197.Vanessa Hörman, James Kumi-Diaka, Marcia Durity and Appu Rathinavelu (2012). Anticancer Activities of Genistein-Topotecan combination in Prostate Cancer Cells J Cellular and Molecular. Medicine, 16 (11), 2631 - 2636.
1198.Vanessa Hörmann, Sivanesan Dhandayuthapani, James Kumi-Diaka and Appu Rathinavelu. (2013). Activation of the intrinsic-apoptotic pathway in LNCaP prostate cancer cells by genistein-topotecan combination treatments. Journal of Functional Food in Health and Disease, 3 (3), 66-79.
1199.Veronin, M.A., Clauson, K.A. (2007). Internet pharmacy drugs delay treatment for congestive heart failure. Journal of the American Pharmacists Association, 47 (4), 436-42.
1200.Veronin, M.A., Clauson, K.A. (2007). Internet pharmacy drugs delay treatment for congestive heart failure [letter]. Journal of the American Pharmacists Association, 47 (4), 436-42.
1201.Viera, A. J., Choksi, R. R., Conrad, J. L. (2004). Prescribing to preserve or restore sexual function: side effects associated with psychotropics and treatments shown to alleviate them. Current Psychiatry, 3 (3), 57-58,64-66,71-73,76.
1202.Visus, C., Ito, D., Dhir, R., Szczepanski, M.J., Chang, Y.J., Latimer, J.J., Grant, S.G., and Deleo, A.B. (2011). Identification of hydroxysteroid (17ß) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinoma. Cancer Immunology Immunotherapy, 60 (7), 919-929.
1203.Vongsutilers, V. & Gannett, P. M. (2018). C8-Guanine modifications: effect on Z-DNA formation and its role in cancer Organic & Biomolecular Chemistry, 16 (), 2198-2209.
1204.W.O Berndt and R.A. Ansari (1990). Nephrotoxicity of Metals:Effects on plasma membrane function Toxicology Letters, 53 (), 87-92.
1205.Waly M, Power-Charnitsky V-A, Hodgson N, Sharma A, Audhya T, Zhang Y and Deth R (2016). Alternatively Spliced Methionine Synthase in SH-SY5Y Neuroblastoma Cells: Cobalamin and GSH Dependence and Inhibitory Effects of Neurotoxic Metals and Thimerosal. Oxidative Medicine and Cellular Longevity , 2016 (), 6143753.
1206.Ward C. T., Chavalitanonda, N. (2006). Atypical Warfarin-Induced Skin Necrosis. Pharmacotherapy, 26 (8), 1175-1179.
1207.Ward C. T., Garrett, S. D., & Marsh, W. A. (2006). Does instructor presence in the classroom influence examination scores in a therapeutics course delivered via interactive video-conferencing technology? Pharmacy Education, 6 (2), 119-123.
1208.Ward C. T., McKoy, Y., Rodriguez, M. A. (2000). Aggrenox: Old Antiplatelets with a New Twist. P&T, 25 (12), 660-663.
1209.Ward C. T., Nemire R.E., Daniel K. (2005). The Development and Assessment of a Medical Mission Elective Course American Journal Pharmacy Education, 69 (3), Article 50.
1210.Ward C. T., Rey, J. A., Mobley, W. C., Evans, C. (2003). Establishing a distance learning site for a traditional, entry-level, Doctor of Pharmacy program. Am J Pharm Educ, 67 (), 153-159.
1211.Weinstock-Guttman B, Badgett D, Patrick K, Hartrich L, Santos R, Hall D, Baier M,Fleitcher J, Ramanathan M. (2003). Genomics Effects of IFN-b in Multiple Sclerosis Patients. Journal of Immunology, 171 (5), 2694-2702.
1212.Weinstock-Guttman,B., Hong, J., Santos, R.,Tamano-Blanco,M., Badgett, D., Patrick,K.,Baier,M.,Ramanathan M. (2006). Interferon-beta Modulates Bone-Associate Cytokines and Osteoclast Precursor Activity in Multiple Sclerosis Patients. Multiple Sclerosis, 12 (5), 541-550.
1213.Wend, P., Runke, S., Wend, K., Anchondo, B. Yesayan, M. Jardon, Hardie, Loddenkemper, Ulasov, Lesniak, Wolsky, Grant, Latimer Miranda-Carbo (2012). WNT10beta-catenin singnaling induces HMGA1 and proliferation in metastatic triple negative breast cancer EMBO Molecular Medicine, ( ), .
1214.Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardan, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M.S., Wolsky, R., Bentolila, L.A., Grant, S.G., Elashoof, D., Lehr, S., Latimer, J.J., Bose, S., Sattar, H., Krum, S.A., and Miranda-Carboni, G.A. (2013). WNT10B/beta-catenin signaling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Molecular Medicine, 5 (), 1-16.
1215.Wenger, S.L., Senft, J.R., Sargent, L.M., Bamezai, R., Bairwa, N., & Grant, S.G. (2004). Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. BioScience Reports, 24 (6), 631-639.
1216.Wilkening LG, Hale GM, & Ross C (2016). Urine drug screens: considerations for the psychiatric pharmacist. Mental Health Clinician: Pharmacokinetics in Psychiatry and Neurology, 6 (1), 42-47.[website]
1217.Williams CA, Khanfar NM, Harrington CA, Loudon D. (2011). Marketing Retail Health Clinics: Challenges and Controversies Arising From a Healthcare Innovation. Health Marketing Quarterly, 28 (3), 270-285.
1218.Williams, S.C., Grant, S.G., Reue, K., Carrasquillo, B., Lusis, A.J., & Kinniburgh, A.J. (1989). cis-Acting determinants of basal and lipid-regulated apolipoprotein A-IV expression in mice. Journal of Biological Chemistry, 264 (32), 19009-19016.
1219.Wine JN, Khanfar NM (2008). Sunny View Memorial Hospital: A Day in the Life of a Busy Hospital Pharmacy. Medication Errors, Managers, and Missing Medications, Oh My! Journal of the International Academy For Case Studies, 14 (5), 130-134.
1220.Wine JN, Sanda C, Caballero J (2009). Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions. Annals of Pharmacotherapy, 43 (4), 707-713.[website]
1221.Wollenberg, L.A., Jett, J.E., Wu, Y., Flora, D.R., Wu, N., Tracy, T.S. & Gannett, P.M. (2012). Selective Filling of a Nanowell Array in Nanowell Arrays Fabricated Using Polystyrene Nanosphere Lithography with Cytochrome P450 Enzymes Nanotechnology, 23 (385101), 385101.
1222.Wollenberg, L.A., Kabulski, J.L., Powell, M.J., Chen, J., Flora, D.R., Tracy, T.S., & Gannett, P.M., (2014). The use of immobilized cytochrome P4502C9 in PMMA-based plug-flow bioreactor for the production of drug metabolites Applied Biochemistry and Biotechnology, 172 (), 1293-1306.
1223.Wolowich WR, Casavant MJ, Walson P, Hadley C. (2003). The Oral Absorption of Methyl Salicylate from Topical Preparations. Journal of Toxicology, Clinical Toxicology, 41 (4), 355-358.
1224.Wolowich WR, Casavant MJ, Fisher CA. (2001). Age-specific and age-adjusted penetrance as poison center outcome measures. J Toxicol Clin Toxicol, 39 (4), 367-70.
1225.Wolowich WR, Perkins AJ, Cienki, JJ. (2006). Psychoactive kappa opioid agonist Salvinorin A content in the herbal product Salvia divinorum. Pharmacotherapy, 29 (9), 1268-1272.
1226.Wolowich WR, Raymo L, Rodriguez JC. (2005). Problems with the use of the modified diet in renal disease formula to estimate renal function. Pharmacotherapy, 25 (9), 1283-84.
1227.Wolowich WR, Steinberg JG. (2012). External validation of aminoglycoside models used in web calculators and clinical decision support systems after laboratory conversion to serum creatinine isotope dilution mass spectrometry assay. Clin Ther, 34 (4), 803-10.
1228.Wolowich, W.R., Casavant, M.J. (2000). Toxic acetaminophen doses are toxic or do you know where your acetaminophen is today? Pharmacotherapy, 20 (7), 862.
1229.Wolowich, W.R., Casavant, M.J., Fisher, C.A. (2001). Age-specific and age-adjusted penetrance as poison center outcome measures. Journal of Toxicology, Clinical Toxicology, 39 (4), 367-370.
1230.Wolowich, W.R., Ekins, B.J., Casavant, M.J. (2001). Phenylpropanolamine and hemorrhagic stroke. New England Journal of Medicine, 344 (14), 1094-1095.
1231.Worton, R.G., Grant, S.G., & Duff, C. (1984). Gene inactivation and reactivation at the emt locus in Chinese hamster cells. Progress in Cancer Research and Therapy, 30 ( ), 265-272.
1232.Wright E, Khanfar NM, Harrington C, Kizer LE (2010). The Lasting Effects of Social Media Trends on Advertising. Journal of Business and Economics Research, 8 (11), 73-80.
1233.Wu, WM., Lai, L. (2008). Prospective of Taiwan Pharmacy Education. The Journal of Taiwan Pharmacy, 24 (4), 61-67.
1234.Xu, X. and Malave, A. (2001). Protective Effect of Berberine on Cyclophosphamide-Induced Haemorrhagic Cystitis in Rats Pharmacology and Toxicology, 88 (), 232-237.
1235.Xu, X., Cubeddu, L.X., & Malave, A. (2001). Expression of Inducible Nitric Oxide Synthase in Primary Culture of Rat Bladder Smooth Muscle Cells by Plasma from Cyclophosphamide-Treated Rats European Journal of Pharmacology, 416 (), 1-9.
1236.Xu, X., and Malave, A. (2000). p38 MAPK but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells Life Sciences, 67 (26), 3221-3230.
1237.Xudong Yuan, A.C. Capomacchia (2005). Effects of Eutectic Binary Mixtures and Formulations of NSAIDs on the enhanced Membrane Transport Journal of Pharmaceutical Development and Technology, 10 (1), 1-10.
1238.Xudong Yuan, Hwee-ling Koh, Wai-keung Chui (2005). A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and glycyrrhizin in tablets of a Herbal Medicine Journal of Pharmaceutical and Biomedical Analysis, 39 ((3-4)), 697-704.
1239.Xudong Yuan,Ling Li,Appu Rathinavelu,Jinsong Hao,Madhusudhanan Narasimhan, Matthew He,Viviene Heitlage,Linda Tam,Sana Viqar, and Mojgan Salehi (2006). siRNA Drug Delivery by Biodegradable Polymeric Nanoparticles Journal of Nanoscience and Nanotechnology, 6 (), 1-8.
1240.Y Joshi, D Mastropietro, H Omidian (2013). Enhanced Bioavailability via Extended Gastric Retention Journal of Developing Drugs, 2 (2), 105.
1241.Y Joshi, D Mastropietro, S Muppalaneni, H Omidian (2015). A New Approach to Determining the Performance of Superdisintegrants, Journal of Bioactive and Compatible Polymers, 30 (1), 1-14.
1242.Y Joshi, S Muppalaneni, A Omidian, D Mastropietro, H Omidian (2018). Determining Abuse Deterrence Performance of Poly(Ethylene Oxide) Using A Factorial Design Advanced Pharmaceutical Bulletin, 8 (3), 495-505.
1243.Y. M. Kwon, H. Chung, C. Moon, J. Yockman, Y. J. Park, S. Gitlin, A. David, & V. C. Yang (2009). L-Asparaginase Encapsulated Intact Erythrocytes for Treatment of Acute Lymphoblastic Leukemia (ALL). Journal of Controlled Release, 139 (), 182-9.
1244.Y. M. Kwon, H. Chung, C. Moon, J. Yockman, Y. J. Park, S. Gitlin, A. David, & V. C. Yang (2009). L-Asparaginase Encapsulated Intact Erythrocytes for Treatment of Acute Lymphoblastic Leukemia (ALL). Journal of Controlled Release, 139 (), 182-9.
1245.Y. M. Kwon, H. Chung, C. Moon, J. Yockman, Y. J. Park, S. Gitlin, A. David, & V. C. Yang (2009). L-Asparaginase Encapsulated Intact Erythrocytes for Treatment of Acute Lymphoblastic Leukemia (ALL). Journal of Controlled Release, 139 (), 182-9.
1246.Y. Zhang, N.W. Hodgson, M.S. Trivedi, H.M. Abdolmaleky, & R.C. Deth (2016). Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PloS One , 11 (1), .[website]
1247.Y. Zhang, N.W. Hodgson, M.S. Trivedi, H.M. Abdolmaleky, & R.C. Deth (2016). Neuregulin 1 Promotes Glutathione-Dependent Neuronal Cobalamin Metabolism by Stimulating Cysteine Uptake Oxidative Medicine and Cellular Longevity, 2016 (), .[website]
1248.Yang T, Fogarty B, LaForge B, Aziz1 S, Pham1 T, Lai, L., Bai S. (2016). Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-secreted Exosome Nanovesicles for the Treatment of Brain Cancer. The AAPS Journal, (), .
1249.Yang T., Nyiawung D., Silber Al, Jao J.,Lai, L., Bai S. (2012). Comparative Studies on Chitosan and Polylactic-co-glycolic Acid Incorporated Nanoparticles of Low Molecular Weight Heparin. AAPS Pharm Sci Tech, 13 (4), 1309-1318.
1250.Yang, C-W., Rathinavelu, A. Borowitz, J.L and Isom, G.E. (1994). Activation of Calcium and pH dependent Phospholipase A2 by Cyanide in Neuronal Model. Toxicol. Appl. Pharmacol., 124 (), 262-267.
1251.Ye, Q., M.Trivedi., Zhang. Y., Bohlke. M., Alsulimani. H., Chang. J., Maher. T., Deth. R., Kim. J. (2018). Brain iron loading impairs DNA methylation and alters GABAergic function in mice. FASEB J., 2018 (7), .
1252.Yellela S.R. Krishnaiah (2010). Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs Journal of Bioequivalence & Bioavailability, 2 ( ), 28-36.[website]
1253.Yellela S.R. Krishnaiah (2009). Bioequivalence of Follow-on Biologics or Biosimilars Journal of Bioequivalence & Bioavailability , 1 ( ), i-ii.[website]
1254.Yuan, X., Chui, W.K. (1998). RP-HPLC Analysis for Active Constituents In some Chinese Herbal Medicine . The European Journal of Phytomedicine, 1 (1), .
1255.Yuan, X., McCall. J.C., et al. (2003). An improved HPLC Analysis for the Quantitation and Stability Studies of Carbamazepine Tablets . Analytical Letters, 36 (6), .
1256.Yugandhar, V.G. and Clark, M.A. (2013). Angiotensin III: A Physiological Relevant Peptide of the Renin Angiotensin System. Peptides, 46C (), 26-32.
1257.Zang T, Pottenplackel LP, Handy DE, Loscalzo J, Dai S, Deth RC, Zhou ZS and Ma J. (2016). Comparison of Protein N-Homocysteinylation in Rat Plasma under Elevated Homocysteine Using a Specific Chemical Labeling Method. Molecules, 21 (), 1195.
1258.Zapantis A (2002). Ortho Evra: A new dose form for hormonal cntaceptions therapeutic update American Academy of Family Physicians, ( ), .
1259.Zapantis A, Lacy MK, Horvat RT, et al. (2005). Nationwide Antibiogram Analysis using the NCCLS M39-A Guidelines Journal of Clinical Microbiology, 43 (6), 2629-2634.
1260.Zapantis A, Leung S. (2005). Tolerance and Withdrawal Issues with Sedation Critical Care Nursing Clinics of North America, 17 (3), 211-223.
1261.Zapantis A, Lopez M, Hoffman E, Lopez A, Hamilton G (2007). The use of colistin in multi-drug resistant infections. Hospital Pharmacy, 42 (12), 1127-1138.
1262.Zapantis A, Machado C, Nemire RE, Leung S (2008). The development and assessment of an an elective course in adult acute care medicine using a hybrid delivery system American Journal of Pharmacy Education, 72 (5), 105.[website]
1263.Zapantis A, Maniscaolco-Feichtl M (2008). Teaching in a distance education program. American Journal of Health-Systems Pharmacy, 65 (10), 912-920.
1264.Zapantis A, Singh-Franco D. (2013). Impact of a Practice-Based Learning Elective Course on Student Pharmacists and Post-Graduates. American Journal of Health-System Pharmacy, 70 (8), 658-660.[website]
1265.Zapantis A, Steinberg JG, Schilit L (2012). Use of Herbals as Galactagogues. Journal of Pharmacy Practice, 25 (2), 222 - 231.
1266.Zapantis, A. (2008). Ortho Evra: A New Dose Form for Hormonal Contraception Therapeutic Update, Home Study Self-Assessment Program. American Academy of Family Physicians, (), .
1267.Zayas-Rivera, B., Zhang, L., Grant, S.G., Keohavong, P., & Day, B.W. (2001). Mutational spectrum of N-hydroxy-N-acetyl-4-aminobiphenyl at exon 3 of the HPRT gene. Biomarkers, 6 (4), 262-273.
1268.Zgarrick, D.P., McHugh, P.P., Droege, M. (2006). Prevalence and Interest in Unionization Among Staff Pharmacists Research in Social and Administrative Pharmacy, 2 (3), 329-346.
1269.Zhang Y, Hodgson N, Trivedi M and Deth RC (2016). Neuregulin-1 promotes glutathione-dependent neuronal cobalamin metabolism by stimulating cysteine uptake. Oxidative Medicine and Cellular Longevity, 2016 (), 3849087.
1270.Zhang Y, Hodgson NW, M.Trivedi, Abdolmaleky HM, Deth RC et al (2016). Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia PLoS ONE, 11 (1), .
1271.Zhang Y, Hodgson NW, M.Trivedi, Abdolmaleky HM, Deth RC et al (2016). Neuregulin 1 Promotes Glutathione-Dependent Neuronal Cobalamin Metabolism by Stimulating Cysteine Uptake Oxidative Medicine and Cellular Longevity, (), .[website]
1272.Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fourniere M, Cuenod M, Quang Do K, Deth RC (2016). Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLOS One, 2016 (), e0146797.
1273.Zhong, Z., Dijkstra, P. J., Feijen, J., Kwon, Y. M., Bae, Y. H. & Kim, S. W. (2002). Synthesis and aqueous phase behavior of thermoresponsive biodegradable poly(D,L-3-methyl glycolide)-b-poly(ethylene glycol)-b-poly(D,L-3-methyl glycolide) triblock copolymers. Macromolecular Chemistry and Physics, 203 (), 1790-1796.
1274.Zohuriaan, M.J., Omidian, H., Doroudiani, S., & Kabiri, K. (2010). Non-hygienic Applications of Superabsorbent Hydrogel Polymers Journal of Materials Science, 45 ( ), 5711-5735.
1275.Zorilla, C., Rivera-Vinas, J., Pujols, A., Garcia-Garcia, I., Rabionet, S., Mosquera, A. (2018). The Zika Virus Infection in Pregnancy: Review and Implications for Research and Care of Women and Infants in affected areas. Puerto Rico Health Sciences Journal, 37 (), Accepted .
1276.Zorrilla, C., Sanchez, I., Mosquera, A., Sierra, D., Lopez, L., Rabionet, S., Rivera-Vinas, J. (2017). Improved Infant Outcomes with Group Prenatal Care in Puerto Rico. Source Journal of Obstetrics and Gynaecology, 1 (1), 1-9.
1277.Zorrilla, C.,Mosquera, A.M., Rabionet, S., Rivera-Vinas, J. (2016). HIV and ZIKA in Pregnancy : Parallel Stories and New Challenges. Obstetrics and Gynecology International Journal, 5 (6), .
1278.Zorrilla, C.D., Rabionet, S., Mosquera, A.M., and Ramirez de Arellano, A.B. (2012). Biomedical HIV prevention strategies: State of the art and implications for Public Health policy in the Caribbean. Puerto Rico Health Sciences Journal, 32 (3), .
1279.castejon (). , (), .
1280. (). Ownby RL, Acevedo A, Jacobs RJ, Caballero J, Waldrop-Valverde D. Quality of life, health status, and health service utilization related to a new measure of health literacy: FLIGHT/VIDAS. Patient Education and Counseling. 2014;96:404-410 , (), .
1281. (2013). Formulation development of albumin based theragnostic nanoparticles as a potential tumor targeting and delivery system Journal of Drug Targeting, 21 (1), 77-86.
1282. (2013). Formulation development of albumin based theragnostic nanoparticles as a potential tumor targeting and delivery system Journal of Drug Targeting, 21 (1), 77-86.
1283. (2006). Cryoetch And Cryo-planing For Low Temperature HRSEM: SE-I Imaging Of Hydrated Multicellular, Microbial And Bioorganic Systems Microscopy and Microanalysis, 12 (S02), 1120-1121.[website]
1284. (2014). Self-medication practices among a sample of Latino migrant workers in South Florida Frontiers in Public Health, 2 (), 1-7.
1285. (2007). Simultaneous chiral separation and determination of ephedrine alkaloids by MEKC-ESI-MS using polymeric surfactant I: Method development Electrophoresis, 28 (9), 1352-63..[website]
1286. (). A survey of new developments in tax-exemption law: what compliance officers need to know (Part II). CCH Tax-Exempt Advisor, (405), Report 405.
1287. (2013). Sorrell v. IMS Health: issues and opportunities for informaticians. J Am Med Inform Assoc, 20 (1), 35-37.[website]
1288. (). , (), .